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FOrEwOrd by AN TAOiSEACh
Problem drug use continues to be one of the most significant challenges facing our country.  It undermines 
the potential of the person involved, devastating the lives of families and causing huge problems for local 
communities. 
Much has changed since the first comprehensive National Drugs Strategy was put in place in 200.  At that time 
the emphasis was on the heroin problem in Dublin and it is heartening that much has been achieved in helping 
to tackle this problem. However, reflecting the situation generally in EU countries and beyond, problem drug use 
has spread to other areas and the range of drugs available has increased.  The challenge involved is complicated by 
the fact that drug use can be linked to circumstances of social exclusion as well as to circumstances of economic 
prosperity. 
It is against this background that I welcome this new National Drugs Strategy for 2009 - 206 prepared by John 
Curran, T.D., Minister of State, which has been developed in partnership with a wide range of Government 
Departments, Agencies, Community and Voluntary interests. 
Real partnership has been very evident across the initiatives of the National Drugs Strategy both at national level 
and at local level, especially through the work of the Drugs Task Forces.  I pay tribute to the continued efforts 
of those working in, and supporting, drug projects in local communities and acknowledge the huge contribution 
made by the community and voluntary sectors in this work. I note that this aspect of the Strategy will be retained 
and developed over the next eight years. 
I look forward to a renewed emphasis on prevention in the Strategy.  It is very important that the number of people 
who decide to experiment with drugs is reduced.  Such experimentation can lead to significant problems for many. 
When people develop problems, we must address their treatment needs effectively, with joined - up inter - agency 
working and with an emphasis on successful rehabilitative outcomes.
At a time of scarce resources, we all recognise the need to secure the maximum impact from the resources we 
invest through the National Drugs Strategy. The achievement of best value for money is to the ultimate benefit of 
individual problem drug users, their families and communities.
Finally, I also welcome the recent decision by Government to develop a National Substance Misuse Strategy that 
will combine a comprehensive response to alcohol issues with the provisions of the National Drugs Strategy.
BrianCowen,T.D.
Taoiseach 
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FOrEwOrd by MiNiSTEr OF STATE
On my appointment as Minister of State with responsibility for the National Drugs Strategy in May 2008, I 
immediately engaged in the consultation process in relation to a new Drugs Strategy.  In many ways it was a good 
time to become directly involved as plans for the next 8 years were being mapped out. 
If I needed any confirmation of the extent of the drugs problem, the consultation process provided it.  While the 
progress made under the 200 - 2008 Strategy was widely praised, and the partnership approach was seen as 
beneficial, it is clear that the drug problem has changed in the intervening period.  The significant contribution 
made to the Strategy by the community and voluntary sectors is also clear and I intend to build upon this for 
the future. The original Strategy grew out of the heroin problem in Dublin.  We now need a Strategy that is truly 
national and that is capable of dealing with a variety of drugs, often mixed by polydrug users.
In the new Strategy the successful emphasis on a partnership approach will be renewed.  I have decided that we 
will retain the 5 pillars of the Strategy - supply reduction, prevention, treatment, rehabilitation and research - as 
these have served us well and still encompass the areas that need to be addressed.  This will also facilitate the 
dovetailing of the Strategy with the provisions of the EU Drugs Action Plan 2009 - 202.
If we could achieve more in regard to prevention, I believe that the impact on the overall problem would be greatly 
enhanced.  We will continue to bring the prevention message to the general public, especially young people and 
their parents, while also endeavouring to target those who are at particular risk.  Supply reduction measures will 
incorporate international co - operation, an emphasis on targeting criminal networks and encouraging community 
involvement.  Meanwhile, the aim is to further develop treatment and rehabilitation services, with an emphasis 
on an appropriate mix of drug - free and harm reduction services, ranging from low key interventions to specialist 
expertise across the sectors.  Drugs research will address the information needs of Government and the provision 
of information to national and international agencies.  
Across all pillars we will maintain the focus on individuals, their families and communities.  I feel that it is vital that 
we support the families of problem drug users and, also, that we encourage their involvement on the rehabilitative 
effort.  In relation to the problem drug users themselves, I think that we must always endeavour to empower 
people to access the social, economic and cultural benefits of life in line with their needs and aspirations.
I would like to thank all the Government Departments, statutory agencies, sectoral representatives and 
organisations, focus groups and individuals for their time and effort in putting forward their ideas and views on 
how best to address the drugs problem in Ireland.  Continuation of this partnership approach is vital to achieve 
the implementation of the actions of the Strategy and I will continue to facilitate this.
I also want to thank the Steering Group, chaired by Ms. Kathleen Stack, who worked tirelessly in developing 
proposals and making recommendations to me on the new Strategy.  The input of the staff of the Drugs Strategy 
Unit of the Department of Community, Rural and Gaeltacht Affairs, the National Drugs Strategy Team and all 
Drugs Task Forces across the country is also greatly appreciated.
Tackling the drugs problem in Ireland is an onerous task but I am determined that, working together and building 
on the progress already achieved, we will make great strides forward over the coming years. 
JohnCurran,T.D.
Minister of State with responsibility for the National Drugs Strategy
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ExECuTivE SuMMAry
In late 2007, a review of the National Drugs Strategy 200–2008 got underway.  The overall objective of the 
review was to examine the progress and impact made under the current Strategy and to make recommendations 
for the period 2009–206, which the new Strategy will cover. A Steering Group, chaired by the Department of 
Community, Rural and Gaeltacht Affairs, managed and oversaw the process. 
An extensive consultation process was undertaken as part of the review to give individuals and groups an 
opportunity to outline their views on the effectiveness of the current policy and what the priorities for the new 
Strategy should be.  An overview of the issues raised under the different areas – which the Steering Group had 
regard to in their deliberations - is outlined in the various chapters. 
A key finding from the review is that the current approach to tackling problem drug use in Ireland – which 
has developed around the five pillars of supply reduction, prevention, treatment, rehabilitation and research 
– continues to be relevant and appropriate. The proposals and actions under the new Strategy, therefore, are 
based around the existing pillar structure.  
The Steering Group also had regard to the current nature and scale of the drug problem in Ireland, which has 
undergone some notable changes over the lifetime of the current Strategy.  The primary focus when the current 
policy was drawn up in 200 was on the opiate problem, primarily in Dublin.  While the prevalence of heroin has 
ameliorated to an extent in the Dublin area, this has been offset to a degree by its wider dispersal around the 
country.  In addition, there is now widespread public concern regarding the misuse of cocaine, particularly when 
combined with other illegal substances and alcohol.  
Widespread public concern was also expressed during the consultation process about the problem use of alcohol 
– both as a stand - alone public health issue and in association with illicit drugs.  On 3st March 2009, the 
Government approved the development of a combined National Substance Misuse Strategy to cover both alcohol 
and drugs.  This Report is, therefore, an interim Strategy pending the development of the combined Strategy.  This 
is due to be developed by the end of 200 and will incorporate the material in this Report, which is the agreed 
drugs element of it.  
As part of its terms of reference, the Steering Group also looked at the effectiveness of the structures and co 
- ordination mechanisms supporting the current Strategy.   To facilitate greater coherence in policy - making and 
service delivery, the establishment of a dedicated Ministerial Office for Drugs is being recommended, the details 
of which are outlined in chapter 6.  
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NATiONAl drugS 
STrATEgy 2009 - 2016 
The conclusions and priorities identified by the 
Steering Group are set out in chapters –6 of this 
Report.  In light of this analysis, the Steering Group has 
identified a series of objectives and key performance 
indicators across the five pillars of supply reduction, 
prevention, treatment, rehabilitation and research. 
Allied to this, the Steering Group has developed 63 
actions that are designed to drive the implementation 
of the new Strategy.  A number of the actions also 
relate to the co - ordination structures, in particular, 
to the establishment of an Office of the Minister for 
Drugs.  
The 63 individual actions are set out in detail in 
chapter 7.
Implementation of the actions will be a matter for the 
Departments and agencies involved in the delivery of 
drugs policy.  Their implementation will be overseen 
by the Office of the Minister for Drugs, supported by 
the Oversight Forum on Drugs, as appropriate. 
Departments and agencies will also prepare a report 
by the end of 2009 detailing how each of their actions 
will be implemented with indicative timelines.  
OverAllSTrATegiCOBJeCTive
The overall strategic objective for the National Drugs 
Strategy 2009–206 is:
To continue to tackle the harm caused to 
individuals and society by the misuse of drugs 
through a concerted focus on the five pillars 
of supply reduction, prevention, treatment, 
rehabilitation and research.
OverAllSTrATegiCAimS
The following are the overall strategic aims of the 
Strategy:
n	 To create a safer society through the 
reduction of the supply and availability of 
drugs for illicit use;
n	 To minimise problem drug use throughout 
society;
n	 To provide appropriate and timely 
substance treatment and rehabilitation 
services (including harm reduction 
services) tailored to individual needs;
n	 To ensure the availability of accurate, 
timely, relevant and comparable data 
on the extent and nature of problem 
substance use in Ireland; and
n	 To have in place an efficient and effective 
framework for implementing the National 
Substance Misuse Strategy 2009 - 206. 
OBJeCTiveSANDKeyPerfOrmANCe
iNDiCATOrS
SuPPlyreDuCTiON
Objectives 
n	 To significantly reduce the volume of illicit 
drugs available in Ireland; 
n	 To prevent the emergence of new markets 
and the expansion of existing markets for 
illicit drugs; 
n	 To disrupt the activities of organised criminal 
networks involved in the illicit drugs trade in 
Ireland and internationally and to undermine 
the structures supporting such networks; 
n	 To target the income generated through illicit 
drug trafficking and the wealth generated by 
individuals involved in the illicit drugs trade; 
and
n	 To tackle and reduce community drug 
problems through a co - ordinated, inter - 
agency approach. 
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Key Performance Indicators 
n	 Increase of 25% in the number of supply 
detection cases by 206, based on 2008 
figures; 
n	 Increase of 25% in the volume of drugs seized 
that are considered to be intended for the Irish 
market by 206, based on 2008 figures; and
n	 Twenty Local Policing Fora established and 
operating by 202. 
PreveNTiON
Objectives
n	 To develop a greater understanding of the 
dangers of problem drug/alcohol use among 
the general population; 
n	 To promote healthier lifestyle choices among 
society generally; and  
n	 To prioritise prevention interventions on those 
in communities who are at particular risk of 
problem drug/alcohol use.
Key Performance Indicators
n	 Decrease in the number of opiate users in 
Dublin area and stabilisation of opiate users in 
rest of country by 20;
n	 Stabilisation in recent, and reduction in current 
prevalence of illicit drugs in 5 - 34 population 
(Drug Prevalence Survey 200/20); 
n	 Reduction in numbers engaged in poly - drug 
use (Drug Prevalence Survey 200/20);
n	 Reduction of level of drug misuse reported 
by school students (regular survey results and 
ESPAD Survey 20);
n	 Delaying the age of first use of illicit drugs 
(ESPAD Survey 20); 
n	 Delaying the age of first drink and reduction in 
binge drinking among young people (ESPAD, 
National Prevalence Survey, HBSC Surveys); 
and 
n	 Reduction in the Early School Leaving figures 
from .5% (2007) to 0% by 202, utilising 
the widely recognised definition of ‘early 
school leaver’ used by Eurostat.  
    The proportion of persons aged 8 to 24 years whose highest level 
of education attained is lower secondary or below, and who did 
not receive either formal or non - formal education in the previous 
four weeks.
TreATmeNT&rehABiliTATiON
Objectives
n	 To develop a national integrated treatment 
and rehabilitation service that provides drug 
free and harm reduction approaches for 
problem substance users; and 
n	 To encourage problem substance users to 
engage with, and avail of, such services.
Key Performance Indicators
n	 00% of problem drugs users accessing 
treatment within one month of assessment by 
202;
n	 00% of problem drugs users aged under 
- 8 accessing treatment within one week of 
assessment by 202;
n	 25% increase in residential rehabilitation 
places by 202 based on 2008 figures; 
n	 25% increase in Hepatitis C cases among drug 
users treated by 202; and
n	 Put a drugs interventions programme in place 
by 202, incorporating a treatment referral 
option, for people who come to the attention 
of An Garda Síochána and the Probation 
Service due to behaviour caused by substance 
misuse.  
reSeArCh
Objectives
n	 To ensure the availability of data to accurately 
inform decisions on initiatives to tackle 
problem substance use; and
n	 To provide appropriate research to fulfil 
the information needs of Government in 
formulating policies to address problem 
substance use. 
Key Performance Indicators
n	 EMCDDA indicators developed on the extent 
and nature of problem drug use in Ireland; 
n	 Comprehensive and timely reporting systems 
in place for:
 (i)  treatment and rehabilitation; and
 (ii)   progression of offenders with drug - 
related offences through the criminal 
justice system
n	 Completion of identified research programme 
by the NACD.
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CO-OrDiNATiON
Objectives 
n	 To bring greater coherence to the co - 
ordination of substance misuse policy in 
Ireland across all sectors; and 
n	 To maintain and strengthen partnerships 
with communities to tackle the problems of 
substance misuse. 
Key Performance Indicators
n	 Establishment of the Office of the Minister for 
Drugs by mid 2009; and
n	 Development of an overall performance 
management framework by end 200. 
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iNTrOduCTiON 
Role of the Steering Group 
In late 2007, the then Minister of State with 
responsibility for the National Drugs Strategy, Pat 
Carey, T.D. established a Steering Group to develop 
proposals and make recommendations for a 
new National Drugs Strategy covering the period 
2009–206.  The Group was chaired by the Department 
of Community, Rural and Gaeltacht Affairs and was 
made up of representatives of the key Departments 
and agencies involved in delivering the current NDS, 
as well as representatives from the community & 
voluntary sectors.  The full membership of the Group 
is set out in Appendix . 
The terms of reference of the Steering Group were as 
follows:
n	 Examine the progress and impact of the 
National Drugs Strategy 200 - 2008 across 
the five pillars of supply reduction, prevention, 
treatment, rehabilitation and research in the 
context of the objectives, key performance 
indicators and actions set out therein; 
n	 Examine the relevance of the current Strategy 
in tackling the current nature and extent 
of problem drug use in Ireland, including 
emerging trends and cross - cutting issues, 
and identify any gaps presenting and indicate 
how they might be addressed;
n	 Review the operational effectiveness of the 
structures of the National Drugs Strategy, 
including co - ordination mechanisms; 
n	 Examine developments in drugs policies, and 
in dealing with problem drug use generally, at 
EU and international level;
n	 In light of the foregoing, to consider how a 
new Strategy, to cover the period 2009 - 206, 
should address problem drug use, including 
the structures through which this would be 
done;
n	 Develop performance indicators to measure 
the future effectiveness of the new Strategy; 
and
n	 Make recommendations for a new Strategy 
to the Minister of State and, subsequently, 
the Cabinet Committee on Social Inclusion, 
Children and Integration by the end of 2008. 
The Steering Group was assisted in its work by 
independent consultants – PA Consulting Group – 
who reported on the consultation process (see below) 
and prepared a report for the consideration of the 
Group to assist it in its deliberations.  
Consultation Process 
As part of its work in developing a new Strategy, 
an extensive consultation process was undertaken 
in early to mid 2008.  This included the following 
elements:
(i)   written/e - mail submissions – an advertisement 
was placed in the national newspapers in late 
February 2008 inviting interested individuals or 
organisations to make submissions.  Relevant 
Departments and agencies were also written 
to inviting them to make submissions. In total, 
53 submissions were received – a full list of 
which are contained in Appendix 2. 
(ii)   public consultation meetings were held at 5 
locations around the country between late 
April and early June 2008 –– five in Dublin, 
and one in Athlone, Portlaoise, Galway, Sligo, 
Limerick, Kerry, Cork, Waterford, Gorey and 
Dundalk (see Appendix 3).  Total attendance 
over all of the meetings was just over ,200, 
giving an average of 80 approx.  The format 
for each session was identical in all locations 
with four key questions being posed:
n	 the key concerns surrounding the issue of 
drug use in the area/region; 
n	 what is working well within the current 
Strategy, 
n	 the main gaps in the current Strategy; and 
n	 the priorities for the future Strategy. 
A report on the key conclusions of each meeting 
was posted on the Department’s website – 
www.pobail.ie. 
(iii)  meetings with Departments/Statutory Agencies 
– in total 8 meetings were held with the 
relevant Departments and agencies during June 
and July 2008.  The aforementioned questions 
also formed the basis for these meetings.  A full 
list is contained in Appendix 4. 
(iv)   meetings with sectoral groups, organisations 
and focus groups– a full list of the groups and 
organisations with whom meetings were held 
is set out in Appendix 5
(v)   engagement with the Oireachtas – in 
September 2008 and in February 2009, 
Minister of State John Curran T.D. met with 
the Oireachtas Joint Committee on Arts, 
Sport, Tourism, Community, Rural & Gaeltacht 
Affairs to hear the views of Members on 
priorities for the new Strategy.  A Seanad 
debate was also held in June 2008 and this 
provided Senators with an opportunity to 
input into the new Strategy. 
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Following the completion of the consultation process 
and the work of the consultants, the Steering Group 
proceeded to analyse all the views and data presented 
before reaching the conclusions and recommendations 
set out in this Report.  
Background 
The current National Drugs Strategy (NDS)2, which 
was launched in 200, came to an end at the end 
of 2008.  The Strategy - which was Ireland’s first co 
- ordinated effort to address the issues of problem 
drug use - was delivered through five inter - connected 
pillars dealing with: 
n	 Supply reduction;
n	 Prevention (including education & 
awareness); 
n	 Treatment; 
n	 Rehabilitation (added as the fifth pillar after 
the Mid - Term Review of the Strategy in 
2005); and 
n	 Research.
In keeping with its terms of reference, the Steering 
Group, in this Report, examined the progress made 
under the current NDS across the different actions 
and have identified a number of areas that need to 
be prioritised in the new Strategy.  In developing its 
proposals, the Steering Group was influenced by a 
number of factors. 
In particular, it was cognisant of the fact that a key 
finding from the review is that the approach and 
rationale outlined in the current Strategy continues 
to be relevant and appropriate.  Consequently, the 
proposals outlined in this Report are based around the 
existing pillar structure, as identified above.  
In meeting the terms of reference, the Group also took 
account of:
n	 the various issues raised during the 
consultation process; and 
n	 new emerging trends such as the increased 
prevalence of cocaine and the increased 
prevalence of heroin outside of the eastern 
region. 
2   All references to the “current NDS” throughout this 
document refer to the National Drugs Strategy 200 
- 08.
These are outlined in more detail below. 
They also drew on:
n	 the work of the consultants (PA Consulting 
Group); 
n	 relevant research findings; and 
n	 the Group’s own experiences of working in 
the drugs field. 
Over the lifetime of the Strategy, there have been 
notable changes in the nature and scale of the drug 
problem.  While in 200 the Strategy was essentially 
concerned about problem opiate use, there is now 
widespread public concern regarding the misuse of 
cocaine, particularly when combined with other illegal 
substances, and alcohol, along with increased reports 
of problem polydrug use.  However, heroin remains a 
significant problem and a matter of serious concern 
for many communities.  
The 2006/07 Prevalence Survey3 is the best estimate 
of the national prevalence of problem drug use. 
Overall, the survey found that, while there had been 
an increase in recent (last year) drug use, current (last 
month) use had stabilised from the previous survey in 
2002/03.  It also confirmed:  
n	 that illegal drug use continues to be 
predominantly a younger adult phenomenon, 
with those under 35 accounting for the bulk 
of usage;  
n	 that males are twice as likely to use illegal 
drugs, although the rate of increase among 
females was significantly higher than that 
among males; and   
n	 the emergence of cocaine as a threat, 
particularly among younger adults.
The recently published 2007 European School Survey 
Project on Alcohol and other Drugs (ESPAD)4 study 
indicated that lifetime use for cannabis had stabilised 
(slight decrease from 20% to 9%) and that lifetime 
use for other illegal drugs, other than cannabis, had 
reduced (from 0% to 7%).  Current use of cannabis 
had also decreased (halved from 7% to 9%), while 
use of other illegal drugs had stabilised.  Since 2003, 
lifetime abstinence from all substances has virtually 
doubled from 6% to % in 2007.   
3   Drug Use in Ireland and Northern Ireland – 2002/2003 
and 2006/2007 – Drug Prevalence Surveys:  National 
Advisory Committee on Drugs & Public Health Information 
& Research Branch (PHIRB) in Northern Ireland.
4   Survey estimates the prevalence of drug use among 
school - going students in their 6th year.  Comparisons 
are between 2003 and 2007. 
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Heroin use continues to be concentrated primarily in 
areas of urban disadvantage in Dublin and in other 
urban centres, particularly in Leinster and the south of 
the country.  The prevalence of heroin has ameliorated 
to an extent in the Dublin area with a significant drop in 
the rate of new entrants identified.  However, this has 
been offset to a degree by its wider dispersal around 
the country.  Overall, the rate of new entrants to 
treatment had dropped significantly by approximately 
20% between 200/2 and 2006/07.  
The use of cocaine continues to grow, albeit from a 
small base, particularly among younger adults.  While 
it is a countrywide problem, it is most prevalent in 
Dublin, and in the east and south of the country. 
The high prevalence of poly - substance use is also a 
marked feature among those presenting to treatment 
services.  
Over and above the damaging health consequences 
for problem drug users, hugely damaging effects are 
caused by drug dealing, drug - related crime and anti 
- social behaviour which can undermine the stability 
of individuals, families and communities.  Significant 
concerns were raised during the consultation process 
about increased levels of intimidation within local 
communities across the country.  The nature and scale 
of intimidation has increased with families of drug 
users increasingly regarded as targets. The increase in 
intimidation is, in part, thought to be due to increased 
levels of drug - related debts, which are particularly 
associated with the rise in cocaine use.  
During the consultation process, there was also 
widespread public concern in relation to the problem 
use of alcohol - both as a stand - alone public health 
issue and in association with illicit drug use.  On 3st 
March 2009, the Government gave approval for the 
development of a combined National Substance 
Misuse Strategy to cover both alcohol and drugs. 
Chapter  deals with these developments and the 
issues arising therefrom.
In framing its recommendations, the Steering Group 
also had regard to the EU Action Plan on Drugs 
2009–202.  The Action Plan is centred on two key 
dimensions of drugs policy - demand reduction and 
supply reduction - complemented by three cross 
- cutting themes - co - ordination, international co - 
operation and information, research & evaluation.   
The Steering Group also noted that a key strength 
of the current NDS has been the bringing together 
of Departments, agencies and the community & 
voluntary sectors to develop a collective response to 
tackling the drugs problem.  The value and importance 
of this partnership approach is recognised and it will 
continue to underpin the implementation of the new 
Strategy over its lifetime. 
Finally, the Group was conscious of the changing 
economic circumstances in Ireland at present 
combined with proposals for public sector change and 
the impact that these developments may have on the 
extent and pace of implementation of the priorities 
and actions set out in this Report.   While this is outside 
the control of the Steering Group, keeping focus and 
maintaining momentum on the priorities identified is 
considered vital if Ireland is to continue to tackle the 
major challenge of drug misuse over the next 8 years.  
Structure of the Report 
The Steering Group’s Report is structured as follows: 
n	 Chapter  – looks at the development of 
a National Substance Misuse Strategy to 
include drugs and alcohol; 
n	 Chapters 2 to 5 of the Report review progress 
under the existing pillars of the NDS and 
outline what the priorities for the next 
Strategy should be;  
n	 Chapter 6 looks at structures and sets out the 
role and responsibilities of the new Office of 
the Minister for Drugs; and 
n	 Chapter 7 sets out the strategic aims and 
objectives of the new Strategy and details 
the priorities and actions - across the 5 pillars 
– that will support its implementation. 
3
CHAPTER  
INCLUSION OF 
ALCOHOL INTO 
A NATIONAL 
SUBSTANCE MISUSE 
STRATEGy
4
N
at
io
n
al
 D
ru
gs
 S
tr
at
eg
y 
 (
In
te
ri
m
) 
20
09
 -
 2
0
6
ChApTEr 1 
iNCluSiONOfAlCOhOliNTOA
NATiONAlSuBSTANCemiSuSe
STrATegy
iNTrODuCTiON
1.1   As outlined in the Introduction, during the 
extensive consultation process that was held 
during 2008, there was widespread public 
concern in relation to the problem use of 
alcohol - both as a stand - alone public health 
issue and in association with illicit drug use.  
1.2   Alcohol is frequently associated with many 
aspects of Irish social and cultural life and 
its use has become deeply woven into 
our national identity.  For many, alcohol is 
also seen as a gateway to illicit drug use, 
particularly for young people, while poly - 
drug use - which very often includes alcohol 
- is now the norm among illicit drug users.  
1.3   At the end of March 2009, the Government 
agreed to include alcohol in a National 
Substance Misuse Strategy, with individual 
Ministers (Health & Children and Community, 
Rural & Gaeltacht Affairs) being responsible 
for the aspects relevant to their respective 
briefs. 
1.4   While the Steering Group strongly welcomed 
this development, it was very conscious that 
developing a National Substance Misuse 
Strategy, which encompasses both drugs and 
alcohol, presents many challenges and will 
take a considerable period of time, given the 
nature of the public health and other issues 
that are involved.  In addressing the multiplicity 
of issues associated with the problem use of 
alcohol and drugs, it is also acknowledged 
that a number of complexities will arise as 
the new Strategy will be addressing both 
legal and illegal substances. 
1.5   At the same time, the Group recognised that 
a substantial amount of work had been done 
at that stage (by the end of March 2009) to 
advance the Drugs Strategy and it felt that 
it was important that this be allowed to 
progress to conclusion as quickly as possible. 
1.6   Accordingly, to implement the Government 
decision, the Steering Group adopted the 
following approach: 
n	 Work on completing the Drugs Strategy 
continued and the Report was approved by 
Government in June 2009.  In the context of 
polydrug use and alcohol issues, references 
within this document reflect the combined 
approach that is now Government policy.  This 
Strategy is being published as an “interim” 
Strategy pending the drafting and finalisation 
of a National Substance Misuse Strategy 
(which will operate until 2016). 
n	 A new Steering Group will be established 
in autumn 2009 to develop proposals for an 
overall National Substance Misuse Strategy 
that will incorporate the already agreed drugs 
policy element.  Membership of the Group will 
reflect the appropriate statutory, community/
voluntary and other relevant interests.  The 
Group will be jointly chaired by officials from 
the Department of Health and Children and 
the Office of the Minister for Drugs (see 
chapter 7).  The secretariat function will be 
shared between the two bodies.  The Group 
will be asked to report by the end of 200. 
1.7    An action is included in this Report - the new 
“interim” Drugs Strategy - to give effect to the 
above approach.  
1.8   The remainder of this chapter sets out the 
context and rationale for the need to address 
the problems caused by alcohol misuse in 
society.  It is intended to inform and direct 
the work of the new Steering Group to be 
established later in 2009 to develop proposals 
for an overall National Substance Misuse 
Strategy. 
Alcohol – No Ordinary Commodity
1.9   Alcohol is a drug and intoxicant which has 
significant pharmacological and toxic effects 
both on the mind and on almost every organ 
and system in the human body. Alcohol is 
implicated in numerous premature deaths 
every year from disease, accidents and 
violence. It has been shown to be causally 
related to more than 60 different medical 
conditions. The negative consequences of 
alcohol include harm to physical health, 
psychological well - being and relationships. 
These consequences impact on all facets of 
society, from the affected individuals and 
their families to the medical, social and 
legal resources of the State. These problems 
range from a once - off problem (fall, 
accident, fight, unprotected sex, violence, 
absence from work) to a recurring problem 
(poor school/work performance, financial 
hardship, relationship difficulties), chronic 
illness (cancer, liver damage) and to a 
sustained dependence (alcoholic disorder). 
Homelessness and domestic violence are also 
among the consequences of alcohol misuse. 
Some of these problems, especially the acute 
problems, arise where the light or moderate 
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drinker drinks to excess on a single drinking 
occasion, while others result from regular 
heavy drinking over a longer period of time.
Alcohol Consumption in Ireland
1.10 Alcohol consumption trends and patterns are 
important from a public policy point of view. 
Alcohol consumption in Ireland has increased 
significantly over recent decades. There has 
been a marked rise in consumption levels 
from the mid - 990s which peaked in 200 
at 4.3 litres of pure alcohol per person aged 
5 and over. The overall consumption rate 
decreased to 3.4 litres by 2007 and fell to 2.8 
litres (provisional) in 20085.  Although there 
is a decrease in consumption from the peak 
in 200, Ireland consumes more alcohol per 
capita than most of its European counterparts 
– approximately 30% higher in 2006. Ireland 
has a higher percentage of abstainers than 
other countries, implying that those who do 
drink, consume alcohol in greater quantities 
when compared to other countries.
1.11 The figures mean that each person aged 
5 and over consumes an average of 20 
standard drinks of alcohol per week. This is 
equivalent to 0 pints of beer or 3 bottles of 
wine or  bottle of spirits per week. Since the 
recommended maximum weekly consumption 
levels are currently 4 standard drinks for 
women and 2 for men, this means that a 
significant number are drinking more than the 
recommended limits.  
Alcohol use in the population
1.12 People in Ireland also engage in drinking 
patterns that are excessive and problematic, 
with heavy and binge drinking now the norm 
for a substantial number of people. The 
Eurobarometer Survey, published in March 
2007, on Attitudes to Alcohol reported that 
54% of Irish respondents binge drink at least 
once weekly, compared to 28% of Europeans. 
1.13 The National Health and Lifestyle Survey - SLÁN 
20076 – reported more encouraging findings.  It 
found that the percentage of respondents 
reporting that they had 6 or more standard 
5   While there was a reduction in alcohol sales in the 
Republic of Ireland in 2008, this is being largely offset by 
a rapid increase in the volume of alcohol being purchased 
more cheaply in Northern Ireland for consumption in the 
South.  The measured consumption data does not take 
account of the imported alcohol from Northern Ireland 
so there is a concern that the reduced consumption data 
reported for 2008 is a false indicator. 
6   SLÁN is a national survey, (carried out by the Department 
of Health & Children), of the lifestyle, attitudes and 
nutrition of people living in Ireland.  The most recent 
survey was carried out in 2007.  It includes questions on 
alcohol and the use of illicit drugs.
drinks at least once per week has fallen from 
45% in 2002 to 28% in 2007.  This pattern was 
reflected across gender, age and social class. 
However, the SLAN 2007 Research Team warn 
that these findings must be viewed with caution 
since the survey method has changed over this 
period (from postal self - report questionnaires 
in 2002 to face - to - face interviews in 
2007) and the willingness to report drinking 
excessively may differ by survey method.
1.14 The Health Behaviour in School - Aged Children 
(HBSC)7 survey in 2006 found that half of the 
children aged 5 - 7 reported being current 
drinkers and just over a third reported having 
being “really drunk” in the last 30 days. 
1.15 young people’s propensity for risk - taking and 
their relative inexperience with alcohol place 
them at particular risk for alcohol - related 
harm.  Research from the United States has 
found that people who begin drinking before 
the age of 5 are four times more likely to 
develop alcohol dependence at some time 
in their lives, compared with those who have 
their first drink at age 20 or older.
Alcohol - related Health and other problems in Ireland
1.16  In 2002, the World Health Organisation (WHO) 
identified alcohol as the third highest risk factor 
(after tobacco and hypertension) for premature 
death and ill - health in developed countries. 
Since the early 990s, there has been a dramatic 
increase in alcohol - related harm in Ireland, with 
the increase most pronounced in the period 
995 to 2002.  As outlined above, the harm from 
alcohol is linked to a range of health and social 
problems such as accidents, injuries, chronic 
ill - health, premature death, public safety, 
violence, child neglect, marital problems and 
lost productivity. Alcohol harm is not confined to 
the drinker but extends to the family, community 
and wider society. The negative role of alcohol in 
family well - being was documented in a number 
of Irish studies, where alcohol has the potential 
to contribute to domestic violence, relationship 
and marriage problems and impact on the most 
vulnerable of children.
1.17  Both the average per capita alcohol consumption 
and individual patterns of drinking are important 
determinants of alcohol - related problems. In 
general, increases in overall consumption are 
accompanied by a greater incidence of health 
and social problems. Evidence of this can be seen 
from research published by the Health Research 
Board (HRB) in 20078 which found that:  
7   Health Behaviour in School aged Children (HBSC) is a 
World Health Organisation (WHO) collaborative cross 
national study. 
8   Overview 6:  Health - related Consequences of Problem 
Alcohol Use:  HRB, 2007.
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n	 Alcohol - related hospital discharges increased 
by 92% between 995 and 2004; 
n	 There were large increases in the number of 
discharges with acute and chronic conditions, 
but the largest increase was observed among 
discharges with alcohol - related liver disease, 
which increased by 47% between 995 and 
2004; 
n	 Alcohol - related mortality also increased 
during the same time period, with an incidence 
of 7. deaths per 00,000 adult population in 
2004, compared to 3.8 in 995; 
n	 Half of all alcohol - related deaths occurred to 
people aged between 50 and 70 years; 
n	 Alcohol is also implicated in fatal road traffic 
accidents. In 2003, alcohol was found to be a 
contributory factor in 36% of road fatalities; 
and  
n	 The high level of alcohol consumption has 
been accompanied by a parallel increase in 
the incidence of alcohol - related crime among 
juveniles.  
1.18   In recent years, a binge drinking culture has 
emerged among women and drunkenness 
has increasingly become socially accepted. 
The consequences of this change in drinking 
patterns can be observed in hospital 
discharges. While women account for just 
a quarter of all alcohol - related discharges, 
among those aged 7 or under, the proportion 
of female discharges is much higher at 47%. 
Policy measures to tackle alcohol misuse – work of the 
new Steering Group 
1.19  As outlined above, identifying the policy 
measures and actions required to incorporate 
alcohol into a National Substance Misuse 
Strategy will be challenging. Potential synergies 
have been identified between alcohol and 
drug treatment and rehabilitation services 
– and in prevention programmes - and these 
are set out in the relevant chapters in this 
Report.  However, the new Steering Group will 
also need to address broader issues around 
the supply and availability of alcohol, pricing, 
marketing, promotion and sponsorship etc. 
1.20  It is noted that there is a developing scientific 
knowledge of what strategies work to reduce 
alcohol - related harm.  The WHO has 
highlighted policies and programmes that have 
been shown to be effective in tackling alcohol 
misuse9. 
9   Second Report of the World Health Organisation (WHO) 
Expert Committee on Problems Related to Alcohol 
Consumption, 2007.
These include:
n	 reducing the demand for alcohol through 
taxation and pricing mechanisms; 
n	 regulating and restricting the availability of 
alcoholic beverages;
n	 regulating the marketing of alcoholic beverages 
(in particular those practices that influence 
younger people); 
n	 enactment of appropriate drink - driving 
policies; 
n	 implementing screening programmes and 
brief interventions against hazardous and 
harmful use of alcohol (e.g. in primary care 
and Emergency Departments); and
n	 providing easily accessible and affordable 
treatment services for people with alcohol 
- related disorders.
1.21   A number of Irish reports will help to inform 
the work of the new Steering Group.  These 
include the reports of:
n	 the Strategic Task Force on Alcohol (2nd Report 
2004); 
n	 the Sustaining Progress Partnership Group 
“Working Together to Reduce the Harms 
Caused by Alcohol Misuse” (2006); and 
n	 the Government Alcohol Advisory Group 
(2008).
Research reports, published by the Health Service 
Executive (HSE) and the Health Research Board 
(HRB), will also aid the work of the Group.
1.22   It is also noted that in order to tackle the 
harms caused by alcohol misuse, Government 
has already taken the initiative via new 
legislation – the Intoxicating Liquor Act 2008 
– and codes of practice on alcohol advertising 
and sponsorship. Current Government policy 
is based on the belief that alcohol policies 
and interventions targeted at vulnerable 
populations can prevent alcohol - related harm. 
In addition, policies targeted at the population 
at large can also have a protective effect 
on vulnerable populations and reduce the 
overall level of alcohol problems.  Therefore, 
both population - based strategies and 
interventions, and those targeting particular 
groups, such as young people and women, 
form the basis of current policy development 
and implementation. 
7
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ChApTEr 2
SuPPlyreDuCTiONPillAr 
iNTrODuCTiON
2.1   The focus of this chapter is predominantly 
on illicit drug use rather than alcohol, with 
the exception of underage drinking, due to 
the fundamental legal difference involved 
in their supply.  As outlined in chapter , 
issues around controlling and influencing the 
supply of alcohol will be considered by the 
new Steering Group which will be set up to 
develop the new National Substance Misuse 
Strategy.
2.2    Problem drug use impacts on society as a 
whole and is a major issue of public concern. 
For communities, the most damaging effects 
are those caused by drug dealing, drug - 
related crime and anti - social behaviour, 
which can undermine the stability of families 
and communities.   Interventions to address 
these issues are key elements of supply 
reduction, one of the five pillars of the 
current NDS.  
2.3    In the current NDS, the main focus of the 
supply reduction pillar is on reducing the 
volume of illicit drugs available, while reducing 
access to all drugs. This chapter provides an 
overview of the pillar and assesses progress 
both in achieving the NDS actions, and 
the impact of those actions by reviewing 
performance against the Key Performance 
Indicators (KPIs).  It also outlines the key 
findings from the consultation process, which 
has helped to inform the priorities for the 
new NDS. 
2.4     Supply reduction accounts for 2 of the 08 
actions outlined in the   current NDS, as 
amended by the Mid - Term Review (MTR) in 
2005.  Law enforcement is a crucial element 
in the pillar and as a result, many of the 
actions fall to the following key Departments 
and agencies to implement:
n	 Department of Justice, Equality and Law 
Reform; including An Garda Síochána, the 
Courts Service, the Irish Prison Service, the 
Probation Service and the Forensic Science 
Laboratory;
n	 Office of the Revenue Commissioners - 
Customs Service; and 
n	 Local Authorities (as regards anti - social 
behaviour).
2.5    The Local and Regional Drugs Task Forces0 - as 
well as the community and voluntary sectors - 
also play an important role in complementing 
the work of the law enforcement agencies, 
bearing in mind that law enforcement is only 
part of the overall supply reduction effort.
Table 2.1 – Strategic Aim and Objectives of Supply 
reduction pillar under the current NdS
National Drugs Strategy 2001 - 2008  
– Supply Reduction
Strategic Aim:
n	 To reduce the availability of illicit drugs.
Strategic Objectives:
n	 To significantly reduce the volume of illicit 
drugs available in Ireland, to arrest the 
dynamic of existing markets and to curtail 
new markets as they are identified; and
n	 To significantly reduce access to all drugs, 
particularly those drugs that cause most 
harm amongst young people, especially 
in those areas where misuse is most 
prevalent.
ASSeSSmeNTOfPrOgreSSDuriNgThe
PeriODOfTheCurreNTNDS
2.6    The following were identified as being among 
the key issues over the lifetime of the current 
NDS:
n	 number of drug seizures and volume of drugs 
seized;
n	 legislative changes in regard to illicit drugs;
n	 Garda resources in Local Drugs Task Force 
(LDTF) areas; 
n	 expansion of Community Policing Fora; and 
n	 specialist training for the judiciary on drug 
related issues. 
Legislative changes in regard to the supply of illicit 
drugs 
2.7    Over the lifetime of the Strategy, the 
Department of Justice, Equality and Law 
Reform has introduced a number of pieces of 
legislation that contain elements related to 
drug trafficking.  These include:
n	 European Arrest Warrant Act 2003;
0   See Appendix 6 for details of the Local and Regional 
  Drugs Task Forces.
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n	 Criminal Justice (Illicit Traffic by Sea) Act 2003;
n	 Criminal Justice (Joint Investigation Teams) 
Act 2004;
n	 Garda Síochána Act 2005;
n	 Proceeds of Crime (Amendment) Act 2005;
n	 Criminal Justice Act 2006;
n	 Criminal Justice Act 2007; and
n	 Criminal Justice (Mutual Assistance) Act 
2008.
Garda resources in LDTF areas
2.8 Much progress has been made in increasing 
the level of An Garda Síochána resources in 
LDTF areas over the lifetime of the current 
Strategy and, in particular, since the MTR in 
2005. Key areas of progress have included:
n	 An increase in Garda resources in LDTF areas 
which includes:
q	 An increase of 8% in general resources 
(200 - 2007);
q	 An increase of 36% in Community Policing 
resources (200 - 2007); and 
q	 An increase of 35% in Drugs Units 
resources (200 - 2007). 
n	 An increase in the personnel numbers in the 
Garda National Drugs Unit;
n	 The establishment of a number of additional 
Drugs Units in both Local and Regional Drugs 
Task Force areas;
n	 The establishment of the Organised Crime 
Unit on a permanent basis to tackle organised 
crime including drug trafficking; 
n	 An increase in the resources of the Criminal 
Assets Bureau (CAB), particularly through 
the recruitment of asset profilers; and 
n	 A series of ongoing special operations. 
Expansion of Community Policing Fora2
2.9 A key priority of the current NDS was the 
expansion of Community Policing Fora 
(CPF) to all LDTF areas and other areas 
experiencing problems with drug misuse. 
Progress has been slower than anticipated 
   Overall staffing levels in An Garda Síochána have 
increased from ,640 (,728 civilians) on 3st December 
2000 to 3,755 (,687 civilians) on 3st December 2007. 
This represents an increase of 8% over that period. 
2   “Community Policing Fora were renamed as “Local 
Policing Fora” under the Garda Síochána Act, 2005. 
in this regard.  In 2005, the Garda Síochána 
Act was enacted and this allowed for the 
establishment of Joint Policing Committees 
(JPC) on a statutory basis.  This is a forum for 
members of An Garda Síochána to meet with 
local representatives to discuss community 
issues and the JPC guidelines have identified 
drugs as a priority area for these discussions. 
In September 2008, the Ministers for Justice, 
Equality & Law Reform and Environment, 
Heritage & Local Government, along with 
the Garda Commissioner, launched the roll 
- out of JPCs from the pilot phase in 29 local 
authority areas to all 4 areas.  Work on the 
establishment of these committees by the 
Local Authorities and An Garda Síochána is 
ongoing, and at the end of February 2009, 
73 such committees were in place.  One of 
the functions of the JPCs is to establish local 
policing fora, in consultation with An Garda 
Síochána.
2.10 CPFs only operate in three LDTF areas3 
at present while Community/Police 
Partnerships operate in a number of other 
areas.  The delay in establishing CPFs in LDTF 
areas, and other areas experiencing drugs 
problems more recently, is related to some 
extent to the overall development of the JPC 
initiative and the need to align more locally 
- based structures with the broader policing 
partnership framework. Guidelines are 
currently being drafted for the establishment 
of CPFs in LDTF areas.
Specialist training for judiciary on drug related issues
2.11 The Judicial Studies Institute was established 
by the judiciary in 996. In this context, 
the Steering Group notes that, due to the 
constitutional independence of the judiciary, 
the role of the Department of Justice, Equality 
& Law Reform is limited to funding the 
Institute on an annual basis.  The Institute 
produces a journal periodically and organises 
conferences, seminars and lectures for 
judges with the objective of enhancing their 
knowledge and understanding of the law and 
legal principles, with particular regard to new 
developments.  
Other areas of progress
2.12 The Steering Group also recognises that 
progress has been made in a number of other 
areas: 
n	 a co - ordinating framework has been 
established to manage drugs policy in each 
3   The three LDTFs are:  (i) Finglas/Cabra LDTF, (ii) North 
Inner City LDTF and (iii) Blanchardstown LDTF.
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Garda District, with Policing Plans now being 
produced in each District. Furthermore, drugs 
are now a priority in all Policing Plans, both 
local and national; 
n	 there has been a 56% increase in the 
strength (resources) of Drugs Units, across 
National, Divisional and District Drugs Units. 
Furthermore, processes are in place that 
support daily contact between the National 
and Local Drugs Units; and
n	 the Criminal Assets Bureau (CAB) has 
focused its efforts more on middle and lower 
ranking criminals involved in drug dealing. 
CAB uses the services of more than 00 
Criminal Asset Profilers, who are in place 
in each Garda division throughout the 
country. The allocation of Divisional Profilers 
continues to be monitored and reviewed on 
an ongoing basis.  In addition, the Revenue 
Commissioners have a number of asset 
profilers in place. 
2.13    An Garda Síochána and Revenue’s Customs 
Services (along with the Naval Service) make 
up the Drugs Joint Task Force and all three 
agencies continue to develop co - operation 
- both nationally and internationally - with 
relevant law enforcement and intelligence 
agencies with the aim of reducing the amount 
of drugs coming into Ireland. An agreed 
Memorandum of Understanding has been 
central in facilitating this co - operation.  In 
particular, the Steering Group notes: 
n	 the establishment of a Maritime Analysis 
Operations Centre – Narcotics (MAOC - N) in 
Lisbon which is an initiative of seven Western 
European countries (Ireland, Spain, Portugal, 
France, Italy, UK & Netherlands) specifically 
focused on reducing the threat of cocaine 
trafficking into the EU. This initiative is funded 
by the Department of Justice, Equality and 
Law Reform and is being operated by An 
Garda Síochána, Revenue’s Customs Service 
and the Naval Service;
n	 the measures that have been implemented to 
address Action 5 of the current NDS focusing 
on coastal watch and other ports of entry to 
restrict the importation of illicit drugs. Coastal 
Watch Programmes have been in place since 
the 990s.  In addition, the Customs Service 
has re - launched the Drugswatch Programme, 
which seeks to enlist the help of the maritime 
community and other strategically placed 
persons in the fight against drug smuggling. 
Confidential reporting arrangements and a 
24/7 freephone service are in place and 
these have facilitated a number of significant 
detections.
n	 various initiatives aimed at reducing the 
supply of drugs, such as the “Dial to Stop 
Drugs” scheme which, have been undertaken 
by the Local and Regional Drugs Task Forces. 
2.14    Notwithstanding the progress outlined above, 
the Steering Group also notes that there has 
been less advances in other areas.  Some of 
these are outlined in the following paragraphs.
2.15    The availability of drugs in prisons continues 
to be a key challenge for the NDS, although 
progress has been made on counteracting 
this as well as on the expansion of treatment 
services in prisons.  The Group acknowledges 
the progress achieved in recent years to 
address this issue through: 
n	 increased security arrangements that have 
been put in place with a focus on supply 
elimination; 
n	 the establishment of Operational Support 
Units in each prison dedicated to (and 
currently developing expertise in) searching 
and intelligence gathering;
n	 the enforcement of more stringent procedures 
regarding all contraband; 
n	 the provision of security screening of all 
persons entering prisons; and 
n	 the further development of the drug detection 
dog service.  
2.16    The Operational Support Units, using 
advanced searching techniques, are in 
addition to the normal prison staff and they 
can target specific problem areas relating to 
the trafficking of contraband, including drugs, 
into prisons.  
2.17    Mandatory drug testing is now established 
in a number of prisons and it is proposed to 
introduce it on an incremental basis to other 
prisons from 2009 onwards. 
2.18    In order to address concerns at the use 
of mobile phones and how such use has 
contributed to the increasing levels of the 
controlling of illegal drug activity from within 
prisons, the Irish Prison Service (IPS) installed 
a pilot scheme of technology to prevent 
their use.  This pilot, which began at the 
Midlands/Portlaoise Prison Complex in April 
2007, was completed in early 2009.  Following 
the evaluation of the inhibition system, which 
proved very positive, the IPS, in 2009, installed 
the technology in Portlaoise Prison.  In 
addition, trials of alternative systems of mobile 
phone blocking technology commenced in 
2009 in Limerick Prison, Mountjoy Prison 
Medical Unit and Cloverhill Prison.
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2.19    The Steering Group notes that the IPS 
Drug Detection Dog Service has now been 
established.  This will ultimately involve 
about 30 dog handling teams, 0 of which 
are currently in operation. The searching 
is concentrated on visitors to prisons, but 
searches within the prison are also undertaken. 
Initial indications suggest that these teams 
have had a significant interception and 
deterrent effect.  
2.20    Overall, while welcoming the increased 
security arrangements that have been put 
in place, the Group considers that there 
is a need to monitor these arrangements. 
Thus, it welcomes the establishment of the 
External Oversight Group on IPS Drug Policy, 
a Monitoring Group that will focus on problem 
drug use in prisons, from both a security 
and a treatment & rehabilitation perspective. 
Furthermore, the Steering Group considers 
that the development of a comprehensive 
treatment and rehabilitation programme in 
prisons is a critical element in counteracting 
problem drug use in our society.  This is dealt 
with further in chapter 4.
2.21    The Steering Group notes that community 
engagement has become more difficult in 
some areas, due to the increased incidence 
of intimidation. Although An Garda Síochána 
continue to develop their intelligence 
- led approach with co - operation from 
communities, there is a need for widespread 
community engagement to support the 
conviction of known drug offenders. This 
engagement is thought to be at risk in areas 
where communities are fearful of increasing 
intimidation. Community engagement was a 
key focus of Action 8 of the current NDS which 
recommended multi - agency participation 
(including the community) in targeting drug 
dealing through local Drug Policing Plans. 
The issue of intimidation is dealt with in more 
detail later in this chapter.
KeyfiNDiNgSfrOmTheCONSulTATiON
PrOCeSS
2.22    While recognition was given during the 
consultation process to the significant increases 
in drug seizures over recent years, the impact 
of those seizures on reducing the overall supply 
of drugs was questioned. Consequently, despite 
the successes of law enforcement agencies in 
seizing drugs, a key theme to emerge during 
the consultation process was the perception 
that illicit drugs are more readily available 
across the country in recent years.
2.23    Other issues highlighted during the process 
include the following: 
n	 There was support for the continued 
development of community policing, with the 
establishment of Local Policing Fora (LPFs  - 
formerly CPFs – see paragraphs 2.9 and 2.0 
above) being widely regarded as important 
to the success of supply reduction measures. 
This requires effective links between An 
Garda Síochána and the community to 
enable an effective response to local drug 
issues. However, these links are currently not 
as effective as they should be, partly because 
of the increased fear of intimidation; 
n	 Significant concerns were raised about 
increased levels of intimidation within local 
communities across the country. The increase 
in intimidation is, in part, thought to be due 
to increased levels of drug - related debts, 
which are particularly associated with the 
rise in cocaine use. In many cases, families 
are faced with demands to cover the debts of 
a family member (with various issues around 
the circumstances of such debt and the 
calculation of the sum alleged to be involved), 
with threats of violent consequences for non 
co - operation; 
n	 While overall visibility of An Garda Síochána 
on the ground has improved - partly due 
to the increase in police numbers in recent 
years - further visibility in the most at risk 
areas is still considered a priority;
n	 The perceived widespread availability of drugs 
in prisons across the country was highlighted 
and the concern that current policies are 
ineffective in dealing with the problem. In this 
regard, some suggested that the number of 
drug detection dogs in prisons be increased;  
n	 There is a perceived lack of consistency 
in the criminal justice system in dealing 
with drug - related offences, in particular 
the perceived reluctance of the judiciary to 
impose mandatory sentences.  The sentencing 
of drug - related offences is seen to vary 
dramatically, depending on the individual’s 
location. People convicted in more rural 
areas are often perceived as receiving stiffer 
sentences than those in Dublin and other 
cities. Overall, the level of sentencing and the 
fear of imprisonment are not seen as sufficient 
disincentives for those dealing in drugs in 
local communities. There is also a sense of 
frustration at the perceived 'wasted' efforts 
of An Garda Síochána to bring an individual 
to court, where a minimal sentence can be 
imposed; 
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n	 There is recognition of the success of the CAB, 
in particular for the new focus on middle and 
lower ranking criminals.There is a perception 
that the majority of funds seized by the CAB 
are directly drug - related, and as such should 
be invested back into local communities 
which have been affected by drugs. The 
Steering Group recognises, however, that 
much of the funds seized represent the 
recoupment of social welfare payments and 
unpaid taxes, and are, therefore, monies 
owed to the Exchequer.  Notwithstanding 
this, there were calls for the successes of the 
CAB at local level to be further highlighted, 
particularly those in relation to the middle 
and lower ranking criminals, which can 
provide a morale boost in the communities;  
n	 The issue of underage drinking was 
consistently raised by many, both as a 
problem in its own right and as a gateway to 
the use of illicit drugs;
n	 Concerns were raised regarding the 
development of new illicit synthetic drugs, 
both within and outside the EU, where 
legitimate chemicals are being diverted 
to manufacture such illicit synthetic drugs 
(paragraph 2.47 also refers). In this regard, 
the Steering Group notes that the Revenue’s 
Customs Service has dedicated Precursor 
Liaison Officers located at key areas around 
the country and that there is a commitment to 
continue to develop the Precursor Programme 
under the new NDS.  Reference was also made 
to the 2008 seizure of methamphetamine in a 
joint operation between An Garda Síochána 
and the Revenue’s Customs Service - the first 
significant seizure of this drug in Ireland; 
n	 The delays experienced in testing of cases by 
the Forensic Science Laboratory to support 
prosecutions was raised.  For the most 
part, this was as a result of the significantly 
increased levels of seizures by An Garda 
Síochána and Revenue’s Customs Service. 
While the Laboratory achieved an impressive 
66% increase in the number of drugs reports 
they produced between 2006 and 2008, the 
number of cases submitted to them also 
increased by 70% over the same period. 
This negated their efforts to reduce delays 
in the criminal justice system.  A shorter 
turnaround time of cases submitted to the 
Laboratory is required to ensure the more 
efficient investigation of drug offences;    
n	 There was some reference to the concept 
of Drug Courts. While many agreed with 
the concept of such a Court, there was 
little awareness or understanding of the 
effectiveness of the model. Consequently, 
there was uncertainty as to whether the 
model should be expanded, given the level 
of resources involved.  The Steering Group 
notes that a review of the Drug Court model 
is ongoing in the Department of Justice, 
Equality & Law Reform; and
n	 The issue of the legislative framework 
governing illicit substances was raised on a 
number of occasions, with some requesting a 
review of that framework. Some people were 
of the opinion that consideration should be 
given to potentially legalising, decriminalising 
or changing/redefining the legal status of 
certain illicit drugs (particularly cannabis) 
and the associated penalties for possession. 
PrOgreSSAgAiNSTCurreNT
KeyPerfOrmANCeiNDiCATOrS(KPis)
2.24    The KPIs for the supply reduction pillar 
were revised in the MTR and relate primarily 
to increases in the volume and number 
of seizures, as well as increases in supply 
detections. The latest data highlights that 
each of the supply reduction KPIs have been 
achieved. Table 2.2 provides a summary of 
the KPIs and progress to date against each.
Table 2.2 - progress against kpis
Target Progress
 Volume of drugs seized 
increased by 50% based 
on 2000 figures.
The volume of drugs 
seized overall, exceeds 
50% based on 2000 
figures, in particular 
for cocaine, heroin and 
cannabis resin. See Table 
2.3 below.
2 Number of seizures 
increased by 20% based 
on the 2004 figures.
The overall number of 
seizures increased on 
average by 59% over the 
2004 figures.
3 Number of supply 
detections increased by 
20% by end 2008 based 
on 2004 figures.
The number of 
detections believed to be 
for supply increased by 
25% over the numbers 
recorded for 2004.
Source:  An Garda Síochána and the Revenue’s Customs Service
Seizures
2.25    Both the volume and value of seizures has 
increased significantly in Ireland since 2000. 
Table 2.3 highlights the increases in the 
volume of drug seized across the various 
categories of drugs.
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Table 2.3 – drug Seizures 2000 – 2007 
TypeofDrug 2000 2001 2002 2003 2004 2005 2006 2007
heroin(kg) 23.9 30.3 6.7 27.046 26.5 32.28 28.4 29.84
Cocaine14(kg) 8 5.3 3.7 07.4 67.3 229.38 90.9 ,78
Cannabisresin(kg) 40 567 3,333 5,349 3,226.5 6259.8 6,95.8 ,67
Cannabisherb(kg) 208 3,208 6,05 29 303 80 305 ,782.62
ecstasy(tablets&
capsules)
557,357 469,94 7,076 ,292,296 ,099,43 327,424 47,306 9,972
Amphetamines
(tabs)
49 N/A 2,728 ,09 9 9,452 6,399 0,395 
Amphetamines(kg) 5.92 7.93 6.4 96.82 92.4 0.5 38.24 55.3
2.26    In relation to the revised KPIs, the Steering 
Group notes that:  
n	 the volume of drugs seized has increased 
across almost all major drug categories, in 
particular cocaine and cannabis resin. While 
heroin seizures between 2000 and 2005 were 
relatively stable, there has been a significant 
increase in the volume seized in 2006 and 
2007; and 
n	 as well as the volume of seizures, the number 
of seizures conducted has increased by 59% 
on 2000 figures, highlighting that the increased 
volumes are associated with an increase in 
the number of seizures and are not solely 
attributed to a low number of large seizures.
2.27    The increases in seizures represent 
important operational successes for the law 
enforcement agencies, mainly due to the 
ongoing co - operation between An Garda 
Síochána, Revenue’s Customs Service and 
the intelligence - led approach being used. 
However, the Steering Group notes that 
the impact of increased seizures on the 
overall supply of illicit drugs is difficult to 
determine. Due to the problems associated 
with estimating the size of the illegal drug 
market in Ireland, it is difficult to conclude 
whether increased seizures are actually 
resulting in a reduction in overall supply 
- or whether the overall supply of drugs has 
increased and the percentage of seizures has 
remained relatively even.  Meanwhile, it is 
acknowledged that the figures often quoted 
in relation to drugs seizures as a percentage 
of the total drugs market in Ireland are 
speculative and currently, have no proven 
basis.  Other factors around supply and 
demand, such as the numbers presenting 
for treatment and the price of drugs on the 
street, also need to be considered.  
2.28    By May 2007, there was a 25% increase in 
the number of supply detections compared 
to the 2004 figures, against a 20% target for 
the end of 2008. This can be compared with 
a doubling of total drug detections over the 
same period.
2.29    There were some concerns amongst the 
Steering Group about the time being allocated 
by An Garda Síochána to what is perceived 
as less serious drug - related crime, such as 
the possession of cannabis for personal use. 
The Gardaí advise that about 20% of drugs 
crime relates to supply offences and 80% to 
possession.  Supply offences generally involve 
much more time and resources. Furthermore, 
Gardaí cannot foretell the outcome of their 
operations in advance.
2.30    The overall conclusion is that all of the 
KPIs were achieved before the end of 2008. 
However, while the Steering Group accept that 
drugs seizures are recognised internationally 
as one of the key indicators for monitoring 
trends in supply, they are also of the view 
that there are limitations in only measuring 
seizures as an indicator of reducing supply. 
In terms of the new strategy, it is important 
to consider whether these KPIs remain the 
most appropriate and relevant measurable to 
indicate whether the overall objective of the 
supply pillar has been achieved, i.e. to reduce 
the availability of illicit drugs.   
CONCluSiONSANDPriOriTieSfOrThe
fuTureDrugSSTrATegy
2.31    The Steering Group acknowledges that 
significant progress has been evident under 
the supply reduction pillar since 200 – both 
in relation to the actions and KPIs. The 
revised KPIs have been exceeded, and many 
of the actions outlined in the current NDS 
have either been completed, are ongoing 
4   The 2007 cocaine figure includes the ,500 kg approx of cocaine seized off the Cork coast in July 2007.  A find of this size may 
distort the figures for comparative purposes.  It is thought that the cocaine was en route to a destination other than Ireland.
Source: Garda Annual Reports, Revenue’s Customs Service & Forensic Science Laboratory.
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tasks, or considerable progress has been 
made and they are well advanced.  Progress 
is also evident in relation to the priorities 
identified in the MTR, although some of 
that progress continues to be slow.  Despite 
this, it is accepted that drugs continue to 
be available on an on - going basis in many 
communities.  
2.32    While the progress made in relation to 
the establishment of the JPCs and LPFs 
is acknowledged, the issue of community 
policingcontinues to be a key priority going 
forward. 
2.33    As outlined in paragraph 2.9 above, following 
a pilot phase, JPCs are now to be rolled 
out to the 4 Local Authority areas.  The 
JPCs cover all aspects of policing (the drugs 
problem would only constitute a small 
part of this) and they facilitate a more co 
- ordinated approach to policing through 
greater co - operation and liaison between 
Local Authorities and An Garda Síochána. 
The Committees are comprised of members 
of the Local Authority, representatives of 
members of the Oireachtas, senior Gardaí, 
the community and voluntary sectors and 
Local Authority officials.  Their meetings are 
held on a periodic basis and, as a rule, they 
are open to the press and to the public. 
2.34    LPFs deal with drugs and associated issues 
such as estate management and anti - social 
behaviour.  They involve a much smaller 
geographical area (e.g. Dublin’s North Inner 
City) and seek to build up a more direct 
bond between An Garda Síochána and local 
communities.  This helps to create conditions 
of trust in which the drugs problems can 
be addressed in a proactive and concerted 
way.  The 3 existing LPFs are provided with 
full - time administrative support and, while 
this greatly facilitates their work, the Steering 
Group notes that the costs involved are a 
factor in expanding LPFs to more areas.  
2.35    The expansion of JPCs is welcome, and 
should be of help in the overall fight against 
drugs.  However, the Steering Group believes 
that progress in this regard should not be 
a reason to ease off on the programme of 
expansion of LPFs.  The latter bodies have 
proven most beneficial where established 
and the Group see it as vital that they are 
set up in further areas on an incremental 
basis, ensuring the optimum level of local 
community engagement, An Garda Síochána 
focus and disruption to the drugs trade.  
2.36    The Steering Group notes that the increasing 
fear and incidence of intimidation has emerged 
as a key concern within communities. The 
nature and scale of intimidation is reported to 
have increased in recent years and is seen as 
having the potential to affect the participation 
of communities in the NDS.  The families, 
friends and associates of drug users, as well 
as the drug users themselves, are increasingly 
the targets of intimidation and violence.  In 
many cases families are faced with demands 
to cover the debts of a family member. 
These debts primarily arise as a result of drug 
usage or drug supply whereby the individual 
is held financially liable for drugs used, or 
seized by the authorities, either in their 
possession or under their control.  Apart 
from the huge impact on the families directly 
affected, the increased levels of violence have 
significant negative consequences for the 
wider communities.  
2.37    The Steering Group note that intimidation 
can take many forms including damage to 
property, threats and physical violence. 
Furthermore, many of the incidents which 
may have their origins in acts of intimidation 
may not be recognised or reported as 
such. This potentially leads to low levels of 
reporting and feelings of helplessness among 
victims and families.
2.38    The Steering Group acknowledges the severe 
consequences that this is having in the 
communities affected and is also aware that 
there is no easy remedy.  The Department 
of Justice, Equality and Law Reform and An 
Garda Síochána are fully aware of public 
concerns in relation to this issue and all of 
the drug - related aspects of crime. An Garda 
Síochána continues to prioritise the tackling 
of serious organised crime in all its facets in 
the Annual Policing Plan.  As outlined above, 
the JPCs and LPFs will provide a forum 
whereby issues that arise at community level 
can be bought to the attention of An Garda 
Síochána. However, those directly affected by 
intimidation will be unlikely to speak at these 
meetings. Furthermore, given the nature of 
the offence, victims may be less likely to 
report incidents directly to the authorities or 
to pursue a prosecution through the court 
system.  The Steering Group recommends 
that An Garda Síochána, in conjunction with 
relevant partners, develop an initiative that 
will allow for communication, either directly 
between the victims and An Garda Síochána, 
or via the Family Support Network or other 
agencies.
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2.39    The establishment of an information system 
to enable the tracking of drug - related 
offences is considered to be a key element 
in assessing the success of enforcement 
activities. While it is recognised that this 
action will have significant technical and 
resource implications, the presence of an 
integrated information system will support 
the development and implementation of 
policy responses in an efficient and timely 
manner.
2.40    The independence of the judiciary is 
recognised as a fundamental principle 
of our criminal justice system.  However, 
the perceived lack of consistency in the 
sanctioning of drug - related offences is an on 
- going concern, as it relates directly to the 
confidence of the public in the success of the 
NDS.
2.41    The Steering Group notes that the Revenue’s 
Customs Service successfully use dogs to 
uncover drugs.  Since the first detector dog 
team was deployed in 984, the resource has 
been increased incrementally and currently 
stands at 3.  Further expansion of drug dog 
teams is recommended. In addition, while it 
is noted that the Customs Service has one 
mobile x - ray scanner that is capable of 
screening vehicles and containers it is felt 
that this is inadequate to meet the threats 
posed by the drugs trade.  Furthermore, the 
fact that it is generally known that only one 
such scanner is available facilitates avoidance 
of detection due to the choice of access 
routes available. It is noted that, in May 2009, 
Revenue were completing the tendering 
process for a second X - Ray scanner.
2.42    The issue of young children (some under the 
legal age of culpability) being used by those 
involved in the drugs trade to “run” drugs 
is also a major concern.  These children are 
particularly sought by drug dealers to avoid 
detection as it is known that many will not be 
subject to legal penalty.  At the same time, 
apart from the dangers involved, the young 
people gain financially and are more likely 
to be led into a life involving drugs and the 
drugs trade.
2.43    The Steering Group is of the view that 
renewed efforts need to be made to address 
the issue of underage drinking which is 
often perceived as the direct cause, or the 
underlying cause, of many of the problems 
encountered by individuals and communities. 
They acknowledge the benefits of the 
enactment of the Intoxicating Liquor Act 
2008, which tackles the increased visibility 
and availability of alcohol through retail 
outlets with off - licences, while tightening 
the conditions under which premises with on 
- licences qualify for special exemption orders 
permitting them to remain open beyond 
normal licensing hours. The Act strengthens 
public order provisions and provides for 
improved enforcement and increased 
penalties.  However, the Steering Group also 
feel that the impact of the measures therein, 
and the situation generally, should continue 
to be monitored to ensure that alcohol is not 
being supplied to under - 8s.  In this context, 
it is noted that, as outlined in paragraph 2. 
above, the issues around controlling and 
influencing the supply of alcohol will be 
considered by the new Steering Group who 
will be developing the National Substance 
Misuse Strategy.
2.44    It is an offence under the Road Traffic Acts 
to drive under the influence of intoxicants. 
The Steering Group is of the opinion that 
procedures need to be developed to provide 
for the equivalence of treatment between 
driving under the influence of alcohol and 
driving under the influence of drugs.  To this 
end, the Steering Group considers that the 
following issues need to be addressed:
n	 road side drug testing should be implemented 
when feasible5; 
n	 random testing should be implemented from 
the introduction of road side drug testing;
n	 legislation on the issue of driving under the 
influence of intoxicants should be reviewed 
and appropriate enforcement options should 
be considered;
n	 the forensic analysis programme of the 
Medical Bureau of Road Safety should be 
expanded to deal with drug driving;
n	 relevant training should be provided for 
Gardaí, doctors and nurses; and 
n	 there should be detailed examination of the 
toxicology reports of all drivers involved in 
fatal road traffic accidents to ascertain the 
level of drug use involved.
2.45    The Steering Group acknowledges that the 
resourcing levels of the Forensic Science 
Laboratory have been reviewed and increased 
recently.  The Group feels that the situation 
should continue to be monitored to ensure 
that appropriate resources are in place to 
facilitate timely prosecution of offenders. 
5   There is as yet no reliable system of preliminary roadside 
testing for drugs, but the Medical Bureau of Road Safety 
is keeping abreast of developments in this area.
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Such timely prosecution would be assisted 
by the introduction of a presumptive testing 
regime in appropriate cases, similar to that 
which has been in operation in U.K. police 
forces for a number of years.   
2.46    In the wider context of supply reduction, 
it is considered that the Forensic Science 
Laboratory is the most appropriate agency to 
undertake purity/potency testing on seized 
drugs as a long - term data collection project. 
This would ensure better intelligence in regard 
to emerging trends in the drugs market.  
2.47   The Steering Group has concerns about 
the sale of psychoactive substances (often 
referred to as “legal highs”), often in 
headshops prominently located in our cities 
and towns.  This concern centres on the 
dangers of such psychoactive substances as 
well as them being a gateway to illicit drug 
use.  The Group feel that every effort should 
be made to monitor the activities of these 
businesses on an ongoing basis, with the 
objective of ensuring that no illegal activity is 
undertaken and that steps are taken speedily 
for changes in legislation where it is deemed 
to be appropriate.  
2.48    Furthermore, it is considered that the 
Department of Health & Children should keep 
drug - related legislation under review, with a 
particular focus on new synthetic substances, 
new or changed uses of psychoactive 
substances and drugs precursors.
2.49    The Steering Group considered the legislative 
framework governing illicit substances.  Most 
were not in favour of legalising, decriminalising 
or changing/redefining the legal status of 
certain illicit drugs (cannabis was the focus 
of most discussion in this context).  In these 
discussions, it was pointed out that findings 
from the Drug Prevalence Surveys of 2002/03 
and 2006/0756 indicated that approximately 
70% of those surveyed were of the opinion 
that recreational use of cannabis should not 
be permitted (support for the medicinal use 
of cannabis was  about 70% over the two 
surveys).
6   Drug Use in Ireland and Northern Ireland 2002/2003 and 
2006/2007 Drug Prevalence Surveys – National Advisory 
Committee on Drugs and Public Health Information & 
Research Branch (PHIRB) in Northern Ireland.
PriOriTieS
2.50     In light of the above, the Steering Group has 
identified the following priorities in relation 
to supply reduction under the new NDS:
n	 the continued disruption of the supply of 
illicit drugs;
n	 the ongoing monitoring of legislative and 
regulatory frameworks with a view to pursuing 
changes where necessary; 
n	 the continued roll - out of LPFs to all LDTF 
areas and other areas experiencing serious 
and concentrated problems of drug misuse; 
n	 the inclusion of drugs issues in a more central 
way in the work of JPCs to ensure that there 
is a concerted effort against drugs, including 
through Drugs Task Force involvement, in the 
Local Authority areas involved;
n	 renewed efforts to address the issue of
underage drinking which is often perceived 
as the direct cause, or the underlying cause, 
of many of the problems encountered by 
individuals and communities;  
n	 the development of an integrated system to 
track the progression of offenders with drug 
- related offences through the criminal justice 
system; 
n	 the continued implementation of increased 
security procedures and arrangements to 
reduce and eliminate the supply of drugs in 
prisons; and 
n	 the continued promotion of greater integration 
and co - operation at EU and international 
level, focusing on the global dimensions of 
drugs supply.   This would include a focus on 
precursors for diversion to the manufacture 
of illicit synthetic drugs. 
2.51    These issues are returned to in Chapter 7 
where actions in relation to the new Strategy 
are identified. 
27
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ChApTEr 3 
PreveNTiONPillAr 
iNTrODuCTiON
3.1    As outlined in the Introduction, the primary 
focus of this Report is on illicit drug use. 
However, alcohol is also referenced in this 
chapter in the context of developing a broader 
prevention strategy to tackle substance 
misuse, particularly in relation to under 8 
year olds.  
3.2 Prevention of problem drug use, in a broad 
sense, seeks to prevent the taking of illegal 
drugs, the prevention of harm where drug 
taking has initiated and the prevention of 
relapse where drug treatment has started. 
It also seeks to increase the awareness and 
understanding of people of the consequences 
of problem drug use and to delay the onset 
of first use.  Prevention as a concept, is 
therefore, highly complex.  
3.3    Research has identified risk and protective 
factors67 and these show that effective drug 
prevention must not rely solely on giving 
information on the harmfulness of drugs, 
but must also build self - efficacy through 
the development of social and personal 
skills.  These skills are only as effective as 
their implementation within a wider context 
of complementary policy development 
relating to such issues as educational 
achievement; provision of family support; 
reducing marginalisation and poverty; 
reducing involvement in crime; rehabilitation 
of offenders; provision of youth supports/
services; and interruption of supply and 
availability of drugs.
3.4    Problem drug use by an individual, or by a 
group of people, is rarely caused by a single 
factor. Instead, the interplay between multiple 
conditions and factors that put an individual 
at risk of using or developing problems 
with drugs influences the experience or 
outcome.  These complex and interlinked 
factors will vary between communities and 
individuals. For instance, the type of drug 
used will depend on the availability, price and 
accessibility of particular drugs. 
7risk factors are:  early school leaving or poor 
educational attainment; history of unemployment; 
poverty; poor mental health; family conflict/breakdown; 
anti - social behaviour; involvement in crime; family 
history of addiction (including alcohol); ethnicity and 
marginalisation and drug - taking in social networks. 
Protective factors are:  family factors; educational 
factors; individual characteristics; personal and social 
competence.
3.5   Under the current NDS, the focus of the 
prevention chapter is on promoting a greater 
awareness and understanding of the dangers 
of problem drug use throughout society.  At 
the outset, this chapter looks at the progress 
achieved across the various actions and key 
performance indicators.  It also examines the 
key findings from the consultation process 
and outlines what the priorities for the new 
NDS should be in relation to this area.   The 
risk factors referred to above also help to 
inform the development of future priorities 
and actions. 
Table 3.1. – Strategic Aim and Objectives 
of the prevention pillar under the current 
National drugs Strategy
National Drugs Strategy 2001 - 2008 
– Prevention
Strategic Aim
n	 To promote throughout society a greater 
awareness, understanding and clarity of 
the dangers of drug misuse.
Strategic 0bjectives
n	 To develop a greater understanding of 
the dangers of problem drug use among 
the general population; and 
n	 To promote healthier lifestyle choices 
among young people and other 
vulnerable groups at risk of problem drug 
use, through personal development, life 
- skills and harm reduction approaches. 
ASSeSSmeNTOfPrOgreSSuNDer
CurreNTNDS
3.6    The actions of the prevention pillar of the 
current NDS can be separated into four 
areas:
n	 Early school leaving;
n	 Education programmes in school - setting;
n	 Education programmes in non school - 
settings, including diversionary programmes 
primarily developed in LDTF areas; and
n	 Awareness campaigns. 
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Early School Leaving (ESL)
3.7   The NDS includes four actions targeting ESL78.
n	 The Government's DEIS Action Plan 
[Delivering Equality of Opportunity in Schools] 
is aimed at identifying and tackling levels of 
disadvantage and it provides the basis for 
school supports to, among others, schools 
in LDTF areas (action 29). The initiatives 
under DEIS are being rolled out on a phased 
basis to 873 schools between 2005 and 
200. It incorporates the School Completion 
Programme which targets children most at 
risk of leaving school early. The Department 
of Education & Science has also developed 
a Traveller Education Strategy, one objective 
of which is to address the problem of ESL in 
this community.   A Traveller Implementation 
Group has been established to co - ordinate 
education policies for Travellers based on 
integration, inclusion, and age - appropriate 
placement.  While the number of Traveller 
students attending primary and post - 
primary schools has increased significantly in 
recent years, absenteeism and retention rates 
remain as major challenges.
n	 The National Educational Welfare Board 
(NEWB) was set up in 2002 to address 
issues of attendance and to encourage 
young people to stay in school or training, 
as appropriate. LDTF areas (action 30) 
were prioritised in the roll - out of NEWB 
services across the country. In accordance 
with available resources, Educational Welfare 
Officers (EWOs) provide an intensive service 
in these areas and work with other agencies 
and services that are engaged with “at risk” 
families. While the Board publishes research 
on school participation, including data on 
attendance and the number of children with 
whom EWOs are engaged on a national and 
regional basis, this data is not broken down 
by LDTF area. The NEWB is also working with 
schools to support them in developing school 
attendance policies (action 36) and has issued 
guidelines for schools on developing Codes of 
Behaviour. It is also developing guidelines on 
attendance strategies for schools.
8   The Education (Welfare) Act, 2000, provides that 
the minimum school - leaving age is 6 years or the 
completion of three years post - primary education, 
whichever is the later.  A widely recognised definition 
of “early school leaver” is that used by Eurostat:  the 
proportion of persons aged 18 to 24 years whose highest 
level of education attained is lower secondary or below 
and who did not received either formal or non - formal 
education in the previous four weeks.  The relevant 
figure for Ireland in 2006 was 2.3% as compared to an 
EU average of 5.2%.  The source of data that Eurostat 
use to create this indicator is the European Labour Force 
Survey, which in the Irish case, is the Quarterly National 
Household Survey (QNHS).
n	 The Department of Education & Science also 
has a number of other programmes which, 
while not specifically included in the NDS, are 
designed to identify and provide supports to 
children at risk. These include the National 
Educational Psychological Service (NEPS) and 
youth Encounter Project Schools.
n	 One of the new actions arising from the 
MTR of the current Strategy was to provide 
additional resources for the Home School 
Community Liaison Scheme (HSCL) which 
was designed to involve parents in their 
children's education. It is regarded by the 
Department of Education & Science as a 
critical intervention in improving outcomes 
of children from disadvantaged areas. The 
HSCL has been expanded to include all DEIS 
schools.
3.8     In summary, three of the four actions relating to 
ESL are ongoing and one (action 03) has been 
completed.  Those that are ongoing are being 
addressed primarily through the broader social 
inclusion agenda.
3.9     There is a strong correlation between ESL and 
all its aspects - poor school attendance, lack 
of engagement in school, disruption, poor 
results etc - and early alcohol/drug use.  The 
socio - economic factors that drive the former 
are primarily the same as those that influence 
the latter behaviour.  These predominantly 
relate, in varying degrees, to the level of 
individual, family and community dysfunction 
experienced and to the level of other negative 
social influences involved, particularly negative 
peer relationships and media influences.  In 
this context, ESL has been identified as a 
critical event in experimentation with drugs 
and, consequently, measures to promote 
successful school completion rates also impact 
on potential problem drug/alcohol use.  
3.10   Projects to address successful school 
completion rates were a central feature of 
the initial LDTF plans.  Many of the initial 
projects have since been mainstreamed, 
with a further tranche of projects currently 
under consideration for mainstreaming.  More 
recently, school completion initiatives have 
figured less prominently in LDTF plans and 
they were not prioritised to any significant 
extent in the RDTF plans.  School completion 
actions have, however, been a strong feature of 
services developed under the young Peoples 
Facilities and Services Fund (yPFSF)89.   
9   Responsibility for the young Peoples Facilities & Services 
Fund transferred to the Office of the Minister for Children 
& youth Affairs from the Department of Community, 
Rural & Gaeltacht Affairs on st January 2009.
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3.11    Meanwhile, addressing ESL and maximising 
successful school completion rates is a central 
pillar of the Government’s social inclusion 
policy.  A number of mainstream actions 
such as youthreach and Senior Traveller 
Training Centres (STTCs) were developed 
by the Department of Education & Science 
under the National Development Plan 200 
- 2006 and are to be further developed under 
Towards 2016.  This focus is also central to 
the activities of Community Training Centres 
administered by FÁS.
3.12    From a community perspective, Area 
Based Partnership Companies also have a 
role in educational development through 
Community - Based youth Initiatives and 
Services for the Unemployed, the two sub 
- measures of the Local Development Social 
Inclusion Programme. The RAPID Education 
Programme, which was implemented in 2008, 
uses RAPID Area Implementation Teams (AITs) 
to develop, from a community perspective, 
suitable educational projects aimed at 
fostering successful school completion.
3.13    Addressing ESL and all its aspects has, 
therefore, been the subject of increased focus 
and attention in recent years, particularly 
since the development of the current NDS. 
Given those developments, the Steering 
Group considers that the role of the new 
NDS in relation to addressing this problem 
lies within the context of complementing 
existing programmes.  This complementarity 
can be best achieved through the further 
development of youth services, particularly 
as they relate to the future educational 
engagement of youth at risk.  Any services 
developed should be based on deepening 
engagement with young people and their 
families in the non - school setting and 
complementing the services being developed 
through the existing programmes.
Education and awareness programmes in school settings
3.14    The two main dimensions of these 
actions were to develop substance misuse 
policies in schools in LDTF areas920 and to 
strengthen drugs education and awareness 
programmes in school settings through a 
variety of measures.  These related to subject 
prioritisation, parental engagement, support 
to teachers and trainee teachers and research 
& evaluation of programmes202. 
20  Action 43.
2  Actions 3, 32, 33, 34, 35, 42 and 02.
Substance Misuse Policies
3.15 The Department of Education & Science 
provides guidance to schools in developing 
substance misuse policies, but the primary 
responsibility for developing and implementing 
such policies rests with individual schools. The 
Regional Office Service of that Department 
monitors compliance with this action and, 
in this regard, it conducted a sample survey 
of schools in December 2005.  Overall, 72% 
of schools responded to the survey and, of 
these, 7% of primary schools and 75% of post 
- primary had policies in place, while a further 
8% and 9% respectively were developing 
policies.  SPHE (Social and Personal Health 
Education) support personnel (para. 3.23 also 
refers) also offer guidance and advice on 
developing school policies but this is only 
available when the school involved seeks such 
support.
3.16    While it is not possible to determine whether 
substance misuse policies exist in all of the 
schools in LDTF areas based on published 
data, it is generally accepted that progress 
in relation to this action is substantially 
completed.  However, there is a lack of 
clarity as to the quality of these policies 
and the degree to which they are actively 
implemented and subject to review.  
Prevention and awareness programmes in schools
3.17    Prevention and awareness programmes in 
schools are a key element of the overall 
prevention pillar. The Social Personal 
Health Education (SPHE) Programme is 
the foundation for developing awareness of 
drugs and alcohol issues in schools.  It is a 
mandatory part of the curriculum at primary 
and junior cycle in second level.
3.18    SPHE is designed to build the esteem 
and confidence of young people through 
developing their life skills, and substance 
misuse is an integral part of the curriculum. 
As part of the programme, the Department 
of Education & Science has developed a 
number of supports for teachers and parents 
through the SPHE Support Services (para.3.23 
also refers).  Drug prevention education is 
part of the pre - service training for primary 
teachers, while it is an elective in the Higher 
Diploma for second - level student teachers. A 
dedicated SPHE inspectorate is also in place. 
The Department of Education & Science is 
currently developing a senior cycle SPHE 
Programme through the National Council for 
Curriculum and Assessment and is working 
on a framework for this with a small number 
of schools.
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3.19    However, a key question has arisen as to 
the effectiveness of SPHE in preventing or 
delaying problem substance use. In this 
context, the SPHE curriculum was reviewed 
and it was found that, in concept and design, 
it is in line with international best practice. 
However, its effectiveness at second level 
was consistently questioned during the NDS 
consultation process, in particular by school 
- goers themselves. 
3.20    One of the key concerns raised during the 
consultation process was the commitment 
given to SPHE by individual schools and 
the support that teachers receive to deliver 
the programme. The findings from the 
consultations suggest that, while a framework 
is in place, there are still key questions to be 
addressed about its delivery in terms of its 
overall effectiveness.
3.21    The Walk Tall Programme and On My Own Two 
Feet are integral parts of the Social, Personal 
and Health Education (SPHE) curricula at 
primary and post - primary level respectively. 
 
The Walk Tall Support Service has, since 
February 2002, supported all primary 
schools in LDTF areas to implement 
the Walk Tall Programme in the context 
of SPHE.  Since September 2007, all DEIS 
schools have been offered similar support. 
 
The Post - Primary SPHE Support Service 
provides support to schools in relation to all 
aspects of the SPHE curriculum, including the 
On My Own Two Feet component.
3.22    Recognising the limitations of the previous 
SPHE evaluation, which did not include the 
views of parents and students, the SPHE 
Management Committee222 commissioned a 
further evaluation by NUIG2223, based on a 
sample of 2 post - primary schools. This 
evaluation found that, while SPHE is regarded 
as challenging, valuable and contributing to 
students’ attitudes to health, the programme 
has a number of limitations:
n	 support services for the delivery of SPHE 
are crucial in developing the competence of 
teachers and schools that find it difficult to 
implement SPHE.  Available support services 
should be targeted at such teachers and 
schools. Whole School Evaluations should 
help to identify such schools. Support for 
22   Membership of the Committee includes representatives 
of the Department of Education & Science, HSE and the 
National Council for Curriculum and Assessment.
23   The Implementation of SPHE at Post Primary Level: A 
Case Study Approach, NUIG, May 2008.
SPHE should be provided in the context of in 
- service training;
n	 there is little engagement with parents in the 
planning and development of SPHE; and 
n	 curriculum overload, timetabling pressures 
and lack of status for SPHE affect its provision 
in schools.
 
The evaluation also noted that the development 
of whole school planning is fundamental to 
the creation of a supportive whole school 
approach and this process should include 
assigning SPHE the same level of importance 
as any other subject area.
3.23   The Steering Group notes that full - time supports 
have been in place since the inception of 
SPHE to provide professional development for 
teachers, as well as school visits, a website and 
a resource directory. However, the evaluation 
has highlighted difficulties relating to second - 
level schools continually assigning responsibility 
for the subject to different teachers, thereby 
diluting the impact of the investment in 
professional development for teachers. The 
lack of a pre - service qualification in this area 
is also a problem. However, the programme is 
being delivered in all schools and the general 
feedback is that the curriculum support services 
are viewed very positively. The Department of 
Education & Science will continue to work with 
those services to strengthen implementation in 
this important area.
3.24   The Steering Group also believes that more 
should be done to  incorporate the self - esteem, 
personal development, health and well - being 
and substance prevention message - that is at 
the core of the SPHE and other prevention/
awareness programmes in schools - into the 
broader school curriculum and environment. 
The Group feel that improvements to the 
programme could be made by delivering it in 
a manner more appropriate to the lifestyle of 
the students, with more focused efforts being 
made to integrate the SPHE message into other 
areas of school work (e.g. science subjects) and, 
indeed, across whole school activity, including 
sport and recreational activities.  
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Education and awareness programmes in non - 
school settings and development of diversionary 
programmes
3.25    The two key dimensions of these actions 
related to the development of diversionary 
alternatives particularly in LDTF areas2324 and 
the application of SPHE - type prevention 
programmes in non - school settings, 
facilitated through the establishment of a 
working group2425. 
3.26    The yPFSF has been the main funding 
mechanism for providing alternative activities 
for young people under the current NDS. 
Between 2002 - 2007, funding of €27.5m 
was provided to approximately 500 services 
and facilities in LDTF areas and four other 
designated urban centres - Limerick, 
Waterford, Carlow and Galway. Drugs Task 
Forces have also been involved in developing 
prevention/awareness programmes.  In 2008, 
some 289 projects, with a value of €8.95m, 
across both Local and Regional Drugs Task 
Forces had either an exclusive education/
prevention focus or included prevention/
education as part of the project remit. These 
figures include LDTF activities in both school 
and non - school settings, with many aimed 
towards at risk populations.  Others focus on 
raising broader community awareness. 
3.27    Non - school projects that focused on at risk 
young people facilitated the development and 
extension of activities. The 2008 evaluation 
of LDTF  projects2526 found that the available 
evidence suggests that diversion may have a 
role to play in preventing problem drug use in 
at risk groups.  However, many LDTF - funded 
projects of this type concentrated on creating 
diversionary opportunities, rather than on 
specific prevention interventions, indicating a 
need for further training among those running 
such projects.  It also concluded that more 
generic programmes to address risk factors 
may be more appropriate for funding through 
mainstream provision.  In this context, a 
particular challenge for these education and 
prevention projects is to improve links with 
other services and to identify appropriate 
referral routes. 
24  Action 3.
25   Action 37 (Implementing Actions 3 - 35 in non - school 
settings).
26   National Drugs Strategy Team:  Evaluation of LDTF 
Projects: Horwath Consulting Ireland Ltd, January 2008. 
The aim of the evaluation was to assess the contribution 
of projects to LDTF plans and the implementation of the 
National Drugs Strategy 200 - 2008.  The evaluation 
examined the structures, effectiveness, efficiency and 
value for money components of the projects.
3.28    In addition to the yPFSF, a number of funding 
streams positively impact on young people 
who are subject to various risks. These 
include:
n	 Special projects to assist disadvantaged youth 
(SPy) (operated through the Department of 
Education & Science);
n	 HSE - funded initiatives in relation to 
education and prevention; and
n	 Garda Juvenile Diversion Programme 
(operated by Juvenile Liaison Officers) 
and Garda youth Diversion Projects 
(funded by the Irish youth Justice Service).  
 
The more general youth Service Grant 
Scheme/Local youth Club Grants (operated 
through the VECs) is also worth noting in this 
regard.
3.29    In recent years, there have been significant 
increases in the Garda Juvenile Diversion 
Programme and the Garda youth Diversion 
Projects, with over 00 projects working with 
young people at risk of engaging in crime 
and substance misuse in targeted locations 
around the country.  However, progress has 
been modest in monitoring the effectiveness 
of such schemes - e.g the Arrest Referral 
Scheme (action 3 of the current NDS refers). 
Under its National Strategy 2008 - 200, the 
Irish youth Justice Service, in partnership 
with An Garda Síochána, intends undertaking 
a programme aimed at improving the 
effectiveness of projects.
3.30    The Garda youth Diversion Projects are 
regarded as being broadly successful in 
diverting large numbers of young people 
from the formal criminal justice system2627, 
with the onward referral of young people 
identified as being at risk. Consequently, 
the Steering Group considers that such 
programmes should continue to be part of 
the broader NDS, with any expansion being 
subject to robust measuring and evaluation 
of the impact of existing projects.  
27   Publications in respect of the Garda Diversion 
Projects and Special Projects: Study on the 
“Impact and Effectiveness of the Garda Special 
Projects”:  Matt Bowden & Louise Higgins, May 2000 
Annual Report of the Committee Appointed to Monitor 
the Effectiveness of the Diversion Programme, 2005.
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3.31    Furthermore, the Steering Group believes 
that greater links are necessary between the 
various agencies with responsibility for the 
wider needs of young people. In particular, 
there should be closer co - operation between 
An Garda Síochána, the Office for the Minister 
of Children and youth Affairs (OMCyA), 
the HSE and the voluntary and community 
sectors (particularly youth organisations), all 
of whom play a role in this area.  This is 
encompassed by the National youth Justice 
Strategy 2008 - 200.
3.32    Overall, as with the yPFSF, the Steering 
Group believes that the focus under such 
programmes on “at risk” young people is 
critical and must  continue into the future. 
This is essential to ensure that additional 
services are provided that complement those 
already provided.
Future youth Service Provision
3.33    Generally, there are two key dimensions to 
youth services provided through community 
and youth organisations:
n	 provision of professional youth services, 
aimed primarily at youth at risk; and 
n	 voluntary based youth and sports activities, 
which have a mainly  recreational focus, 
aimed at facilitating the engagement of the 
youth population in activities and pursuits. 
This is primarily volunteer - driven where 
people come together to engage in a common 
interest (e.g. youth theatre, environmental 
issues), to run a youth club or to pursue a 
sporting activity.   
Provision of professional youth services aimed 
primarily at youth at risk
3.34    There is a wide range of youth services 
operating that are aimed at the at risk youth 
population.  These have been developed 
under a range of agencies with a health, 
justice, education or drugs focus to address a 
variety of issues from child protection through 
to promoting health awareness.  In essence, 
these services try to address broadly similar 
risk factors associated with the individuals 
involved, their families, their peers and their 
communities and it is generally accepted that 
there is a need for greater integration and co 
- operation between agencies. 
3.35    Bringing all youth services under the OMCyA 
aims to facilitate the integration of youth 
services at a national level. Co - ordination 
between the services and provisions for young 
people is aimed at ensuring better efficiency 
and effectiveness. In this regard, it is noted 
that elements of the youth Work Act 200 
(particularly the county planning mechanism) 
could promote a more coherent approach to 
the provision of youth work services across 
the country. In terms of the NDS, it is critical 
that the drugs issue remains central to the 
ongoing development of youth services and, 
in particular, to educational/recreational 
activities for young people who are most at 
risk.
3.36    The fact that a working group (action 37) was 
not established to facilitate the implementation 
of actions 3 - 35 in non - school settings 
has, the Steering Group believes, contributed 
to preventative initiatives remaining largely 
unco - ordinated at a national level. This, 
in turn, has led to significant potential for 
inconsistent approaches to drug education 
by different groups and organisations. 
In order to develop a uniform approach 
to drugs education in school, youth and 
community settings throughout the country, 
the Drug Education Workers Forum (DEWF) 
developed a quality standards framework and 
also provided seminars for people working in 
drugs education. Funding was provided from 
the Department of Community, Rural and 
Gaeltacht Affairs to print the training manual 
and to roll out a 3 - year training programme 
on the quality standards.  The aim is to bring 
more consistency in approaches utilised and 
the Steering Group believes that the DEWF 
framework should be used as the standards, 
or the basis for the standards, to be applied 
in respect of drugs education across all 
youth services. A lead agency is required 
to drive this formal recognition of a set of 
national standards and the Steering Group 
feels that the OMCyA is best placed to take 
on this role.  The standards agreed (subject 
to amendments over time) should also be 
applied to future preventative and awareness 
messages aimed at voluntary - based youth 
and sport activities.
3.37    As outlined above, the yPFSF has been 
the key mechanism for developing youth 
facilities under the current NDS.   In regard 
to facilities, the Steering Group considers 
that a number of issues need to continue 
to be pursued in regard to accessing new 
and existing community, sports and schools 
buildings.  These include: 
n	 ensuring that appropriate supervision and 
support is in place;
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n	 guaranteed access for the most at risk young 
people; and 
n	 late night and weekend access. 
3.38    The Steering Group understands that the 
OMCyA is currently examining the issue 
of youth café development.  During the 
consultation phase for the new Strategy, 
the need to ensure late night and weekend 
opening of such facilities was highlighted, as 
was the need to put in place structures that 
promote preventative measures to the youth 
who use them.  In this regard, international 
evidence suggests that activities on their own 
are not sufficient to prevent substance misuse 
– there is also a need to have complementary 
structured programmes of supports.  These 
could include brief interventions, referral to 
other services, as appropriate, and educational 
activities.  This is not only relevant to youth 
cafes, but also to all diversionary activities 
aimed at both youth at risk and the general 
youth population.
Voluntary - based youth and Sport Activities
3.39    Internationally, it is accepted that it is vital 
to promote drug prevention messages to 
the general youth population, as well as 
putting particular focus on youth at risk.  The 
Drug Prevalence Survey 2006/72728 confirms 
the availability of drugs across the country 
and given the mix of drugs involved, all youth 
are clearly at risk of becoming involved. 
Furthermore, the fact that at any particular 
time certain drugs are seen as “fashionable”, 
along with their association with general 
recreation, dance etc, can increase the risk 
for some young people.   
3.40    Many youth initiatives in Ireland are aimed 
at the general youth population (which 
includes youth at particular risk).  These 
are managed and developed in the main by 
the various youth organisations and sports 
clubs, often with Government supports under 
various schemes.  These settings afford an 
opportunity to promote substance awareness 
and prevention messages.  They also afford 
a significant opportunity to promote peer 
- led approaches to the dissemination of 
prevention messages.  
28   Drug Use in Ireland and Northern Ireland – 2002/2003 
and 2006/2007 – Drug Prevalence Surveys:  National 
Advisory Committee on Drugs and Public Health 
Information & Research Branch (PHIRB) in Northern 
Ireland.
3.41    Under the yPFSF, funding for the employment 
of drugs education officers was provided 
to a number of youth organisations to 
develop and implement drugs education 
programmes for the young people involved. 
The Steering Group believes that there is 
scope for developing such drugs education 
programmes further.
Awareness Campaigns - National, Regional and Local 
Level
3.42    These actions involved a national awareness 
campaign2829, community - based initiatives to 
promote awareness including involvement 
of user groups2930 and the role of the media 
in developing understanding of substance 
misuse303.
3.43    A national awareness campaign which
was conducted between 2003 and 2005 
incorporated a number of elements aimed at 
raising: 
n	 drug awareness among the general 
population;
n	 drug awareness among parents; 
n	 awareness about cocaine primarily among 
younger adults; and  
n	 awareness about cannabis among the 5/6 
age group.
3.44    The evaluation of the campaign subsequently 
commissioned by the NACD332 found that 
it was difficult to demonstrate whether the 
campaign had been effective in achieving its 
objectives.  The review highlighted tensions 
in the co - ordinating structures, as well as an 
inadequate level of funding, that contributed 
to limiting the effectiveness of the campaign. 
3.45    The Steering Group notes that the evidence 
of the general effectiveness of awareness 
campaigns  - as stand - alone activities - has not 
been proven in terms of success in changing 
behaviours. The NACD evaluation concluded 
that stand - alone mass media campaigns are 
less effective than multi - component, multi 
- level interventions that reflect the complex 
nature of drug prevention and harm reduction. 
The evaluation also called for greater inter 
- agency working to maximise the impact 
of campaigns and that national and local 
campaigns should be closely linked. 
29  Action 38.
30  Actions 95, 96 and 97. 
3  Action 73. 
32   A Process Evaluation of the National Drug Awareness 
Campaign 2003 - 2005:  NACD, January 2008.
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3.46    The 2008 national drugs awareness campaign 
(focusing on cocaine) which was led by 
the HSE utilised multi - media approaches 
appropriate to the target audience.  Local 
cocaine campaigns which linked in with the 
aims and objectives of the national campaign 
were implemented in late 2008.   In developing 
these and future campaigns, there is a need 
to focus on ensuring that local, regional and 
national campaigns complement each other. 
The Steering Group considers that specific 
segments could also be aimed at third - 
level institutions, workplaces and recreational 
venues. 
3.47    A national website funded by the HSE and 
run by Crosscare (www.drugs.ie) and a 
number of project - based websites that 
promote awareness and provide information 
and points of contact, have also been 
developed under the NDS.   However, the 
use of the internet and modern technologies 
is underdeveloped and the Steering Group 
believes that these should be a focus for 
development under the new Strategy, with a 
view to providing comprehensive information 
on issues involved and services available.  
3.48    With regard to the new Strategy, the Steering 
Group considers that a series of awareness 
campaigns should be developed that would: 
n	 ensure that local and regional campaigns 
complement and add value to national 
campaigns; 
n	 optimise the use of ICT in drugs awareness 
initiatives (e.g. through internet search 
engines and social network websites); 
n	 ensure a co - ordinated approach by all 
key players to the development and 
implementation of a designated drug 
awareness week/day with agreed themes 
and methodologies; and 
n	 through the engagement with services users, 
representatives or services working with the 
following communities, target:
 q  third level educational institutions, 
workplaces and recreational venues; 
 q  at risk groups (Travellers, new communities, 
lesbian, gay, bi - sexual, transgender 
community (LGBTs), homeless people, 
prisoners and sex workers); and 
 q  education/awareness among drug users 
to minimise the levels of usage and to 
promote harm reduction measures.
3.49    In general, it is felt that the media, in their 
broadest context, play a significant role in 
society’s understanding and perception of 
problem alcohol and drug use.  In relation 
to alcohol, advertising and sponsorships 
(especially in the sporting context) are 
seen as particular problems, especially as 
they are often targeted at the young and 
impressionable.  In this context, it is noted 
that strengthened codes on advertising and 
sponsorship, which were developed between 
the Department of Health & Children and 
representatives of the Irish drinks and 
advertising industries, came into effect on 
st July 2008.  Under these codes, the Irish 
alcohol industry may not sponsor any sporting 
competitions, leagues, events or competitors 
where such events are designated specifically 
for participants under 8 years of age. In 
this context, the Department of Health & 
Children established a Working Group to 
engage with relevant stakeholders and the 
sporting bodies to examine the extent of 
sport sponsorship by alcohol companies and 
to consider how the health - related concerns 
might be further addressed.  The Working 
Group is expected to report in Autumn 
2009.  The Steering Group welcomes these 
developments. 
3.50    While much media coverage is responsible 
and informed, the view was expressed 
during the consultation process that the 
media does, in many ways, contribute to the 
glamourisation of drugs - rather than creating 
an understanding of the dangers of substance 
misuse.  It clearly can have both negative and 
positive effects ranging from benign reporting 
on drug use among celebrities - with fears 
that this promotes drug use - to the factual 
exposition of the consequences of problem 
drug use - be it for individuals and their 
families or for communities.  
KeyfiNDiNgSfrOmTheCONSulTATiON
PrOCeSS-quAliTATiveASSeSSmeNT
3.51    One of the key themes to emerge from the 
consultation process is the perception that 
drug and alcohol use is more widespread and 
that the age profile of those involved is getting 
younger. Measures to prevent and/or delay 
drug and alcohol use – especially amongst 
young people – are, therefore, particularly 
important and urgent.
3.52    While it is possible to demonstrate clear 
progress in implementing the current 
NDS actions in relation to prevention, the 
consultation process found that prevention 
measures are not seen to be making sufficient 
impact. 
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3.53    The key themes to emerge from the 
consultation were:
n	 school - based education programmes, on 
which the NDS places particular emphasis, 
were considered to be very uneven in their 
delivery and, therefore, in their overall 
impact. The impact fundamentally depends 
on the commitment of individual schools and 
the confidence and competence of individual 
teachers. young people consulted were highly 
critical of their experiences of the delivery of 
SPHE. The recent evaluation of SPHE has 
also identified areas to prioritise in order to 
achieve improvements in the effectiveness of 
school programmes, in particular, support for 
teachers and schools and significantly better 
engagement with parents.  
n	 access to recreational and other facilities 
for young people was considered to be 
important in preventing them from misusing 
drugs and alcohol. While numerous examples 
of worthwhile youth clubs, and other out - of 
- school facilities that provide alternatives for 
young people were highlighted throughout 
the consultation process, the lack of such 
facilities and appropriate supporting 
structures across the country emerged as 
a key gap.  Such facilities are particularly 
important for young people who leave school 
early.  In this regard, the Steering Group 
believes that the scope to provide access to 
school facilities outside of school hours is an 
issue that should be progressed as a matter of 
urgency. 
PrOgreSSAgAiNSTCurreNTKPis
3.54   This assessment of impact is based on the revised KPIs agreed during the MTR of the current NDS, which 
was carried out in 2005: 
KeyPerformanceindicator Outcome
The 3 source Capture - Recapture study 
estimate of opiate misusers to show a 
stabilisation in terms of overall numbers and 
to show a reduction of 5% of the prevalence 
rate based on 2001 figures published in 2003 
The latest 3 source capture - recapture study had not been completed by 
the time the Steering Group finalised this Report.  However, it is noted 
that heroin use continues to be concentrated primarily in areas of urban 
disadvantage in Dublin and in other urban centres, particularly in Leinster 
and the south of the country.  The prevalence of heroin has ameliorated 
to an extent in the Dublin area with a significant drop in the rate of new 
entrants identified.  However, this has been offset to a degree by its wider 
dispersal around the country.  Overall, the rate of new entrants to treatment 
had dropped significantly by approximately 20% between 200/02 and 
2006/07.  Heroin remains a significant problem and a matter of serious 
concern for many communities, however.   
The NACD Drug Prevalence 2006/07 Survey 
to show a reduction of 5% of the prevalence 
rate of recent and current use of illicit drugs in 
the overall population based on the 2002/03 
rate 
Prevalence of recent drug use (use in last year) increased from 5.6% in 
2002/03 to 7.2% in 2006/07 among all adults aged 5 - 64.  
The trend for overall current drug use (use in last month) remained stable 
at 2.9%, though, for the younger adults group (5 - 34), it decreased from 
5.2% to 4.8%.  
Substance use policies in place in 100% of 
schools 
A Department of Education & Science study in 2005 indicated that substance 
misuse policies were in place in between 89% and 94% of primary and post 
- primary schools that made returns (72% of schools made returns). 
Early school leaving in LDTF areas reduced by 
10% based on 2005/06 rate 
Data specific to LDTF areas is not available. Current data on early school 
leaving is available through: 
I. School retention rates of pupils; 
II. Eurostat; and 
III. Quarterly National Household Survey (QNHS).
While it is not possible to definitively conclude that ESL has reduced by 
0% in LDTF areas, both Eurostat and the QNHS suggest that the number 
of early school leavers is reducing. Eurostat data shows that the percentage 
of people aged 8 - 24 who have, at most, lower secondary education has 
decreased from 4.7% in 2002 to 2.3% in 2006. While the QNHS survey 
shows that 6.% of people had not attained a Leaving Certificate in 200, 
this had reduced to 4.37% in 2006. 
Thus, the figures show a downward trend in early school leavers. Together 
with feedback from the LDTFs, it is reasonable to contend that this indicator 
is, at least, going in the right direction.
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3.55    The Steering Group notes that while the 
increase in levels of last year drug use is a 
cause for concern, the stabilisation of current 
drug use is welcome and is broadly similar to 
what is happening in the rest of the EU.   
CONCluSiONSANDPriOriTieSfOrThe
fuTureDrugSSTrATegy
3.56    Overall, the Steering Group believes that a 
tiered or graduated approach to prevention 
and education measures in relation to drugs 
and alcohol should be developed with a 
view to providing a framework for the future 
design and development of interventions. 
This would involve varying degrees of 
intervention involving a “light touch” for the 
general population who are less at risk, up to 
a more concerted effort at a younger age for 
those most at risk.  It would necessitate well 
- developed inter - agency working, with all 
involved needing to be clear of their own roles 
and knowledgeable on the roles of others. 
In assessing the level of risk involved, the 
overall environment incorporating individual 
development, parents, peers, school and 
community would all be factors.  
3.57    Interventions could be seen to fall under the 
following broad headings:
(i)  Universal (primary) prevention programmes: 
n	 Aimed at reaching the general population 
such as students in schools, to promote overall 
health of the population and to prevent the 
onset of drug and alcohol misuse.  Measures 
often associated with this type of programme 
include awareness campaigns, school drug/
alcohol education programmes and multi  - - 
component community initiatives.
(ii)  Selected (secondary) prevention programmes:
n	 Aimed at groups at risk, as well as subsets 
of the general population including children 
of drug users, early school leavers and those 
involved in anti - social behaviour.  These 
programmes aim to reduce the effect of risk 
factors present in these subgroups by building 
on strengths and developing resilience and 
protective factors.
(iii) Targeted (tertiary) prevention programmes:
n	 Targeted at people who have already started 
using drugs/alcohol, or who are likely/
vulnerable to engage in problematic drug/
alcohol use (but may not necessarily be drug/
alcohol dependent), or to prevent relapse. 
These require individual or small group 
programmes aimed at addressing specific 
needs.
3.58    As outlined above, prevention is a particularly 
complex pillar with intricate connections 
between skills and understanding of the 
consequences of problem drug/alcohol use, 
exposure to risk factors and early drug/
alcohol experimentation. The focus of 
prevention measures in the current NDS has, 
to a large extent, been on the provision of 
education services in school - settings for the 
school - going population. While conceptually 
these programmes are sound, and in line with 
evidence - based practice on prevention, the 
Steering Group notes that their application 
and delivery limit their effectiveness. 
3.59    Provision of education in non - school 
settings remains fragmented and unco 
- ordinated, in part due to the failure to 
set up a working group (action 37) to co 
- ordinate the application of school - type 
programmes in non - school settings.  The 
provision of alternative recreational facilities 
for young people is also underdeveloped. In 
addition, despite significant expenditure on 
recreational activities, many young people do 
not have access to such facilities in out - of 
- school settings. There is considerable scope 
to streamline funding mechanisms to provide 
a comprehensive range of structured, out - of 
-  school alternatives. However, in order to be 
most effective, they will need to be targeted 
at young people who are most at risk and 
be developed as part of overall prevention 
programmes. The Steering Group believes 
that the enhanced role of the OMCyA offers 
the potential to bring more coherence in this 
area.  
3.60    The Steering Group is of the view that there 
is a need to further develop and promote 
prevention strategies in a number of other key 
areas – third - level institutions, workplaces, 
sports and other community and voluntary 
organisations.  Much work has been done in 
these areas to date:
n	 All universities have alcohol policies in place; 
n	 IBEC promotes a policy on intoxicants among 
its membership; 
n	 Trade unions have consistently been involved 
with the issue, both in the workplace and the 
wider community; and 
n	 Many sports and youth organisations have 
substance misuse policies in place or in 
development.  
The Steering Group considers that there is a 
need to further promote the development of 
substance misuse policies in these settings, 
along with the development of a brief 
interventions approach, where appropriate.
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3.61    As outlined in chapter , the considerable 
negative impact that problem drug and 
alcohol use has on families is well known. 
The effects include deteriorating relationships 
and making the family dysfunctional, 
psychological and social problems, increased 
stress, depression and behavioural disorders, 
and financial difficulties – all of which can 
contribute to family breakdown and negative 
impacts on adults and, particularly, on 
children in families.  The latter are likely to 
be at high risk due to the prevalence of drug/
alcohol misuse within their families, peers 
and communities and are at risk of becoming 
problem drug users in later life.  Accordingly, 
the Steering Group recommends that actions 
to support the families of drug users should 
be developed as part of the new NDS. 
3.62    In the context of this pillar, the potential role 
that an overdose prevention policy could play 
is also noted.  This issue is developed in more 
detail in chapter 4.  
3.63    A key feature of Towards 2016 is the 
identification of improved educational 
outcomes as an important priority. Measures 
to address key risk factors to delay/
prevent people from using substances are 
fundamentally connected to the wider 
Government policy of improved educational 
outcomes.  A key future priority is a more 
concerted approach to prevention, in 
particular to address the risk and prevention 
factors that can affect early experimentation 
with drugs and alcohol.
3.64    Evidence suggests that the nature of the 
drugs problem is changing and becoming 
more complex.  Drugs are generally more 
widely accessible to young people. These 
trends require a more concerted approach 
to prevention, with a strong emphasis on 
co - ordinating the actions of the different 
agencies involved in delivering programmes, 
as well as funding diversionary programmes 
such as the yPFSF.   
3.65    The Steering Group acknowledges social 
capital as a critical component in building 
resilience in communities, as was pointed 
out in the NACD Community Drug Study3233. 
High levels of social capital (encompassing 
engagement in the community, volunteering, 
working together and overall positive 
community spirit and identity) act as a buffer 
against the dangers of problem drug and/or 
alcohol use.  On the other hand, the lack 
of social capital in a community can act as 
an early warning in regard to the presence 
33   A Community Drugs Case Study – Developing 
Community Indicators for Problem Drug Use:  NACD, 
2006.
of problems relating to drugs and/or anti 
- social behaviour.  Accordingly, supporting 
community development to enable the 
building of capacity to avoid, or respond to 
and cope with, drug problems, is important in 
terms of substance misuse prevention.  Such 
capacity can also facilitate more effective 
local level activity around drug and alcohol 
prevention and awareness initiatives. 
3.66    The important role which Civil Society plays 
in drugs prevention is now being more 
recognised at EU level.  It is considered 
important that the experiences of people in 
their communities contribute to the debate 
and thus inform public policy.  The Steering 
Group notes that Ireland has a strong 
history in this regard and can contribute to 
developments at EU level. 
PriOriTieS
3.67    In light of the above, the Steering Group has 
identified the following  priorities in relation to 
prevention under the new NDS: 
n	 the further development of a tiered or 
graduated approach to prevention and 
education measures in relation to drugs and 
alcohol.  This approach would provide a 
framework for the future design of targeted 
prevention and education interventions;
n	 improved delivery of SPHE in primary and 
post - primary schools,  encompassing the 
implementation of the recommendations of 
the SPHE evaluation in post primary schools 
and the development of a whole school 
approach to substance use education in the 
context of SPHE; 
n	 the co - ordination of the activities and 
funding of youth interventions in out - of - 
school settings to optimise their impacts; 
n	 a continued focus on orienting educational 
and youth services towards early interventions 
for people and communities that are most at 
risk; 
n	 the promotion of healthier lifestyle choices 
among young people in regard to the dangers 
of alcohol, with particular reference to misuse 
and binge drinking; and
n	 the development of timely awareness 
campaigns targeted in a way that take 
individual, social and environmental 
conditions into account.  
3.68   These issues are returned to in Chapter 7 
where actions in relation to the new Strategy 
are identified. 
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Tertiary
Prevention 
indicative 
programmes
Targets 
drug users
Selected(Secondary)Prevention
programmes:
target those with increased risk 
such as early school leavers, young offenders, 
children of drug and/or alcohol dependent 
parents and disadvantaged communities.
universal(Primary)Preventionprogrammes:
target the general population with school programmes and 
workplace initiatives, population health, awareness campaigns, 
multi - component community initiatives including supply reduction, 
thereby creating an environment conducive to health and well - being supporting 
engagement of people in community life.
POPulATiON
Prevention:
Treatment 
& Rehabilitation 
Targets people 
who have already used 
drugs/alcohol 
or who are 
likely/vulnerable 
to do so.
iNDiviDuAl
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4
CHAPTER 4 
TREATMENT AND 
REHABILITATION 
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ChApTEr 4 
TreATmeNTANDrehABiliTATiON

iNTrODuCTiON
4.1 The Treatment and rehabilitation pillar of 
the current NDS focused on developing 
services to address the health and social 
consequences of problem drug use by 
individuals, particularly those misusing 
opiates.  The primary aim was to put in place 
services to cater for opiate misusers with 
a strong focus on the original LDTF areas 
(primarily in Dublin) where the problem was 
most concentrated.  More recently, the focus 
has broadened to re - engineering services 
to develop a comprehensive substance 
treatment service capable of dealing with all 
substances, particularly given the increasing 
geographic dispersal of problem drug use 
(including opiates), the increased prevalence 
of polydrug use and cocaine use, the 
increasing strength of cannabis, as well as the 
pervasive misuse of alcohol and the level of 
misuse of prescription drugs in society.
4.2 In developing this chapter, and in line with the 
Government decision to develop a National 
Substance Misuse Strategy, the Steering 
Group was conscious of the need to bring 
greater coherence and co - ordination to 
alcohol and drug issues at a policy, planning 
and operational level.  In this context, the 
Group strongly endorses the approach of 
the HSE involving the re - orientation of its 
addiction services towards polydrug issues 
(including alcohol), using a 4 - tiered model 
approach3334 as a national framework through 
which to deliver services. The integration of 
treatment services within the context of the 
NDS relates to the integration of addiction 
services and the development of appropriate 
pathways to and from general health service 
provision.  
ASSeSSmeNTOfPrOgreSSDuriNgThe
PeriODOfTheCurreNTNDS
4.3 The strategic aim of the pillar is set out in 
Table 4.. below. Treatment and rehabilitation 
accounted for nearly 40% of the actions 
in the current Strategy.   Given the health 
focus involved, the HSE3435 was responsible for 
delivering/leading on many of the actions, 
but there were important roles for a number 
of other Departments/Agencies including:
n	 Department of Health & Children; 
n	 Department of Community Rural & Gaeltacht 
Affairs;
n	 NDST/Drugs Task Forces;
n	 FÁS;
34   Four tiers of service delivery are used to denote 
different levels of service provision.  These are: 
Tier 1:  Generic services which would include drug - 
related information and advice, screening and referral 
and would be aimed at those who might consider, or 
who are at the early stages of, experimentation with 
drugs or alcohol.  Service providers might include An 
Garda Síochána, General Practitioners or community 
and family.  Tier2:  Services with specialist expertise 
in either mental health or addiction, such as juvenile 
liaison officers, local drugs task forces, home - school 
liaison, youthreach, General Practitioners specialising 
in addiction and drug treatment centres.  The types 
of service delivered at this level would include drug 
- related prevention, brief intervention, counselling 
and harm reduction and would be suitable for those 
encountering problems as a result of drug or alcohol 
use.  Tier 2 interventions are delivered through outreach, 
primary care, pharmacies, emergency departments, 
liver units, antenatal clinics or in social care, education 
or criminal settings (An Garda Síochána, the Probation 
Service, the Courts Service, Irish Prison Service).  Tier3: 
Services with specialist expertise in both mental health 
and addiction.  These services would have the capacity 
to deliver comprehensive treatments through a multi - 
disciplinary team.  Such a team would provide medical 
treatment for addiction, psychiatric treatment, outreach, 
psychological assessment and interventions, and family 
therapy.  Tier 3 interventions are mainly delivered in 
specialised structured community addiction services but 
can also be sited in primary care settings such as level  
and 2 GPs, pharmacies, prisons and probation services. 
Tier4:  Services with specialist expertise in both mental 
health and addiction and the capacity to deliver a brief, 
but very intensive, intervention through an inpatient or 
day hospital.  These types of service would be suitable 
for those encountering severe problems as a result of 
drugs or alcohol. 
35   HSE, when it was established, took over delivery of 
services from the relevant Health Boards.
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n	 Irish Prison Service;
n	 Department of Education & Science; and
n	 Department of Environment, Heritage & Local 
Government.
4.4 In addition, the voluntary sector have 
historically played a significant role in the 
development and delivery of treatment 
and rehabilitation services nationally.  The 
Probation Service and the Homeless Agency3536 
have also had important roles in facilitating 
the development of services.  Overall, this 
has resulted in a significant increase in the 
range of services being delivered by the 
statutory, community and voluntary sectors. 
Table 4.1. – Strategic Aims and Objectives 
of the Treatment pillar under the current 
National drugs Strategy
National Drugs Strategy 2001 - 2008 
– Treatment
Strategic Aims
n	 To enable people with drug misuse 
problems to access treatment and other 
supports and to re - integrate into 
society;
n	 To reduce the risk behaviour associated 
with drug misuse; and
n	 	To reduce the harm caused by drug misuse 
to individuals, families and communities.
Strategic Objectives
n	 To encourage and enable those 
dependent on drugs to avail of treatment 
with the aim of reducing dependency and 
improving overall health and social well 
- being, with the ultimate aim of leading a 
drug - free lifestyle; and
n	 To minimise the harm to those who 
continue to engage in drug - taking 
activities that put them at risk.
4.5 With respect to treatment, the following were 
identified as being the key issues over the 
lifetime of the current NDS:
n	 Access for drug misusers to treatment within 
one month;
36   The Probation Service, working both in prisons and the 
community, provides a significant level of resources 
and services for problematic substance misusers on 
Probation Orders, Community Service Orders, in prison 
or on Post Release Supervision.  The Homeless Agency 
was established in 200 and has sought to co - ordinate 
the development of services for homeless people in 
the Dublin area, as outlined in their strategies, most 
recently, “A Key to the Door 2007 - 200”.
n	 Development of a range of treatment options, 
including harm reduction approaches;
n	 Access for under - 8s to treatment following 
the development of an appropriate protocol; 
and
n	 Development of prison - based drug treatment 
services. 
Access for drug misusers to treatment within one month
4.6 Over the period 200 - 07, opiates were the 
main problem drug treated (on average, 
opiates accounted for 63% of all cases entering 
treatment annually over the period), followed 
by cannabis (23%), and cocaine (7%).  The 
main change has been the increase in the 
numbers reporting cocaine as their main 
problem drug, which has increased from 
approximately 2% in 200 to 3.5% in 2007.
4.7  A central feature of those entering into 
treatment has been the poly - substance 
nature of their misuse.  Each year between 
200 and 2007, between 70% and 75% of 
people entering treatment services (includes 
new cases and previously treated cases) had 
problem use of more than one drug3637.   
4.8 An early and urgent priority of the NDS was 
to increase the availability of treatment for 
opiate users, in particular, through developing 
access to methadone treatment.  The NDS 
set a target of 6,500 treatment places by 2002. 
This has been surpassed with the number 
of individuals on methadone treatment 
increasing from 4,963 in 200 to 8,794 by 
end March 2009 - an increase of 77%. This 
has resulted in the condition of many users 
stabilising, leading to a much improved quality 
of life for them.  The above figures do not 
reflect the full number of people who receive 
treatment in a full year.  In 2007, for example, 
9,756 received methadone treatment during 
the course of the year, while approximately 
8,500 were in receipt of treatment in any 
particular week.
4.9 The HSE indicates that people who present 
for treatment are generally assessed within 
 week and offered treatment within 8 to 
0 weeks.  Notwithstanding this, and the 
significantly increased numbers in methadone 
treatment, there are a number of places where 
services, particularly methadone services, are 
not provided within one month, as envisaged 
under the current Strategy. Waiting times 
37   HRB Trends Series 2, Trends in treated problem drug use 
in Ireland, 200 to 2006, Health Research Board, 2008. 
Figures for 2007 from the NDTRS, ADRU, HRB, March 
2009.
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vary around the country.  Analysis at the end 
of 2008 indicates that:
n	 7 of the 26 clinic areas throughout the 
country have waiting times of 3 months or 
less (less than one month in 8 areas); and 
n	 the remaining 9 areas currently have waiting 
times in excess of 3 months (with 4 of these 
areas reporting waiting times of a year or 
more). 
4.10  Recent data3738 from the HSE indicates that 
there were approximately 550 people waiting 
for methadone treatment across the country 
- with 7% of these relating to 7 treatment 
centres.  These centres are in the midlands, 
the south east, the south and in Dublin. 
4.11  The Steering Group notes that the main 
reason for the waiting lists outside of Dublin 
is the lack of level 2 GPs3839 (this is looked at in 
more detail later in the chapter).  With respect 
to Dublin, a primary cause of waiting lists in 
one of the centres relates to the complex 
nature of the cases being dealt with, resulting 
in longer turnover times being experienced 
and the lack of appropriate services for 
onward referral.  Overall, the Steering Group 
notes that an underlying problem has been 
the lack of adequate additional resources for 
the development of treatment services within 
the HSE addiction services. 
4.12  The HSE is currently considering the adoption 
of a standard definition and national 
protocol concerning waiting times for opiate 
treatment.  This is with a view to ensuring 
that a comprehensive data system is in place 
to monitor the progress of opiate treatment 
service provision.
4.13  As the primary focus under the current 
Strategy has been on timely provision of 
opiate services, no register of the treatment 
for other drugs such as cocaine and cannabis 
has been developed.  However, on the basis 
of the cases reported to the National Drug 
Treatment Reporting System (NDTRS) in 
2007, it is noted that treatment for non - 
opiate addiction was provided in almost all 
cases within the target one month waiting 
period.
38   Figures supplied to the Inter Departmental Group on 
Drugs (IDG) in December 2008. 
39   Level 2 GPs can initiate treatment.
4.14  The expansion of methadone treatment has 
been possible across the country through 
the expansion and development of HSE 
clinics, many of which are in community and 
voluntary sector premises, and the increase 
in the number of GPs and pharmacies 
participating in the Methadone Protocol. 
Table 4.2: participation in the Methadone protocol
200 2007 %increase
No. of participating pharmacies 268 47 76%
No. of participating GPs 95 256 3%
No. of trained Level  GPs N/A 562
No. of trained Level 2 GPs N/A 33
Source:		HSE
4.15  Table 4.2 illustrates that there has been 
a substantial increase in the number of 
participating pharmacies and that a basic 
national coverage has been achieved, 
notwithstanding concerns about the 
availability of services out - of - hours and at 
weekends.  
4.16  The process of getting problem drug users 
to access and remain in treatment has been 
enhanced as a result of services developed 
through the Drugs Task Forces, with its focus 
on developing Community Drug Teams and 
the development of local treatment and 
rehabilitation services.  These include family 
support interventions that complement the 
work being done through the statutory sector. 
These services have been primarily at tiers  
and 2. 
4.17  While there has been an increase in overall 
GP numbers, their level of recruitment and 
involvement remains a critical constraint in 
eliminating waiting lists and in the further 
expansion of substitute treatment services. 
Both the Irish College of General Practitioners 
(who, in late 2008, developed an on - line 
training module covering level  training 
that can be accessed by all GPs), and the 
HSE, through the work of the GP Co - 
ordinators for service delivery and training, 
have made significant efforts to recruit GPs. 
Despite these efforts, the recruitment of 
GPs to undertake level 2 training, which 
enables doctors to initiate treatment, remains 
difficult.  This is an enduring problem for the 
NDS and was also highlighted during  the 
MTR in 2005.   
4.18  In this context, the Steering Group notes 
the factors that are contributing to the 
slow growth of participation can include a 
perceived lack of supports for participating 
GPs and lack of access by GPs to sufficient 
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local addiction centres and specialist services. 
Other factors may include limitations on 
the community and voluntary sectors from 
employing medical staff, clinical governance 
issues, concerns about the appropriateness of 
methadone as a treatment, the lack of referral 
pathways and a lack of focus at graduate level 
on addiction services.   Protocols and clinical 
governance guidelines should be developed 
further in this area.
4.19  Problem drug and alcohol use among the 
homeless population is a serious concern 
with a significant number of homeless 
people requiring access to treatment and 
rehabilitation services.  There have been 
significant developments, both at the 
strategic level3940 and in relation to the level 
of services available, with respect to the 
homeless.  In the Dublin area, a report in 
2008 by the Homeless Agency404 indicates 
that expenditure on homeless services 
has increased by 22% from €5m in 2005 
to €62.5m in 2008.  The majority of this 
increase relates to accommodation for the 
homeless. There has been a 4% increase in 
expenditure on support services generally, 
with the increase in respect of health/detox/
rehab/outreach being 0%. However, the 
Steering Group recognises that gaps in the 
provision of services persist, particularly in 
regard to attracting (and retaining) drug users 
with complex needs into treatment.  These 
comments also apply to other hard to reach 
groups involved in problem substance use.
4.20  It is clear that methadone treatment has 
had significant beneficial effects44242, with 
approximately 2,900 completing their treatment 
in the period 2000 to 2007.  As highlighted in 
Table 4.3, 6,872 entered treatment for the first 
time in the same period, with the number of 
new entrants towards the end of the current 
Strategy period being approximately 80% of 
the rate of new entrants at the beginning.
40  See “The Way Home:  Strategy to Address Adult 
Homelessness in Ireland 2008 - 203” Department of 
Environment, Heritage & Local Government, 2008 and “A 
Key to the Door 2007 - 200”, The Homeless Agency, 2007.
4  Review of Finances and Expenditure for Homeless 
Services in Dublin:  Homeless Agency, 2008.
42  Results of NACD ROSIE studies which show significant 
and sustained improvements for both the individuals 
involved, in terms of health and wellbeing, and for society, 
particularly in terms of reduced criminal activity.
43  It is not possible to determine whether those who have 
successfully completed treatment programmes remain 
drug free.  No follow - up system is in place, as it would 
be overly intrusive given that most will want to move on 
with their lives.
Table 4.3: New entrants and completion in 2000 
- 2007 period
2-year
Period
Summaryper2-year
periodofnumbers
comingontheCentral
Treatmentlist(CTl)for
thefirsttime.
Numbersof
Personswho
successfully
completed
treatment43.
2000/01 2,107 637
2002/03 1,598 718
2004/05 1,511 742
2006/07 1,656 831
Total2000/07 6,872 2,928
Source:		HSE
4.21  While methadone treatment has made an 
important contribution to retaining people in 
treatment, data is not available on the length 
of time people are remaining on methadone. 
In this regard, it is noted that the HSE is 
currently reviewing the issue of data collection 
and analysis with a view to developing a more 
comprehensive data system for management 
and research purposes.       
4.22  Methadone is the principal substitute 
treatment provided in Ireland with alternatives 
not generally made available.  However, the 
Steering Group notes that a feasibility study 
to examine the use of a buprenorphine - 
based product in both clinical and community 
settings is being undertaken in 2009.  
4.23  While it is clear that there has been significant 
success in attracting problem drug users 
into services and retaining them there, it 
is acknowledged that if they lapse from 
treatment, it can be difficult to get them to re 
- engage.  Also, it is noted that some people 
are reluctant to seek treatment as they do not 
feel they are ready for, or necessarily need, it. 
There is no reliable estimate of the size of this 
cohort.
4.24  With respect to both cocaine and cannabis, 
for which psycho/social treatments are the 
most effective, services have been developed 
under the NDS both directly by the HSE and 
through the Drugs Task Forces.  The HSE has 
provided cocaine services in Dublin South 
West, Cork and Galway and in 2008 the Drug 
Treatment Centre Board commenced a service 
in Dublin’s north inner city. The Drugs Task 
Force projects include those funded through 
the Emerging Needs Fund (2005/2006) 
and the Cocaine/Rehab Initiative (2008). 
In addition, a number of mainstreamed 
and interim Drugs Task Force projects have 
adapted their services to respond to cocaine 
use in their areas.  Overall, the services seek 
to provide for a range of treatments, both 
medical and non - medical, to be available 
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and the HSE is moving towards the provision 
of an integrated treatment service for all 
substance users. A key element in addressing 
the challenges faced in meeting emerging 
drug needs is the appropriate skilling of staff. 
4.25  Arising from work done by the National 
Drugs Strategy Team (see chapter 6) in 2004, 
training was provided through Merchants 
Quay Ireland (MQI) to upskill front line staff 
and volunteers to respond to cocaine use. 
In addition, the HSE’s National Addiction 
Training Programme, on its inception in 2007, 
concentrated on providing training to staff 
around emerging cocaine use.  Training in 
cognitive behavioural coping skills was also 
provided for qualified counsellors through 
Leeds University, in partnership with the HSE. 
Community, voluntary and statutory service 
providers participated in this training. The 
broader voluntary and community sectors 
also provide a wide range of courses to 
address the educational needs of staff. 
Residential Services/Abstinence
4.26  While there has been a significant expansion 
of treatment services in clinical and 
community settings since 200, detoxification 
and residential services have not progressed 
to the same extent.  
4.27  Between 200 and 2006, 68,754 cases were 
treated for substance misuse and 54% of 
these received methadone treatment4244.  In 
the same period, 7% (4,985 cases reported by 
the NDTRS) accessed residential services. 
4.28  As Table 4.4. illustrates, there was a small 
increase in the number of residential cases 
over the period, with 20% more cases 
reported in 2005/06 compared to 200/02. 
The development of residential services 
needs to be considered in the context of the 
four - tier model and the target of dealing 
with clients at the lowest appropriate tier. All 
reports point to a need for more residential 
places but this needs to be addressed within 
the context of services being developed in 
communities also.
44   HRB Trends Series 2:  Trends in treated problem drug use 
in Ireland, 200 to 2006:  Health Research Board 2008. 
This analyses data from the National Drug Treatment 
Reporting System (NDTRS) and the Central Treatment 
List (CTL).  It should be noted that the trends refer to 
cases – not individuals – and therefore, does not give a 
true picture of the number of people being treated for 
substance misuse.
Table 4.4 residential Treatment Cases 2001 - 2006
Period NumberofCases
200/02 ,525
2003/04 ,639
2005/06 ,82
Source:		Health	Research	Board
4.29  The further development of residential and 
aftercare services is a central element of 
providing alternative drug - free approaches 
to problem drug users, particularly opiate 
users.  The Steering Group notes that this 
approach is resource intensive and there can 
be heightened risks involved in the event of 
relapse.  It is critical, therefore, to ensure that 
the individuals involved have access to follow 
- on structured supports in the community 
and a continuum of care model to maximise 
their potential for success. 
4.30  The Steering Group also notes that a key 
issue is the lack of detox facilities.  The Report 
of the HSE Working Group on Residential 
Treatment & Rehabilitation (Substance 
Abuse)4345 identified the additional residential 
services, including detox facilities, that need 
to be developed to ensure that an adequate 
minimum residential infrastructure is in place. 
It also sets out a possible framework for the 
development of an appropriately monitored 
quality set of standards (see para 4.65 also).  
4.31  Concerns were also expressed about the 
“Vision for Change” Report of the Expert 
Group on Mental Health Policy4446.  The full 
implementation of the Report would have a 
significant negative impact on the availability 
of detox places for problem substance 
users.  Such implementation of the Report 
would require the realignment of funding in 
the HSE, with the necessity to transfer the 
relevant mental health services resources to 
its addiction services.
Harm Reduction approaches
4.32  The current NDS included 3 actions to reduce 
harm arising from substance misuse which 
relate to the expansion of needle exchanges 
and the reduction of drug - related deaths. 
Among the aims of these actions is to reduce 
the prevalence of Blood Borne Viruses (BBVs) 
among intravenous drug users (IDUs). 
45   The Report of the HSE Working Group on Residential 
Treatment & Rehabilitation (Substance Abuse): Health 
Service Executive, 2008.
46   Vision for Change:  Report of the Expert Group on 
Mental Health Policy: Department of Health & Children, 
2006.
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4.33    A key intervention in reducing the prevalence 
of BBVs is the provisionofNeedleexchange
Programmes(NEPs).  Needle exchanges have 
been expanded but are still only available in 
5 of the 0 RDTF areas and in 3 of the 4 
LDTF areas (coverage provided in the greater 
Dublin area, the midlands and the mid - 
west). A combination of fixed and outreach 
services are involved and it is noted that a 
service will be commissioned in the remaining 
LDTF area in 2009.    While needle exchange 
services are in place in areas that traditionally 
experienced high levels of substance misuse, 
it is acknowledged that there are significant 
gaps in the availability of such services around 
the country.  The Steering Group believes 
that NEPs are required across the country 
and, in areas that are already covered, out - of 
- hours and week - end provision is needed. 
A particular gap is the lack of development 
of needle exchange in community pharmacy 
settings.   In this regard, the HSE and the 
Irish Pharmacy Union have agreed a plan to 
roll out Needle Exchange services through 
Community Pharmacies in 65 prioritised new 
locations. This will commence in the second 
half of 2009 and the Steering Group greatly 
appreciate the support of the Elton John 
AIDS Foundation with this project.
4.34   While some can be successfully treated for 
Hepatitis C, and a treatment is available 
and provided through the HSE, the trends 
in relation to the disease are a particular 
concern. While the trends are difficult to 
gauge, due in part to the initial asymptomatic 
nature of the disease, the Health Protection 
Surveillance Centre (HPSC), which has been 
charged with monitoring its incidence since it 
became a notifiable disease in January 2004, 
have identified approximately 6,885 cases 
(approximately two thirds male) to the end 
of 20084547.  Of these cases, 77% have been 
in the HSE Eastern Region. While there is 
no definite measure of the number of IDU 
cases involved, it is generally accepted that 
the majority of cases (approx. 70%) are drug 
- related4648.  In response to these concerns 
the HSE established a Working Group on 
Hepatitis C and their report is now being 
considered by the HSE. 
47  Data from HPSC Annual and Quarterly Reports to end 
2008. 
48  Data from Blood - borne viral infections among IDUs 
in Ireland, 995 to 2005:  HRB Drug Misuse Research 
Division, 2006 estimated that 70% of IDUs attending 
treatment tested positive for the Hepatitis C virus.  More 
recent data from the HPSC for the 2nd and 3rd quarters of 
2008 indicate that 74% of the cases, where risk factors 
were reported (approx 33%) were IDU cases.
Drug Related Deaths
4.35  In November 2008, the HRB published a 
National Drug - Related Deaths Index4749 
covering the period 998 - 2005.  It covers 
deaths arising not only from illegal drugs, 
but also from legal substances ranging from 
prescription drugs to volatile inhalants. It 
is the first comprehensive report of its kind 
in Ireland and shows an increasing rate of 
deaths from drug misuse.  Table 4.5 sets out 
the overall figures for the period. 
Table 4.5 poisonings and non - poisonings by year of 
death, 1998 to 2005 
998 999 2000 200 2002 2003 2004 2005 Total
Poisonings* 78 87 82 75 20 84 205 232 ,553
Non - 64 84 79 0 26 2 55 68 889
Total 242 27 26 276 336 296 360 400 2,442
*  54% of poisoning deaths were aged between 20 and 40 years 
and males accounted for 67% of poisoning deaths. Poisonings 
are defined as deaths directly due to the toxic affect of the 
consumption of a drug(s) and/or other substances.  Non - 
poisoning are defined as deaths in people with a history of drug 
dependency or non - dependent abuse of drugs, whether or not 
the drug use was directly implicated in their deaths.
4.36    The Report indicates that, while heroin and 
other opiates, including methadone and opiate 
analgesia, continue to be mainly responsible 
for deaths by poisoning, poly - substance use 
(of both illicit and licit drugs) is a significant 
factor and has been a consistent feature over 
the period 998 to 2005. Prescription and 
over - the - counter medication is implicated 
in many poisoning deaths. Specifically, it 
is noted that benzodiazepines, often in 
conjunction with an illicit substance, have 
been implicated in more deaths than any 
other drug.  The number of deaths due to 
cocaine - either alone or in conjunction with 
another drug - has increased significantly 
in 2004 and 2005.  Overall, alcohol (in 
conjunction with one or more other drugs 
or substances) was implicated in a quarter 
of deaths by poisoning. This represents an 
underestimation of the total number of 
alcohol - related deaths because deaths due 
to alcohol alone were not included in the 
analysis.  The number of deaths as a result of 
poisoning illustrates the need for a National 
Overdose Prevention Strategy and it is noted 
that work on developing such a Strategy has 
commenced through the HSE.  
49  HRB Trends Series 4:  Trends in Drug - Related Deaths 
and Deaths among Drug Users in Ireland 998 - 2005: 
Health Research Board, 2008. 
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4.37  The Steering Group notes that progress 
has been slow in implementing the 
recommendations of the Report of the 
Benzodiazepine Committee5048 Specific 
concerns, as highlighted by the conclusions 
of the report, relate to their overuse by those 
on methadone, as well as to their overuse 
generally in the population.  Among the factors 
influencing this misuse is their perceived over 
- prescription, and the levels of access through 
the internet and through illegal procurement, 
whether locally or through importation.  In 
this context, it is noted that a number of 
issues need to be addressed, including a 
review of the regulatory framework covering 
their availability and increased monitoring 
and application of sanctions already in 
place.  While the monitoring of prescribing 
to patients under the GMS scheme has 
been improved, the monitoring of private 
prescribing has proved more problematic and 
needs to be addressed. 
4.38  While issues surrounding the oversupply 
and overuse of benzodiazepines need to 
be addressed in the National Overdose 
Prevention Strategy, as referred to above, the 
Steering Group also believes that there is an 
urgent need for the Irish Medicines Board to 
review the current regulatory controls and 
the implementation of clinical guidelines.
4.39  As Table 4.5 illustrates, there has been a 
sharp increase in non - poisoning deaths 
(deaths indirectly due to drugs) over the 998 
- 2005 period.  While they represented 24% 
of deaths in 998, by 2005 they accounted for 
42% of drug - related deaths.  Of the deaths, 
84% were male and, overall, 64% were in 
Dublin with the median age being in the 
early 30s.  The highest increases occurred in 
the NDRDTF and the SWRDTF areas495 with a 
doubling in the rate in the former area and 
an increase of just over 50% in the latter 
area. The Steering Group notes that this is 
an important area for further research, with 
a view to developing an appropriate public 
health policy response.   
50  Report of the Benzodiazepine Committee:  Department 
of Health & Children, 2002. 
5  HRB identifies these areas as NDRDTF – North Dublin 
City and Council Regional Drugs Task Force – consisting 
of North Dublin City and County, including the 5 LDTF 
areas within these boundaries, and SWRDTF – South 
Western Regional Drugs Task Force – consisting of south 
west Dublin, west Wicklow and Kildare including the 6 
LDTF areas within these boundaries.
Treatment of Under - 8s
4.40  There were three specific actions in the 
current NDS relating to provision of treatment 
services for young people:  
n	 Access to counselling services;
n	 Treatment to include family therapy; and
n	 Implementation of the guidelines agreed for 
treatment of under - 8s.
4.41  Counselling and family therapy services 
are both recognised as being important 
components in the treatment of under - 8s. 
While counselling and family services have 
been developed under the current NDS, 
particularly in LDTF areas and in the under - 
8s service provided in the south west area of 
the HSE (Dublin and Mid Leinster), accessing 
services by some in this cohort is problematic. 
This reflects the fact that the level of services 
in some areas is not sufficiently developed to 
ensure access to them within an acceptable 
timeframe.  The Steering Group notes, 
however, that no under - 8s are waiting for 
access to a HSE methadone programme. 
4.42  Services for under - 8s have been developed 
through both the HSE and Drugs Task Force 
projects over the course of the current 
Strategy.  The HSE has taken a number 
of measures to implement the Guidelines 
for Treatment of Under - 8s5052, (developed 
under the aegis of the Department of Health 
and Children), including hosting a national 
workshop in 2006.  The national workshop 
highlighted a number of key enduring 
issues relating to services for young people 
including:
n	 inter - agency collaboration to implement the 
4 tier model for services; 
n	 the lack of tier 3 and 4 services outside of 
Dublin; and
n	 the need for family intervention support 
models.  
   The outcomes from the national workshop 
and the Guidelines for the Treatment of 
under - 8s are now being utilised to develop 
HSE - led under - 8s services in the HSE 
Regions, both in Dublin and beyond. These 
will complement the under - 8s service 
in place in the south west area of the HSE, 
referred to above.
52   Report of the Working Group on Treatment of Under 
8 year olds Presenting for Treatment to Services with 
Serious Drug Problems:  Department of Health & 
Children and Health Service Executive, 2005. 
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Treatment in prison settings
4.43   There are 4 actions in the current NDS 
relating to treatment in prisons (actions 2 - 
24) and they are primarily aimed at expanding 
treatment and rehabilitation programmes, 
involving the community and voluntary 
sectors and conducting an independent 
evaluation of the Irish Prison Service (IPS) 
Strategy in regard to drugs.  
4.44   The IPS adopted its Drugs Policy and 
Strategy in 2006553 and it is aimed at reducing 
availability and expanding treatment services 
within prisons.  The former is referred to 
in chapter 2 while the focus in this chapter 
is on developing the level of treatment 
and rehabilitation services in prison and 
maintaining the continuity of such services 
for prisoners on their release. 
4.45  The IPS, in partnership with statutory and 
voluntary agencies, seeks to provide people 
in its custody with programmes to assist 
in the prevention, treatment, rehabilitation 
and aftercare so as to minimise the harmful 
effects of substance misuse and to prevent 
the spread of HIV, Hepatitis B & C, as well 
as other infections.  It seeks to provide 
clinical services for the assessment, treatment 
and care of patients, comparable to those 
available in the community and appropriate 
to the prison setting.  Treatment programmes 
provided within the prison environment are 
patient - focused, with the objectives of 
harm reduction, stabilisation of the patient’s 
addiction and with a longer - term aim of 
assisting the return of the patient to a drug 
- free lifestyle.
4.46  The IPS Drugs Policy and Strategy has 
witnessed active IPS investment in responding 
to people with drug problems in the prison 
system. Phase  of the policy has commenced 
the process of putting in place the necessary 
staffing levels to provide a quality service 
to prisoners. Phase 2 will seek to further 
focus on providing prisoners with access 
to the range of drug treatment options, 
consistent with the objective of achieving a 
standard of care which is equivalent to that 
available in the community. This will, in part, 
be achieved by augmenting current staffing 
levels, and also by strengthening community 
links.  It is noted that the number of prisoners 
treated between 2006 and 2007 increased by 
approximately 7% and this attests to the 
high level of need for services amongst the 
prison population. 
53  Keeping Drugs Out of Prisons:  IPS Drugs Policy and 
Strategy –  Irish Prison Service, 2006.
4.47  Working to fulfill the commitments contained 
in their Policy and Strategy involves the 
implementation of stringent measures to 
prevent drugs from getting into prisons while, 
at the same time, continuing to invest in 
services within prisons to reduce the demand 
for illicit drugs in the prisoner population.  It 
also involves meeting prisoners’ treatment 
and rehabilitative needs.
   It is noted that specific developments to date 
include: 
n	 Addiction Counselling Service – this consists of 
24 counsellors and, in conjunction with other 
developments, is delivering approximately 
,000 hours per month of prisoner access to 
addiction counselling;
n	 Funding under the Dormant Accounts Fund 
to community groups to provide addiction 
counselling and support to prisoners while in 
prison and on release in the community;
n	 Additional specialist sessions in addiction 
psychiatry at the Mountjoy complex and 
Cloverhill/Wheatfield.  These are significantly 
improving the quality, co - ordination and 
availability of drug treatment; 
n	 In Mountjoy, the treatment services comprise 
(i) a dedicated pharmacy service responsible 
for the management of all medicines (mainly 
methadone) used as substitution treatment in 
the management of addiction. Drug treatment 
is provided to all those availing of services in 
Mountjoy on an equivalent basis to that 
available in the community, while meeting all 
legal and professional requirements, (ii) six 
specialist nurses who have a distinct role with 
regard to addiction assessment, treatment 
planning and delivery and evaluation of care 
and (iii) a clinical addiction team involving all 
of the disciplines engaged in drug treatment 
services; and
n	 The IPS is seeking to enhance specialist 
input, similar to Mountjoy, at all prisons, 
but particularly at Cloverhill/Wheatfield 
and other prisons where demand for drug 
treatment services is high.
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4.48  While substitute treatment services are 
being provided in the majority of prisons, 
the Steering Group notes that this is not the 
case in all prisons and this constitutes a key 
gap.  In relation to harm reduction in a prison 
setting and arising from a recommendation 
of the joint NACD/NDST report5254, a small 
expert group has been convened to consider 
the issues of providing needle exchange in 
prisons and they are due to report in 2009.  
4.49  In recognition of the high risk of overdose 
or relapse immediately following release 
from custody, a critical priority and a key 
enduring concern for all parties involved 
is the development of an effective and co 
- ordinated interagency approach to ensure 
the seamless transition from prison back into 
the community. This requires the availability 
of, and timely access to, a range of supports 
including suitable accommodation, treatment/
counselling services, training/education/
employment options and personal supports. 
These were identified in the Report of the 
Working Group on Drugs Rehabilitation5355 
and the Report of the HSE Working Group 
on Residential Treatment & Rehabilitation 
(Substance Abuse)5456.  Expanded use of 
Integrated Sentence Management within 
the prisons will also help to underpin the 
development and implementation of 
prisoners’ case management plans.  These 
plans, based on a full assessment of needs, 
seek to ensure timely effective interventions, 
using a multi - agency approach.  It is noted 
that clarity is required around who will deliver 
these services, including planned release and 
post - release arrangements, is essential in 
this regard.
4.50  The provision of substitute treatment 
services, and planning for continuity of those 
services on release, for remand prisoners in 
particular, needs to be addressed.  However, 
the Steering Group notes that the IPS does 
not have authority in regard to overseeing 
a prisoner’s release from remand, as that is 
a matter for the Courts.  However, as far as 
possible, they should endeavour to plan for 
continuity of treatment service.  
54   Needle Exchange Provision in Ireland:  National Advisory 
Committee on Drugs & National Drugs Strategy Team, 
2008.
55   Report of the Working Group on Drugs Rehabilitation: 
Department of Community, Rural & Gaeltacht Affairs, 
2007. 
56   Report of the HSE Working Group on Residential 
Treatment & Rehabilitation (Substance Abuse):  Health 
Service Executive, 2008. 
4.51  The Steering Group also notes that the IPS 
treatment services can only initiate substitute 
treatment services if the individual has a 
treatment place in the community.  
4.52  The Group welcomes the setting up of the 
External Oversight Group on IPS Drugs Policy, 
which will focus on problem drug use in 
prisons from both a security and a treatment 
& rehabilitation perspective.  
rehABiliTATiON
4.53  Rehabilitation measures were included 
originally under the treatment pillar of the 
NDS. However, a key recommendation of the 
MTR in 2005 was to prioritise rehabilitation 
by developing it as a separate pillar of the 
Strategy.  This led to the establishment of 
the Working Group on Drugs Rehabilitation 
that reported in 2007 with a comprehensive 
range of recommendations addressing 
rehabilitation. (See Appendix 7 for full list of 
recommendations). 
4.54  The Report provides a broad definition of 
rehabilitation and sees it as a structured 
development process focusing on individuals, 
involving a continuum of care and aimed at 
maximising their quality of life and enabling 
their social and economic reintegration into 
communities.  A key aim of the overall 
process is the empowering of recovering 
problem drug users so that they can re - 
engage with society in a manner consistent 
with their needs and expectations.  It stresses 
the importance that clients be activated 
and prepared to fulfill their role on the path 
towards rehabilitation.  In this context, the 
level of motivation of clients is critical to the 
degree of likelihood of achieving a successful 
outcome.
4.55  Many Departments and agencies are providing 
an array of services in this regard,  including:
n	 health - based services;
n	 educational services; 
n	 training and employment services; 
n	 community development services; 
n	 family support services; 
n	 probation services; 
n	 Garda services; and 
n	 housing services.  
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4.56  It recognises that all or some of these 
services can play a role in the rehabilitation 
of a problem drug user.  However, the Report 
recognises that there is a need to build on 
these existing services and improve their co - 
ordination while promoting a more integrated 
and client - centred approach to the process 
of rehabilitation. 
4.57 One of the key recommendations relates 
to the establishment of a National Drug 
Rehabilitation Implementation Committee 
(NDRIC), chaired by the HSE, as part of 
their lead role in rehabilitation.  The Steering 
Group notes that this Committee was set 
up in late 2008, along with the assignment 
of the Senior Rehabilitation Co - ordinator 
who chairs and leads the work of the group. 
The Committee has also agreed its terms of 
reference for addressing the rehabilitation 
needs of people in treatment.
4.58  Among the issues identified in the Report 
that will need to continue to be addressed 
are the development of: 
n	 protocols for inter - agency working;
n	 Service level agreements between parties;
n	 case management and care plans;
n	 case managers and key workers; and
n	 Quality Standards Frameworks.
4.59 The recommendations in the Working Group 
Report also cover a number of other areas: 
Medical support 
  The expansion and integration of treatment 
options for recovering drug users is 
recommmended, particularly counselling 
and therapeutic services and the further 
development of detox and residential services 
(these latter elements are more fully dealt 
with by the HSE Residential Rehabilitation 
Report),
Role of families in rehabilitation 
  The active encouragement of family 
participation is recommended, subject to 
the agreement of the individual, and the 
reconciliation of problem drug users with 
estranged family members should be pursued. 
Families should be seen as service users in their 
own right and information, support and advice, 
including advice on guardianship options, 
where applicable, should be made available to 
parents (and others as appropriate) who are 
coping with a family member’s problem drug 
use.
Childcare 
   The need for additional childcare facilities be 
addressed and the better integration of these 
services with treatment and rehabilitation 
services is recommended.  The services need 
to have a stronger focus on child development. 
The provision of parenting programmes also 
needs to be addressed.
   In this context, the Steering Group believes 
that the NDRIC and OMCyA should work 
together within the context of existing policies 
and services to:
n	 Facilitate closer engagement between child, 
outreach and drug services at a local level; 
n	 Consider ways to address the needs of the 
children of problem drug users through 
flexible provision under any successor 
programme to the Community Childcare 
Subvention Scheme 2008 - 200; and
n	 Establish and disseminate best practice.  
Community Employment/Employment/Access to 
education and training  
   The impact of Community Employment on 
rehabilitation should be strengthened by 
complementary support and involvement 
from the HSE, the Department of Education 
& Science and relevant agencies to ensure 
that the health and educational needs of 
participants are being properly addressed, not 
only during, but also before and after their 
participation.  
   In this context, the Steering Group considers 
that there is also a need for targeted 
employment support mechanisms given that 
recovering problem drug users are likely to be 
particularly vulnerable in the current labour 
market.
Housing
   The provision of appropriate housing and 
developing inter - agency procedures are 
recommended to facilitate recovering drug 
users in accessing appropriate accommodation 
and the services necessary to ensure that 
tenancies can be maintained.
Rehabilitation of offenders 
   The provision of treatment and rehabilitation 
services in prison are recommended, as well 
as the need to ensure continuity of care in 
the community on release. 
52
N
at
io
n
al
 D
ru
gs
 S
tr
at
eg
y 
 (
In
te
ri
m
) 
20
09
 -
 2
0
6
4.60 The Steering Group recognise that many 
people using drugs can acquire criminal 
convictions as a consequence of their drug 
use. Such convictions can often act as a 
significant barrier in terms of successful 
rehabilitation and reintegration in terms of 
access to employment and travel for people in 
the longer - term. In this regard, the Steering 
Group recommends that consideration be 
given to developing a legislative framework 
whereby certain convictions could be 
considered spent after an appropriate period 
of time.
4.61 As mentioned at 4.4, the Report of the HSE 
Working Group on Residential Treatment 
& Rehabilitation (Substance Abuse) was 
published in early 2008.  It identified the 
number of detox and rehabilitation beds 
needed to provide a minimum adequate level 
of coverage (see Appendix 8 for the full list 
of recommendations).  It also addressed the 
issue of the development and monitoring of 
standards in residential care. This report, and 
the Report of the Working Group on Drugs 
Rehabilitation (May 2007) have a significant 
degree of commonality and the Steering 
Group believes that they should be actioned 
and progressed with this in mind.
Training and Skills Development of Staff and Volunteers
4.62  The training and re - skilling of staff in a range 
of existing and emerging addiction issues is 
seen as a key component in the continuing 
development of a comprehensive and 
responsive addiction service. To this end, the 
statutory, voluntary and community sectors 
have all played important roles in providing 
training and support to staff around addiction 
and alcohol issues - and related issues such 
as health & safety and risk management. 
While much of this has been done within 
the National Qualifications Framework, thus 
enhancing the opportunities available to 
people working in the field, some courses 
have been provided outside that framework. 
Initiatives include:
n	 the voluntary and community sectors provide 
a wide range of certified and accredited 
courses and modules for staff, both in their 
own services and in the statutory services;
n	 the Local and Regional Drugs Task Forces 
provide a programme of courses and 
seminars; 
n	 the National Addiction Training Programme 
(NATP), which commenced in 2007, provides 
a comprehensive suite of training to staff 
in the HSE and in partner agencies. During 
the first 6 months of 2008, almost 400 
staff attended a broad range of continuing 
professional education programmes. The 
Programme, which is reviewed and amended 
on an ongoing basis, is provided in liaison 
with Waterford Institute of Technology and 
was independently evaluated after 2 months 
of operation. Within this context, the HSE 
Addiction Training Unit (ATU) in Dublin 
has been to the forefront of the continued 
development of the Cognitive Training Coping 
Skills Programme for addiction counsellors5557. 
A follow - on programme was subsequently 
provided by the HSE ATU, while a third 
programme is scheduled for 2009 as a result 
of funding made available via a cross Task 
Force Initiative involving representatives of 
the RDTFs, the ATU and the NATP; and
n	 graduate courses in addiction studies, 
counselling, and related fields, provided 
through 3rd level institutions.
4.63   The Steering Group considers that these 
initiatives have established a solid basis for 
moving forward on this vital issue. However, 
despite these developments, it is accepted 
that there still is significant work to be done 
in rolling out national training standards for 
addiction services, including accreditation 
standards (aligned to the National 
Qualifications Framework) for workers in the 
addiction field.  All future course provision 
should be developed and provided within the 
Framework.   
4.64   In addition, the Group believes that it is 
important that the training programmes 
outlined above, and those provided by link 
partners such as the Homeless Agency and 
others, take cognisance of each other’s work 
so as to avoid overlap and to ensure value for 
money.
Quality and Standards for Addiction Services
4.65   The provision of quality assurance of the 
care received by service users of drug 
treatment services is key to the outcomes 
that are achieved in terms of treatment 
and rehabilitation. In addition, such quality 
assurance has been shown to be critical to 
patient safety. Quality and standards for 
addiction services need to be developed 
within a clinical and organisational governance 
framework that is based on adopting a 
systematic approach to assuring the quality of 
patient care. It is a framework through which 
the addiction services will be accountable for 
57  Originated from the recommendations of the Cocaine 
Subgroup of the NDST in 2004. 
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continually improving the quality of service 
and for safeguarding high standards of care by 
creating an environment in which excellence 
in clinical care will flourish. Clinical and 
organisational governance needs to promote 
clinical and organisational leadership and 
accountability with clear protocols for the 
delivery of care. 
4.66    A Report5658 into the issue of clinical governance 
identified key features to be addressed to 
ensure patient safety.  The aim is to have 
well - informed patients receiving safe and 
effective care from skilled professionals, in 
appropriate environments, with assessed 
outcomes. A similar commission in the UK 
in the 990s identified the following seven 
pillars of clinical governance: 
n	 Risk Management;
n	 Clinical Effectiveness;
n	 Education, Training and Continuous Personal 
and Professional Development;
n	 Use of Information;
n	 Staffing and Staff Management;
n	 Clinical Audit; and
n	 Service User involvement.
4.67   The HSE recognises that there is a need for the 
appointment of clinical directors at regional 
level who will work with managers appointed 
at a similar level to ensure organisational 
competence in the delivery of drug treatment 
services. Such a goal ties in neatly with the 
plan to ensure that sufficient tier 3 and 4 
resources are available to support both the 
community and primary care sector, as well 
as the voluntary sector, in working with 
problem substance users. This organisational 
framework and clinical governance system 
needs to apply to all outpatient settings, as 
well as to residential and medical inpatient 
units.
4.68   Specific standards of care and clinical 
competence are required in order to evaluate 
and continually improve services. Such 
standards have been developed within the 
UK drug treatment field, where the quality of 
drug and alcohol services is evaluated using 
an instrument specifically designed for the 
purpose - the Quality in Alcohol and Drug 
Services (QuADs) system.
58  Report of the Commission on Patient Safety and Quality 
Assurance:  Department of Health & Children, 2008.
4.69    In addition to clinical standards, providing 
quality patient care must also include the 
organisational capacity to recruit competent 
professionals, with key skills, to perform the 
tasks and jobs required – in this case to treat 
and rehabilitate patients. With this in mind, 
it is envisaged that the new NDS will adopt 
a clinical and organisational governance 
structure working to standard protocols such 
as those laid out by the QuADs, or equivalent 
systems. This ensures an equivalent standard 
in the delivery of care between the statutory 
sector and the voluntary sector. Professional 
competence standards also need to be 
addressed to ensure quality of care. In 
the UK, the Drug and Alcohol National 
Occupational Standards (DANOS) have been 
agreed at a national level.  While an informal 
system has grown up in Ireland, this will need 
to be developed further in order to meet 
a formal national standard which would 
provide transparency and clear guidelines for 
employing organisations. 
4.70   In terms of development of standards in the 
Irish context, a pilot project was developed 
under the HSE’s National Drug and Alcohol 
Working Group.  This was spearheaded by the 
former Dublin East Coast area, which tested 
the QuADS system. The HSE established a 
Working Group in early 2008 to examine the 
issue of introducing benchmarked quality 
and standards to addiction services.  The 
Report of the Working Group5759 was adopted 
by the HSE as policy in January 2009.  The 
first phase involves the introduction of the 
QuADs quality standard or equivalent to 
all addiction services. The voluntary sector 
have also been working on the development 
and implementation of quality standards and 
has some good working examples that can 
feed into agreed national standards. It is 
planned that, within the timeframe of the new 
Strategy, this will roll - out to all services with 
the establishment of national standards and 
clinical and operational governance to ensure 
that these standards are met.  The aim is that 
clinical and organisational governance will be 
established throughout the drug treatment 
services thereby ensuring organisational and 
clinical capacity to deliver a high standard of 
safe care to patients.
59   The Report of the Working Group Examining Quality 
and Standards for Addiction Services:  Health Service 
Executive, 2008.
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Counselling
4.71   At present, neither counselling nor 
psychotherapy are statutorily regulated 
within Ireland. However, both professions 
have been progressing voluntary regulation, 
and standards have been set for the training 
of counsellors and psychotherapists.  More 
recently, a joint forum convened by the 
Minister of State for Equality, Disability and 
Mental Health at the Department of Health 
and Children encouraged dialogue between 
all of the professional bodies involved under 
the title “Psychological Therapies Forum”. 
This Forum provided a report5860 on training 
standards and professional accreditation 
in order to progress statutory regulation. 
The report recommended that counsellors 
be trained to Higher Diploma level and 
psychotherapists to Masters level. 
4.72   Despite moves towards a national framework 
and areas of good practice, the Steering Group 
notes that there has been no formalisation 
of professional training standards and 
competencies across the voluntary and 
statutory sectors. There is, therefore, a 
need for this to be formally addressed. For 
many years, the HSE has required higher 
diploma level training and accreditation with 
the Irish Association for Counselling and 
Psychotherapy (IACP), Irish Association of 
Alcohol and Addiction Counsellors (IAAAC) 
or Irish Council for Psychotherapy (ICP). 
Higher Diploma level training is considered 
appropriate as the area of addiction is 
complex. The Steering Group considers that 
staff working as counsellors within the Irish 
health system need to have considerable 
training in order to handle the complex needs 
of this client group. 
4.73   Counselling services are appropriately placed 
to treat, or be part of a treatment response 
for those who have become dependent on 
substances. There is clear evidence from 
international literature596 that counselling and 
other psychosocial interventions enhance 
and improve the outcomes in conjunction 
with substitute prescribing for those who are 
opiate dependent.  It has, therefore, been 
the policy of the HSE to provide counselling 
and psychosocial interventions alongside 
substitute prescribing. The Steering Group 
believes that counselling, under clinical 
supervision, should be an integral part of 
these programmes. 
60   Submission by the Psychological Therapies Forum to the 
Department of Health & Children regarding Statutory 
Registration of Counsellors and Psychotherapists in 
Ireland, September 2008.
6  Ball & Ross, 99 and McLelland, 996
4.74   In relation to problem alcohol, cocaine and 
stimulant use, there is good evidence6062 to 
support the use of Motivational Interviewing 
and Cognitive Behavioural Coping Skills 
(CBCS) training. Although many counsellors 
in the addiction services are trained in 
skills - based Motivational Interviewing 
and approximately 50 have been trained in 
Cognitive Behavioural approaches, between 
the voluntary and statutory sector (mainly 
in the east coast), there is a need for further 
up - skilling of staff in all relevant sectors. 
It is recommended that an audit of skills of 
counselling staff be undertaken to identify 
the training need of this professional group. 
The delivery of such training falls under the 
remit of the NATP (see para. 4.62) and other 
agencies, as appropriate. 
4.75   The current Strategy envisages the development 
of a more robust rehabilitation pillar to help 
the progression of problem drug users into 
further community integration. Evidence - 
based approaches such as the Community 
Reinforcement Approach (CRA)663 and Social 
Behavioural Networking Therapy6264 should be 
used as adjunctive to these services. 
4.76   The Steering Group notes that the general 
hospital setting (Emergency Departments in 
particular) is a key area to deliver interventions 
designed to address both psychological 
and social harms associated with problem 
substance use. The training of trainers within 
the general hospital setting, particularly 
addiction counsellors and nurses, is necessary 
in order to provide adequate screening and 
brief interventions for all substances of abuse 
including nicotine, alcohol and drugs. 
62  Project Match – multisite clinical trial designed to test a 
series of priority hypotheses on how patient - treatment 
interactions relate to outcome (alcohol): University of 
Conneticut Health Centre, supported by the US National 
Institute on Alcohol Abuse and Alcoholism (NIAAA).
63  The Community Reinforcement Approach (CRA) is a 
comprehensive behavioural programme for treating 
substance misuse problems.  It is based on the belief 
that environmental contingencies can play a powerful 
role in encouraging or discouraging drinking or drug use. 
Consequently, it utilises social, recreational , familial and 
vocational reinforcers to assist in the recovery process. 
64  Social Behaviour and Network Therapy (SBNT) is an 
intervention package developed by integrating strategies 
found to be effective in other substance misuse treatment 
approaches.  It is built upon the premise that social 
network support for change is central to the resolution 
of addictive behaviour.  The core principle of SBNT is 
that positive change is promoted by support from a close 
network of family members and/or friends (referred 
to as “network members”) who provide a person who 
wishes to abstain from, or reduce substance use, with 
positive social support for change. 
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Service User – Information and Engagement
4.77   Providing information on available services 
emerged as an important theme from the 
consultation process.  The current NDS 
included actions to provide information on 
the availability of services.
4.78   In this context, it is noted that the HSE 
has completed a mapping process of local 
services.  Local Health Offices have compiled 
directories of all services (including addiction 
services) in their areas and these are posted on 
the HSE’s website www.hse.ie.  Several Drugs 
Task Forces have (i) produced directories in 
booklet form, (ii) listed drug services in their 
area on their websites and (iii) provided input 
to the national service directory at www.
drugs.ie.  The Steering Group believes that it 
is vital that information/directories provided 
by the HSE, Local and Regional DTFs and the 
community and voluntary sectors are readily 
accessible, consistent in format, relevant 
and regularly updated, as well as being 
understandable to their target audience.
4.79   The National Strategy for Service User 
Involvement in the Irish Health Service - 
“your Service your Say” - was published by 
the Department of Health & Children and 
the HSE in consultation with the Health 
Services National Partnership Forum in May 
2008.  This Strategy provides a template for 
engagement with socially excluded groups, 
including drug users.  In addition, a number 
of fora have been established to facilitate 
user group engagement with Drugs Task 
Forces, principally through the Drug Users 
Forum.  Despite these developments, there is 
a continuing need to further develop service 
user engagement – both as an essential part 
of clinical governance procedures and service 
planning.  
Family support
4.80   The MTR in 2005 identified the need to 
strengthen support for families.  There were 
3 main dimensions to the actions on families 
under the current NDS: 
n	 Prioritise the provision of family supports 
by Drugs Task Forces:  In this context, it 
is noted that a significant number of DTF 
projects (6%) include a family dimension. 
In addition, €.7m was secured under the 
Dormant Accounts Fund for family support 
projects in DTFs, with several running the 
Strengthening Families Programme;
n	 Development of family support networks: 
There has been tangible progress in the 
development of family support networks over 
recent years. The umbrella organisation, the 
Family Support Network, has received funding 
from both the Department of Community 
Rural & Gaeltacht Affairs and the Family 
Support Agency to develop its capacity to 
support networks across the country. In 
addition, there is evidence that family support 
networks are being established more broadly 
across the country;  and
n	 Implementation of the NACD report on 
families6365 which proposed increasing the 
capacity of services, strengthening interagency 
links and networks, and developing relevant 
monitoring and evaluation tools: While there 
are growing inter - agency linkages, which 
are beginning to strengthen services, the role 
of Family Resource Centres and the Family 
Support Agency needs to be more explicitly 
linked in with Drugs Task Forces and family 
support networks so as to enhance service 
provision.  
4.81   In recent years, the HSE has significantly 
developed its family support services.  Family 
support programmes are provided by a range 
of professionals including family workers, 
social workers, child - care workers, youth 
and community workers, public health 
nurses.  Examples of these programmes 
include services provided by the Community 
Mothers, Family Support Workers, Teen 
Parents Support Projects, and Spring Board 
Projects and may encompass a range of 
general parenting programmes and supports. 
The HSE indicates that expenditure on 
family support services has increased by 80% 
over the period 2003 - 2007 (from €46m to 
€82m).
4.82   In this context, the Steering Group notes 
the reference in the Report of the Working 
Group on Drugs Rehabilitation6466 (see 
para. 4.53) that families of problem drug 
users have the potential to be key to the 
rehabilitation effort.  That report made five 
recommendations in regard to the role of 
families in the rehabilitation process, varying 
across supports for families to their more 
central involvement in the rehabilitative 
process.  The establishment of the NDRIC, 
as outlined in para.4.57 above, will provide a 
forum (with formal links to the family support 
network) where the implementation of these 
recommendations can be examined in more 
detail and progressed. 
65   Report on The Role of Family Services in Drug Prevention: 
National Advisory Committee on Drugs, 2004. 
66   National Drugs Strategy 200 - 2008 – Rehabilitation: 
Report of the Working Group on Drugs Rehabilitation: 
Department of Community, Rural & Gaeltacht Affairs, 
2007. 
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Emergency Services and Ambulance Services
4.83   While the current NDS did not include 
emergency services under its remit, it is clear 
from the experience of such services over 
the lifetime of the Strategy that problem 
substance use (predominantly alcohol), 
particularly on week - end nights, needs to 
be addressed.  The Steering Group considers 
that training for Emergency Service personnel, 
as well as for paramedics in the ambulance 
service, is necessary to ensure that they are 
familiar with drugs issues and alternative care 
pathways.  
4.84   This is being developed at present under the 
NATP (see para. 4.62), as evidenced by the 
specific programme recently undertaken with 
the Emergency Department of Waterford 
Regional Hospital.  The Population Health 
Pillar of the HSE is also leading out on the 
training of emergency service staff in selected 
acute hospitals in the use of brief intervention 
programmes.  This includes screening and 
appropriate referral for clients presenting 
with alcohol and drug issues.  
4.85   While some screening6567 and brief interventions 
are carried out in general hospital settings, 
there is a need to further develop these with 
a view to putting in place a comprehensive 
screening programme for those who present 
with problems that are related to problem 
substance use.  At the same time, the capacity 
of hospital personnel to deliver appropriate 
brief interventions needs to be developed 
further.   
4.86   It is envisaged that the development of a 
National Overdose Prevention Strategy, as 
outlined earlier in this chapter, by the HSE, 
will result in the further development and 
co - ordination of the overall approach in 
these areas.  A key issue in this regard is the 
provision of training (including training in 
the administration of naloxone in particular) 
for all paramedics to deal with overdose 
incidents.  
67   ASSIST – Screening and Brief Interventions programmes 
delivered in some hospitals. 
AlCOhOl
4.87   As outlined in chapter , the health 
consequences of problem alcohol use manifest 
themselves in a number of ways, ranging 
from alcohol - related mortality to alcohol - 
related road fatalities, to the role of alcohol in 
suicides and self - harm6668.  The extent of the 
health consequences of problem alcohol use 
can be illustrated through examining alcohol 
- related discharges from acute hospital 
services. Table 4.6 outlines those discharges 
during the course of the NDS.
Table 4.6: No. of alcohol - related discharges by year 
2001 - 20076769  
2001 2002 2003 2004 2005 2006 2007
male ,805 3,234 3,08 3,050 0,852 2,629 3,340
female 4,08 4,523 4,523 4,328   4,073   4,424   4,677
Total 15,823 17,757 17,541 17,378 14,925 17,053 18,017
Source:			Hospital	In	-	Patient	Enquiry	system,	which	relates	to	data	
from	60	hospitals
It should be noted that alcohol - related 
discharges increased significantly from the 
mid 990s, when, between 995 and 2002, the 
number of annual alcohol - related discharges 
virtually doubled (92% increase).  Since then, 
the number of discharges has been relatively 
stable.
4.88   With respect to the age profile of those 
discharged, an analysis of data for the period 
995 to 20046870 by the HRB showed significant 
differences between  males and females as 
illustrated in Table 4.7: 
68   Reach Out:  National Strategy for Action on Suicide 
Prevention, 2005 - 204:  Health Service Executive 
National Suicide Review Group and Department of 
Health & Children, 2005.
69   There was a substantial decrease in the number of 
alcohol - related discharges in 2005.  However, coding 
in the HIPE changed from ICD 9 to ICD 0 in that 
year.  This may account for the variation, as the overall 
consumption did not change from 2004 to 2005.  The 
figures for 2007 are provisional.
70   Between 995 and 2004 there were 39,692 alcohol - 
related discharges, of which 75% were male and 25% 
were female.
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Table 4.7: No of alcohol - related discharges by 
gender between 1995 - 2004
Age lessthan30 30to49 50ormore
male 7% 3% 52%
female 25% 33% 42%
Source:			Department	of	Health	and	Children
While males accounted for approximately 75% 
of discharges annually over the period, an 
underlying trend is the significant increase in 
alcohol consumption and binge drinking among 
young women in recent years, with women 
under 30 comprising 25% of females being 
treated.  This is further emphasised by the fact 
that 47% of discharges of those under 8 years 
were women.
4.89   The analysis also showed that of the 
approximately 40,000 cases treated in the 
period, 48% were treated for acute conditions, 
43% were treated for chronic conditions 
and 9% were treated for liver conditions. 
However, over the period, the severity of 
the condition for which people were treated 
increased.  Data shows, that by 2004 the 
number of acute condition cases increased 
by 75%, the number of chronic condition 
cases and liver condition cases increased by 
92% and 75% respectively.  The analysis 
further indicated that 2% of the cases had 
an additional drug - related diagnosis.
Treatment for Alcohol use
4.90   Treatment data for problem alcohol use is 
recorded through two systems, the National 
Psychiatric In - patient Reporting System 
and the National Drug Treatment Reporting 
System (NDTRS).  While the former has 
been in place since 965, the latter was 
only introduced in 2004.  It is noted that the 
extent of overlap between the two systems is 
unknown.  
4.91   While the number of alcohol disorders cases 
reported through the National Psychiatric In - 
patient Reporting System have approximately 
halved since 995, they were stable over the 
2006/07 period.  This change relates primarily 
to the enhanced community - based approach 
introduced in regard to mental health.  Data 
for 2007 indicates that 2,699 were treated for 
alcohol disorders as their primary diagnosis, 
with a further 724 diagnosed with other 
drug disorders as their primary diagnosis. 
At the same time, the problem of people 
with alcohol disorders not seeking to access 
treatment persists.  In addition, the Steering 
Group notes that many in society suffer 
harmful consequences of the use of alcohol, 
while not at the level of addiction.  
4.92   Table 4.8 sets out data from the NDTRS697 on 
people treated for alcohol disorders in the 
period 2004 - 2007.
Table 4.8: people treated for alcohol disorders
2004 2005 2006 2007
Previously treated cases 2,77 2,230 2,345 3,0
New cases 2,827 3,228 3,432 3,736
Unknown   40     68     99    466
All Cases 5,44 5,526 5,876 7,32
Source:			Health	Research	Board
  The cases reported cover those treated in 
outpatient and residential settings only and 
so do not include those treated in primary 
care settings. HRB analysis shows that in the 
case of problem drug users entering treatment 
between 200 and 2006, 70% to 75% had 
problem use of more than one drug.  In contrast, 
only about 20% of those entering treatment 
for alcohol (new cases and previously treated 
cases) had problem use of a second drug.
4.93   It is not possible to quantify the number of 
problem alcohol users that require addiction 
treatment.  However, the significant 
difference between the number of cases 
reported in the hospital system for treatment 
for the consequences of alcohol use and 
the number of cases reported through the 
treatment system for alcohol addiction 
indicates that there is a considerable cohort 
of problem alcohol users that could benefit 
from engagement with addiction treatment 
services.
4.94   Early interventions are targeted at hazardous 
and harmful use of alcohol and are designed 
to reduce alcohol consumption before 
dependence develops. There is strong 
evidence7072 that brief interventions provided 
within various healthcare contexts are 
effective in reducing hazardous and harmful 
use. These contexts, in particular, include 
primary care, general hospital wards, mental 
health services and Emergency Departments. 
The Steering Group believes that training in 
brief interventions needs to be rolled out 
across the healthcare service to maximise the 
impact of this cost–effective approach. 
7   Data covering the period 2004 - 2006 was sourced from 
the HRB Trends Series, Trends in treated problem drug 
use in Ireland, 200 to 2006, HRB 2008.  Figures for 2007 
from the NDTRS, ADRU, HRB, March 2009
72   Cochrane Review:  Cochrane collaboration is a global 
network of volunteers dedicated to improving healthcare 
decision - making globally, through systematic reviews 
of the effects of healthcare interventions. 
58
N
at
io
n
al
 D
ru
gs
 S
tr
at
eg
y 
 (
In
te
ri
m
) 
20
09
 -
 2
0
6
4.95   The MTR included four new KPIs to measure 
performance in achieving objectives. 
Performance under the new KPIs can be 
summarised as above.
KeyfiNDiNgSfrOmTheCONSulTATiON
PrOCeSS
The findings presented here arise from the consultation 
process outlined in the Introduction.
4.96   The overall increases in funding and the 
expanded range of treatment services in 
place since the publication of the current 
NDS were acknowledged.  The consultation 
process also highlighted the willingness to 
test new approaches and pilot initiatives as 
a positive aspect in the response to drugs. 
It was recognised that there is significant 
potential for shared learning across the 
country with regard to best practice and 
successful initiatives.
4.97   While examples of good practice were 
acknowledged, the key gap is that treatment 
services are not consistently available across 
the country.  More specifically, the consultation 
process highlighted the following:  
n	 The commitment to a continuum of care 
approach, with a comprehensive service 
from engagement, through detox and on to 
aftercare, was a strong theme throughout 
the consultations. This requires greater 
coordination and integration of services 
and the development of formal care plans 
(including a focus on aftercare) to place the 
individual’s needs at the centre of any response. 
It also implied an approach that would offer 
both drug - free and harm reduction options. 
This view was most prevalent in relation to 
the treatment of heroin addiction through 
methadone programmes, where there was 
strong support for abstinence - based options 
to also be put in place;   
n	 The lack of residential detox services around 
the country was consistently raised.  Access 
to such services is seen as being difficult. 
The ‘drug - free’ requirement to access many 
residential rehabilitation services was also 
identified as a problem, given this lack of 
detox services;
n	 Access to methadone services is an issue, 
particularly outside Dublin as prevalence 
increases geographically. The number of GPs 
who can initiate and prescribe methadone 
varies significantly between areas;   
n	 At the same time, there was concern about 
the long - term effects of methadone on 
individuals, as well as the inappropriate 
location of some treatment centres.   While 
research has been carried out on long - term 
treatment effects, these are not evident to 
ASSeSSmeNTOfimPACT
Progress against KPIs - quantitative assessment of impact
100% of problematic drug users
accessing treatment within one
monthafterassessment.  
The primary focus of the current Strategy has been on putting substitute treatment 
services in place for opiate users.  In this regard, while there has been continuing 
growth in the number of treatment places provided, and while access to treatment 
within one month after assessment for methadone services is available in many areas, 
the provision of such services in some areas continues to be problematic for the 
reasons outlined in this chapter.  
On the basis of the cases reported to the NDTRS in 2007, treatment for non - opiate 
addiction was provided in almost all cases within the target one month waiting 
period.
100% of problematic drug
users aged under - 18 accessing
treatmentwithin onemonth after
assessment.  
Under - 8s are a priority group for drug treatment and none have been waiting for 
more than a month for initial treatment (methadone). However, the availability of 
appropriate residential and community support services is problematic and needs 
to be addressed. 
harmreductionfacilitiesavailable,
including needle exchange where
necessary, open during the day,
and at evenings and weekends,
according to need, in every local
healthofficearea.
Facilities are available in limited areas, primarily in the Dublin area, the Midlands and 
the Mid - West, through a mixture of fixed site and outreach services.  Progress in 
implementing these harm reduction measures present ongoing challenges. 
incidence of hiv in drugs users
stabilised,basedon2004figures.
Data available from the Health Protection Surveillance Centre indicates a drop in 
the number of HIV cases among IDUs although the actual number of cases reported 
each year is relatively small.  There has been a gradual and consistent drop from 7 
in 2004 to 36 in 200873.  The incidence of blood borne viruses (BBV), particularly 
Hepatitis C, among IDUs is a continuing cause of concern 
73   Newly diagnosed HIV infections in Ireland – Quarters 
3 & 4 of 2007, 2007 & 2008 Annual Summaries: Health 
Protection Surveillance Centre (HPSC)
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the general public.  At the same time, it was 
acknowledged that access to a methadone 
programme had allowed a significant number 
of people to return to, and maintain, a 
stable work and social/family life. The lack of 
alternative options to methadone treatment 
was also highlighted as a key development 
priority; 
n	 The implications of the “Vision for Change” 
Mental Health Strategy, (referred to in 
para 4.3, above) was consistently raised. 
The implementation of this strategy has 
raised significant concerns about access to 
appropriate treatment for individuals.  While 
alcohol and drug addiction are classified 
internationally as a mental health disorder, 
this is no longer the case in Ireland, leading 
to concerns that people may not get the 
treatment they require. 
n	 The specific issues of dealing with problems 
of drug use in prisons were identified, with 
perceived high levels of addiction among 
those leaving this setting.   The perception is 
that drugs are freely available in prisons and 
that current programmes are inadequate;
n	 There was strong support for further 
investment in most types of intervention 
including clinics, counselling, stabilisation 
programmes and rehabilitation services; 
n	 The need to implement the recommendations 
of the Reports of the Working Group on 
Drugs Rehabilitation and the Working Group 
on Residential Treatment & Rehabilitation 
(Substance Abuse) was highlighted.  The 
need for the development of co - ordinated 
inter - agency working was also raised; 
n	 Priorities differed from area to area with an 
overall focus on ensuring a consistent level 
of provision across all areas of the country. 
A further gap was the absence of out - of 
- hours services and services operating at 
weekends;
n	 Strengthening family support services also 
emerged as a priority from the consultation 
process. Gaps remain in services for families 
across the country, with the focus still 
predominantly on the drug user.  Services 
required for families include respite, 
counselling, alternative therapies, mediation 
and marriage/relationship guidance.  In 
addition, family support groups have identified 
specific issues in relation to guardianship, 
men's issues and siblings as key future 
priorities in development of services; 
n	 The role of FÁS Community Employment 
schemes in helping recovering drug users to 
develop their personal and employment skills 
and find a pathway back to work is strongly 
valued. In this context, the implementation of 
the Individual Learner Plan was highlighted. 
This identifies participant’s needs and 
records progression towards labour market 
reintegration.  The development of targeted 
programmes by FÁS was seen to be essential 
and should be an integral part of the new 
NDS, with a commitment to ensuring that 
such initiatives are available to recovering 
drug users in all parts of the country; and
n	 Most people felt that there is a need to 
combine treatment and rehabilitation 
services for drugs and alcohol, given the 
growing evidence of polydrug use and the 
role of alcohol as a potential 'gateway' drug. 
Overall, across the consultation process, there 
was strong support for combining alcohol and 
drugs in a single Strategy.  Where concerns 
were expressed about this approach, the 
reservations primarily related to the danger 
that the drugs issue could be lost in the 
context of dealing with alcohol, particularly 
if adequate additional resources were not 
provided. 
Needs of specific groups
4.98  A key theme that emerged throughout all 
elements of the consultation process was the 
requirement to focus the NDS on the needs 
of specific communities in accessing services. 
In general, it was felt that the current NDS 
does not sufficiently differentiate the needs of 
specific groups and tailor services accordingly. 
Along with the needs of prisoners, the key 
constituencies with specific needs highlighted 
during the consultation process are set out 
below.  In addition, the work that has been 
ongoing in targeting drug misuse amongst 
these groups is highlighted, as is research on 
the current levels of prevalence, where it is 
available.  
New communities
The Steering Group notes that there is a lack of 
information on the prevalence of drug taking among 
new communities so it is not possible to accurately 
determine the extent of any problem that may exist. 
Drug treatment data suggests that the number of non 
- Irish national cases treated for drug misuse grew from 
35 in 200 to 95 in 2006, constituting 2.8% and 3.8% 
respectively of total cases treated774.  The number of 
new cases has almost doubled from 47 to 93 over the 
same period (or 2.3% and 4.2% of total new cases). 
74   HRB Trends Series 2:  Trends in Treated Problem Drug 
Use in Ireland, 200 to 2006, Health Research Board, 
2008.
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Data from MQI indicate that approx 30% of their clients 
in 2008 (comprising 35 nationalities) were non - Irish. 
Of these, 90% were from Europe - with 47% of those 
coming from new EU Member States (30%) or non - 
EU states (7%). Use of cocaine, cannabis and heroin 
is evident, as well as a range of other drugs.  A specific 
problem for new communities is a lack of information 
about the support services available.  Representative 
bodies of new communities have also found it difficult 
to engage with NDS structures, including Drugs Task 
Forces, due to lack of knowledge on how to do so.  
The HSE, in consultation with key partners, including 
NGOs representing new communities, in part response 
to their Intercultural Health Strategy report7275, have 
sought to address this concern.  These efforts included 
engagement through focus groups with members 
of new communities to ascertain their views and an 
independent report of these engagements has been 
prepared.  As much information is spread to new 
communities through informal channels, a key priority 
for the new NDS is to build on this engagement with 
representative organisations.  In doing this, their 
channels of communication can best be utilised to 
target information so as to raise awareness about 
treatment and rehabilitation services. 
Travellers 
Data is not available to indicate the number of 
Travellers who present for treatment as, heretofore, 
they have not been recorded as a distinct group under 
the NDTRS.  However, the NACD found that the 
prevalence pattern broadly mirrors that of the general 
population, with cannabis, sedatives and tranquillisers 
most commonly used, followed by cocaine, ecstasy 
and, lastly, heroin7376.   The issues experienced by 
Travellers in relation to drugs are entwined with issues 
of inequality and marginalisation.  This means that 
Travellers are more likely to be exposed to the risk 
factors that lead to problem drug use.  It also implies 
that response mechanisms to address the associated 
problems need to factor in these issues.  There are 
heightened concerns within that community about the 
growth in problem drug use. This is also acknowledged 
by the HSE as a key and growing concern.  The NACD 
report found that, while there are some good models 
of service provision, Travellers experience specific 
problems relating to access to services arising from 
a lack of awareness of the existence and nature of 
drug services, lack of formal education, stigma and 
embarrassment and lack of culturally appropriate 
services.  
In the context of an overall Traveller Health Strategy7477,
75   National Intercultural Health Strategy 2007 - 2, Health 
Service Executive, 2008.
76   An Overview of the Nature and Extent of Illicit Drug 
Use amongst the Traveller Community:  An Exploratory 
Study, National Advisory Committee on Drugs, 2006.
77   Traveller Health:  A National Strategy 2002 - 2005, Health 
Service Executive, 2002.
the HSE has a Regional Traveller Health Unit in place 
in each former Health Board area.  These Units work 
with, and advise, the HSE on the health and social care 
needs of Travellers. In addition, in areas where there are 
significant numbers, the HSE has engaged members of 
that community as peer primary carers working to link 
Travellers to services. The All - Ireland Traveller Health 
Status Study, undertaken by the HSE, commenced in 
2008, will report on the broad spectrum of health and 
social care needs of Travellers. 
It is also noted that current models of good practice in 
relation to Traveller - specific drugs work can be drawn 
on to develop guidelines for best practice in relation 
to such work. In this context, the Steering Group 
noted the completion, in May 2009, of a framework 
document in respect of the implementation of the 
recommendations of the NACD Report on the nature 
and extent of illicit drug use amongst the Traveller 
Community.  The Steering Group is of the view that 
the implementation of this framework should be 
considered in the context of developments of drugs 
policies over the lifetime of the new NDS.
Lesbian, Gay, Bisexual and Transgender (LGBT) 
Community
While there is no comprehensive data on prevalence 
within the LGBT community, research indicates that 
young LGBT people are more likely to take drugs, in 
particular “recreational”7578 drugs, than in the general 
population.  The use of poppers7679 was highlighted as 
a particular concern.  The research also found that 
2% have systematically used drugs (i.e. on more than 
60 occasions) and that 60% had taken drugs over the 
2 months preceding the survey.   Unlike the general 
population where current illegal drug use tends to 
decline significantly among the older population, the 
perception and concern in this community is that 
current drug use is sustained to an older age. 
People presenting with dual diagnosis
People who experience both mental health and 
substance misuse problems experience specific 
difficulties in accessing treatment.   Research by the 
NACD7780 found that there was no systematic provision 
of care services for this group of people and that many 
services operated exclusion criteria (58% for addiction 
services and 43% for mental health services).  As 
outlined earlier in this chapter, the Steering Group 
has concerns that difficulties in accessing services 
78   Data from Drug Use amongst Lesbian, Gay, Bisexual & 
Transgender young Adults in Ireland:  BeLong To, 2007. 
Other surveys (Gay Men’s Health project 2000;  LGBT 
2008)  in the LGBT community confirm that rates of 
“recreational” drug use among that cohort are much 
higher than in the general population. 
79   Poppers” is the popular name for various alkyl nitrites 
– the effects include a “rush” sensation and relaxation of 
muscles that facilitate sexual intercourse.
80   Mental Health and Addiction Services and the 
Management of Dual Diagnosis in Ireland:  National 
Advisory Committee on Drugs, 2004.
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for people presenting with both mental health and 
substance misuse could be exacerbated by the 
implementation of the “Vision for Change” Mental 
Health Strategy.  While the prevalence of dual 
diagnosis is not known, as it is not recorded by service 
providers, the NACD study reported previous research 
in Ireland that indicated it could be relatively high.  In 
addition, the NACD found that homeless people are 
more likely than the general population to experience 
both mental health and substance misuse problems 
due to environmental factors, particularly the lack of 
supported housing. 
Homeless people
NDTRS drug treatment data shows that the number 
of homeless cases, relative to total cases treated, 
increased from 53 to 265 between 200 and 2006 
(3.2% and 5.% respectively of total cases)788.  The 
needs of homeless people are particularly complex 
and highlight key gaps in inter - agency working, 
particularly at local level.  
The NACD study of homeless people7982 highlighted that: 
n	 50% had been in prison at some time; 
n	 30% had received some treatment for 
psychiatric illness; 
n	 Polydrug use was reported by 72% of current 
drug users (52%8083); 
n	 5% were problem alcohol users while 36% 
were problem drug users884;
n	 50% of problem drug users reported contact 
with methadone treatment services in the 
last month; and 
n	 50% of problem drug users were positive for 
Hepatitis C. 
This profile highlights the specific problems 
facing people who are homeless with substance 
misuse problems.  At present, the Drug 
Treatment Centre Board provides a significant 
level of treatment services for homeless people. 
Key issues that arise include:
81   HRB Trends Series 2:  Trends in Treated Problem Drug 
Use in Ireland, 200 to 2006, Health Research Board, 
2008.
82   Drug Use Among the Homeless Population in Ireland: 
National Advisory Committee on Drugs, 2005.  While 
the Study provided an assessment on the nature and 
context of drug misuse among people who are homeless 
in 4 locations – Dublin, Cork, Galway and Limerick - it 
did not estimate prevalence.  The figures are indicative 
of the extent and type of problems faced by homeless 
people. 
83  In contrast to 2.9% in overall population.
84   As defined by Alcohol USE Disorders Identification 
Test (AUDIT) and Drug Abuse Screening Test (DAST) 
respectively.
n	 accessing social housing – need for secure 
and stable environment;
n	 elimination of waiting lists for access to 
treatment; 
n	 localising treatment provision;
n	 the possible provision of methadone in 
hostels;     
n	 lack of safe places for people to inject drugs; 
and
n	 provision of outreach services to where 
homeless people reside. 
The Steering Group notes that the provision 
of appropriate housing is seen as the critical 
need that must be addressed if treatment and 
rehabilitation services are to deliver sustained 
successful outcomes with this cohort.
Sex Workers 
A small number of agencies in the statutory, community 
and voluntary sectors are seeking to provide support 
services for sex workers.  As with the homeless, the key 
requirement is for a holistic approach to the needs of 
those working in prostitution and inter - agency co - 
operation is the key to providing these services. While 
some funding for interventions has been provided 
through the Drugs Task Forces, insufficient support 
services have been developed to date.  In addition, 
concerns about the growth in sexually transmitted 
infections (STIs) among this cohort emphasises the 
need for improved harm reduction services - including 
access to needle exchange and condoms - which should 
be provided on an outreach basis.  The Steering Group 
is of the view that there should be better integration 
between infectious disease services, addiction services 
and general hospital services. In this context, the 
Steering Group also notes that an NACD Report8285 on 
drug use and sex workers was published in May 2009.
4.99   Overall, the specific needs of these groups, 
outlined above, highlight important issues 
for the new NDS around the provision of 
treatment and information, in particular the 
capacity to identify and address their needs. 
The capacity of professionals working in 
treatment is also critical and specific training 
is required.  It also underlines the need 
to ensure that they have the opportunity 
within the NDS framework to engage with 
key agencies.   However, it is important to 
acknowledge that the fundamental problems 
of these groups relate to social and economic 
disadvantage and addressing these wider 
social inclusion issues is critical.  
 
85   Drug Use, Sex Work and the Risk Environment in Dublin: 
National Advisory Committee on Drugs, 2009.
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CONCluSiONSANDPriOriTieSfOrThe
fuTureDrugSSTrATegy
4.100   There has been a significant expansion of 
treatment services, particularly in relation to 
methadone treatment, which has dominated 
the development of treatment over the 
lifetime of the current NDS.  However, 
there have been significant changes in the 
patterns of drug use, involving a greater 
range of drugs, increased use of cocaine, poly 
- substance use (including alcohol) and a 
greater geographical spread of problem drug 
use. Overall, the Steering Group is of the 
view that future treatment and rehabilitation 
services need to be integrated and responsive 
to changing trends.  This is essential to deal 
with the range of problems caused by drugs 
and alcohol across the country. 
4.101   In terms of the new NDS, the Steering Group 
believes that there are two broad contexts 
within which services should be developed:
n	 opiate use, and polydrug use that involves 
opiates. This continues to be concentrated 
in socially disadvantaged areas, among 
marginalised communities and primarily in 
urban communities across the country; and 
n	 other drug use, and polydrug use generally 
not involving opiates, spread across the 
general community. 
4.102   It is the view of the Steering Group that, 
while methadone substitution treatment 
must continue to be a cornerstone of opiate 
treatment services, it should be augmented 
by other approved substitution treatments, 
as appropriate.  With respect to continuing 
to improve timely access to, and exit from 
treatment, the Steering Group considers that, 
along with the continuing recruitment of 
level 2 GPs, the Methadone Protocol should 
be reviewed with respect to expanding the 
options through which the service is provided. 
This would include: 
n	 Increasing the upper limit on the number of 
drug users that more experienced GPs can 
work with; 
n	 Examining ways of supporting level  & 2 GPs 
to take a full complement of clients;
n	 Considering whether future GP training 
should include addiction issues to allow GPs 
operate at level  & 2;
n	 Consideration of the development and use 
of an Advanced Nurse Practitioner or Clinical 
Nurse Specialist8386 role;
n	 Considering the case for voluntary 
organisations to recruit doctors in relation to 
drug treatment, particularly in the case where 
such organisations have a significant history 
in dealing with individuals with complex 
social needs; 
n	 Facilitating the use of mobile units; and
n	 Monitoring and reviewing the progress of 
clients with a view to creating appropriate 
opportunities for clients to successfully 
complete their treatment and exit the 
programme drug - free.
4.103   The Steering Group endorses the view of the 
Working Group on Alcohol and Drug Synergies 
that there is a clear need to bring greater 
coherence and co - ordination to alcohol 
and drug issues at a policy, planning and 
operational level.  With respect to treatment 
and rehabilitation, the Steering Group sees 
the re - orientation of all addiction services 
towards dealing with problem substance use 
as a key feature of the new Strategy.  This 
will necessitate the use of the 4 - tiered 
model approach, (outlined in paragraph 
4.2) involving the statutory, community and 
voluntary sectors, within a national clinical 
and governance framework through which 
to develop and deliver these services.  The 
focus of the new Strategy will be on the 
development of addiction services and 
pathways between these and other elements 
of the health and social services that deal 
with the consequences of problem substance 
use.  
4.104   Future development of treatment and 
rehabilitation services must also take place 
within the context of the HSE’s current 
reconfiguration of services and the move 
towards an integrated care model.  It must 
also reflect the development of Primary Care 
Teams and Social Care networks to deliver 
community - based health services. The 
realignment of the mental health services will 
be a significant element of this and will have 
a direct relevance to clients with addiction 
issues.  
86   The nurse specialist is a nurse who is qualified beyond 
the level of a nurse generalist and is authorised to 
practice as a specialist in a branch of the nursing field. 
Titles for the nurse specialists include the designation 
nurse modified by the name of the speciality.  There are 
clinical/advanced nurse specialists in a variety of areas 
e.g. emergency, hospice home care, older adults, stroke 
care.
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4.105   The model of treatment and rehabilitation 
services is based on the development of an 
inter - agency approach based on a continuum 
of care, key worker and the availability of a 
range of treatment options to meet individual 
needs. These are widely accepted as core 
principles underpinning treatment and 
rehabilitation. The continued development 
of psychosocial services, including brief 
interventions, is central to the development of 
such a service.  In addition, the Group believes 
that comprehensive treatment facilities for 
problem drug users should be available in all 
areas where a problem exists or arises.
4.106   The Steering Group is of the view that 
tier 3 and 4 services are underdeveloped 
and their further development must be a 
priority if a comprehensive treatment and 
rehabilitation service is to be achieved.  In 
this regard, the Steering Group acknowledges 
the current financial constraints that face the 
public service, but see this objective as an 
achievable goal over the lifetime of the new 
NDS.  Particular opportunities in this regard 
might arise through the ongoing restructuring 
of the HSE and the reconfiguration of the 
mental health services.
4.107   The implementation of the recommendations 
of the Report of the Working Group on Drugs 
Rehabilitation and the HSE Working Group 
on Residential Treatment & Rehabilitation 
(Substance Abuse) will provide a basis 
through which the rehabilitation needs of 
people presenting for treatment can be 
delivered.  As outlined earlier in this chapter, 
the recommendations cover a wide range of 
issues and supports. 
4.108   The Steering Group is also of the view that 
the development of needle exchange facilities 
and other harm reduction approaches is vital 
if the risk from BBVs is to be lessened, and 
consequent deaths reduced.  To this end, 
the incidence of Hepatitis C among IDUs 
needs to be tackled in a comprehensive 
way.  In this context, the Group believes that 
the forthcoming HSE report on Hepatitis C, 
subject to it being considered and agreed, 
should be implemented as a priority. 
4.109   The increase in drug - related deaths, as 
identified through the National Drug - Related 
Death Index 998 - 2005, shows the clear 
need for a National Overdose Prevention 
Strategy. This is currently being developed 
by the HSE. Addressing concerns about the 
availability and use of prescription drugs in 
general, but of benzodiazepines in particular, 
along with providing training in the use 
of naloxone for Emergency and Ambulance 
staff should be fundamental elements of this 
policy.   
4.110   It is noted that there has been a significant 
increase in non - poisoning deaths (those 
indirectly related to drugs).  The Steering 
Group considers that further research is 
needed to identify the factors contributing to 
these deaths, with a view to developing a co 
- ordinated health policy response to address 
such issues.
4.111   It is critical that adequate and appropriate 
treatment services are available for under 
- 8s, focused in particular on youth most 
at risk (including homeless, those at risk of 
homelessness and those coming out of care 
at 8) that come to the attention of social, 
justice and youth services.  Many of these 
young people may still be at the early stages 
of problem substance use and most will have 
underlying personal problems that need to 
be addressed.  Early intervention is a critical 
factor in minimising the chances of them 
developing more severe problem substance 
use.  For those with more severe personal 
problems, additional residential services will 
be necessary.  Putting in place a formalised 
referral service, governed by protocols, is 
central to these services being developed. 
Support services for families, including 
family therapy services, need to be further 
developed in this context.
4.112   The Steering Group is of the view that a drugs 
interventions programme, incorporating a 
treatment referral option for those for whom 
it is appropriate, should be developed for 
people, primarily youth and young adults, 
who come to the attention of the Gardaí due 
to behaviour caused by substance misuse. 
The key services involved in developing such 
a co - ordinated referral option would be An 
Garda Síochána, the Department of Justice, 
Equality & Law Reform, the HSE treatment 
services, the Irish youth Justice Service, 
the Probation Service and voluntary and 
community youth services.  In this context, 
the Group feel that many of the required 
services are already in place for this, but that 
inter - agency co - operation needs to be 
more developed.   
4.113   While the IPS has significantly expanded its 
treatment services in a number of prisons in 
recent years, there needs to be a continuation 
of this expansion with a view to developing a 
comprehensive treatment and rehabilitation 
service for problem substance users in all 
prisons. It is also critically important that a 
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managed release programme continues to 
be developed that connects those released 
from prison with follow - on treatment and 
rehabilitation services. 
4.114   With respect to the specific groups outlined 
in paragraph 4.98, there is a need to further 
develop outreach services (in a multiplicity 
of languages as far as feasible) that will 
facilitate timely access to treatment, allied to 
the need to develop appropriate residential 
rehabilitation options.  
4.115   The Steering Group believes that the 
expansion of harm reduction approaches, 
based on an evidence - based approach 
covering developments internationally 
requires further consideration.  It is envisaged 
that research in this area will be undertaken 
by the NACD and this is addressed in chapter 
5. 
4.116   As outlined above, among the most difficult 
cohort to engage with are those experiencing 
both substance misuse and mental health 
issues.  Many of these also have other 
problems, such as being homeless.  The 
development of a comprehensive service to 
deal with the needs of dual diagnosis clients 
is an essential component of an integrated 
treatment and rehabilitation service. 
4.117  Treatment and rehabilitation services 
intermittently encounter challenges in 
managing clients’ behaviours.  This can range 
from the general anti - social behaviour of 
some clients to more serious cases related to 
threatening behaviour (often related to gang 
feuds) and can undermine the provision of 
treatment.  The Steering Group, while fully 
acknowledging these difficulties, considers 
there is no ready solution to this problem 
but is of the view that when such situations 
do arise, that the safety of staff and clients is 
paramount.  It is recommended that protocols 
be developed to facilitate the better handling 
of these situations. 
4.118   The consequences of problem substance use 
(including alcohol) often have a significant 
and disproportionate impact on Emergency 
services, particularly at week - ends. While 
there are good examples where training 
(e.g. brief intervention training) has been of 
benefit to staff, it is accepted that training (in 
the administration of naloxone in particular) 
for staff needs to be developed over the 
coming years.  The Steering Group is of the 
view that there is a need to put protocols in 
place that facilitate acute hospitals to provide 
an early intervention service for people with 
substance misuse and related issues who 
present to Emergency services.
4.119   An appropriate educational model for 
paramedic (ambulance service), nurse and 
midwife training should be developed to 
ensure that they are familiar with relevant 
drug treatment issues and alternative care 
pathways.  
4.120   While training is now available for GPs, there is 
a need to develop training for undergraduate 
doctors in regard to substance misuse and its 
treatment. 
4.121  There is also a need to: 
n	 continue to develop service user fora to 
engage with problem drug users; and   
n	 continue to develop, review and update 
directories of services currently available, and 
to explore innovative and accessible ways of 
disseminating information on services.
4.122   Progress has been made across statutory, 
voluntary and community services in 
introducing benchmarked standards for 
services, including accreditation for staff 
and competency frameworks. However, it is 
accepted that this is an issue that requires 
to be further developed to ensure national 
coverage to an acceptable standard across 
the range of services provided. The Steering 
Group is of the view that a quality and 
standards framework, based on the Report 
of the Working Group Examining Quality 
& Standards for Addiction Services and on 
the clinical and organisational framework 
developed by the HSE, should be introduced 
building on the initiatives in the HSE, voluntary 
and community sectors among others.
4.123   The Steering Group believes that the feasibility 
of cross - border initiatives on drugs and 
alcohol (e.g. needle exchange and residential 
services) within the all island health agenda 
should also be explored. This should be done 
in line with HSE cross - border arrangements 
for other health and social services.
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PriOriTieS
4.124   The Steering Group has identified the 
following priorities in relation to treatment 
and rehabilitation under the new NDS: 
Development of General Problem Substance Use 
Services
n	 Develop an integrated national treatment 
and rehabilitation service for all substances, 
using a 4 - tier model approach, underpinned 
by an appropriate  clinical and organisational 
governance regime;  
n	 Maximise operational synergies between 
Drug Addiction Services, Alcohol Treatment 
& Rehabilitation Services, General Hospital 
Services and Mental Health Services;
n	 Expand the availability of detox facilities, opiate 
substitution services, under - 8 services and 
needle exchange services where required;
n	 Implement the recommendations of the: 
  (i)  Report of the Working Group on Drugs 
Rehabilitation; and
  (ii)  Report of the HSE Working Group on 
Residential Treatment & Rehabilitation 
(Substance Abuse); 
n	 establish a drugs interventions programme, 
incorporating a treatment referral option, 
for those who come to the attention of the 
Gardaí due to behaviour caused by substance 
misuse.
Specific Groups
n	 Further develop engagement with, and the 
provision of services for, specific groups: 
Prisoners, Homeless, Travellers, New 
Communities, LGBTs and Sex Workers.
Quality and Standards Framework
n	 Develop a clinical and organisational 
governance framework for all treatment and 
rehabilitation services.
Training and Skills Development
n	 Develop national training standards 
for all those involved in the provision of 
substance misuse services, and co - 
ordinate training provision within a single 
national substance misuse framework. 
4.125   These issues are returned to in chapter 7 
where actions in relation to the new Strategy 
are identified. 
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CHAPTER 5 
RESEARCH 
AND INFORMATION
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ChApTEr 5
reSeArChANDiNfOrmATiON
iNTrODuCTiON
5.1   The current NDS set out to develop data 
sources and research on the extent and 
nature of drug misuse in Ireland with a view 
to having an informed, evidence - based 
approach to the on - going development of 
the Strategy.  The pillar has been crucial in 
deepening our understanding of the drugs 
situation in Ireland and placing it within an 
international context.  
5.2   The EU Action Plan on Drugs 2009 - 202 
views the understanding of the drug problem 
in society as a priority and identifies research 
and information as a cross - cutting theme. 
In this context, information flows need to 
be put in place with a view to ensuring a 
uniform approach to data collection across 
Europe.  This will facilitate the development 
of an overall European perspective on 
problem substance use and will allow for 
comparability of data between different 
jurisdictions.  From an Irish perspective, 
information flows need to be further improved 
so as to have comprehensive and more timely 
data available.  This will facilitate improved 
planning and management of services with 
a view to ensuring quicker responses to 
problems as they arise.  This is particularly 
relevant with respect to treatment and 
rehabilitation services.  It will also improve 
the evidence - base for future research.    
reSeArChPillAr-KeyfeATureS
5.3   The strategic aim of the research pillar in the 
current NDS is set out in Table 5.. below. 
Two groups are tasked with providing health 
and social information to inform the approach 
to tackling drug - related issues - the National 
Advisory Committee on Drugs (NACD), and 
the Alcohol and Drug Research Unit (ADRU) 
of the Health Research Board (HRB). The 
NACD was set up to conduct, commission 
and analyse research on issues relating to 
drugs and to advise Government on policy 
development in the area. The ADRU of the 
HRB manages drug - related information 
systems and collates and synthesises all 
information and research for the European 
Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA)8487.  
87   The European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) was established in 993 and 
is based in Lisbon.  The Centre through its collection, 
analysis and dissemination of objective, reliable and 
comparable information on drugs and drug addiction, 
provides an evidence - based picture of the drug trends 
at European level.
5.4   A number of other Government Departments 
and agencies have contributed to developing 
data collection processes and commissioning 
or conducting research.  The resultant 
information has increased our understanding 
of the drugs problem in Ireland. They 
included:
n	 Department of Health & Children;
n	 The HSE;
n	 Drug Treatment Centre Board;
n	 Health Surveillance Protection Centre 
(HSPC);
n	 National  Drugs Strategy Team (NDST) - 
including Drugs Task Forces;
n	 Department of Justice, Equality & Law 
Reform;
n	 An Garda Síochána;
n	 Forensic Science Laboratory;
n	 Irish Prison Service;
n	 Irish Courts Service;
n	 Central Statistics Office; 
n	 FÁS;
n	 Department of Environment, Heritage & Local 
Government;
n	 Department of Social & Family Affairs;
n	 Department of Education & Science;
n	 3rd Level Institutions;
n	 Joint Oireachtas Committee on Arts, Sport, 
Tourism, Community, Rural & Gaeltacht 
Affairs; and 
n	 Community and voluntary sectors.
Table 5.1 – Strategic Aim and Objectives of research 
pillar under the current NdS
National Drugs Strategy 2001 - 2008  
– Research 
Strategic Aim:
n	 To have valid, timely and comparable data 
on the extent and nature of drug misuse in 
Ireland.
Strategic Objectives:
n	 To have valid, timely and comparable data 
on the extent of drug misuse amongst the 
Irish population and specifically amongst all 
marginalised groups.
n	 To gain a greater understanding of the 
factors which contribute to Irish people, 
particularly young people, misusing drugs.
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ASSeSSmeNTOfPrOgreSSuNDer
CurreNTNATiONAlDrugSSTrATegy
5.5   There were two main streams of work under 
this pillar: 
Information Collection (4 actions – 4, 65, 67, 07) 
These actions focused on:
n	 the collation of data on the progression 
of offenders with drug - related offences 
through the criminal justice system (arrests, 
prosecutions etc.);
n	 securing the co - operation of treatment 
providers in returning NDTRS information; and 
n	 developing an accurate mechanism to record 
drug - related deaths and further developing 
the Central Treatment List (CTL)8588, coupled 
with the development of treatment waiting 
lists on a regional basis.
Research (4 actions - 98, 99, 00, 06)
These actions concentrated on the following research 
studies:
88   Central Treatment List (CTL) fulfils its core statutory (SI 
225/998) function – to be a complete register of all patients 
receiving methadone (as treatment for problem opiate use) 
in Ireland.  Once on the list, the current treatment status of 
the majority of clients can be tracked by means of transfer 
and exit records.
n	 estimating the prevalence of drug use among 
the general population; 
n	 estimating the number of opiate users; 
n	 exploring the experience of drug use among 
specific vulnerable populations; 
n	 documenting opiate treatment outcomes; 
and 
n	 examining the effects of sharing drug - using 
equipment.  
Action 06 dealt with the monitoring of NACD 
recommendations, as set out in the different 
reports. 
Information collection
5.6   The EMCDDA has developed five 
epidemiological indicators (see Table 5.2) that 
monitor the changing nature of problem drug 
use across Europe. The indicators provide a 
framework through which to examine problem 
drug use in our society and to place it within a 
European context. There has been considerable 
improvement in the quality of data collated on 
these indicators, though some gaps remain. 
Table 5.2: progress on development of indicators
indicator Progress
Prevalenceandpatterns
of drug use among the
generalpopulation
The NACD, in conjunction with their colleagues in Northern Ireland, have undertaken two all - island Drug 
Prevalence Surveys (2002/03 and 2006/07).  These have established the national prevalence of drug use 
among the general population, given insights on the spread of drug use by region, and provided more detailed 
information on the use of particular drugs in the general population.
The ESPAD89 survey undertaken every 4 years (2007 report was released in March 2009) estimates the 
prevalence of drug use among school - going students in their 6th year. 
The HBSC90 cross - national research study also gives some insight into alcohol and cannabis use of the youth 
population (age group  - 7). 
The survey of lifestyle, attitudes and nutrition in Ireland, SLÁN9, published by the Department of Health and 
Children, also gives some insight into the population’s alcohol and drug use (age group 8 and over).
Prevalenceandpatterns
ofproblemdruguse
The NACD undertook a 3 - source Capture Recapture Study to estimate the prevalence of problematic opiate 
use throughout Ireland in 200. This built on a similar 996 study that covered the Dublin area only. A further 
study to estimate the 2006 prevalence is currently underway.
The Research Outcome Study in Ireland (ROSIE), and the information provided through the NDTRS provide 
significant insights into the patterns of problem drug use.
The issue of estimating the prevalence of problematic drug use, other than opiate use, has been considered 
but the current lack of a unique identifier (see para 5.7 below) in data sources does not facilitate this.  At this 
point, the Drug Prevalence Surveys provide the best available prevalence estimates for cocaine, cannabis and 
other problem drug use. 
Demand for drug
treatment (statistics from 
drug treatment centres on 
clients starting treatment)
Drug treatment data has also improved substantially through the NDTRS (which records treatment for problem 
drug and alcohol use), and the CTL (which records methadone treatment). However, there are limitations on 
the information available.  The NDTRS records episodes of drug treatment and does not reflect the number of 
individuals who received treatment. In addition, it is still not fully automated and, critically, does not include 
outcome/exit data for all areas.   
Data on waiting lists is being collected by the HSE. They report regularly to the Inter - Departmental Group on 
Drugs (see chapter 4) on this issue. 
Drug-relatedinfectious
diseases
The HPSC has introduced a surveillance system for Hepatitis B and C (notifiable diseases) and HIV.   While risk 
factors for HIV are reported for the vast majority of cases, risk factors for Hepatitis B and C are reported on a 
minority of cases.  There is no national prevalence estimate of BBVs among the drug using population.
Drug - related deaths
and mortality of drug
users 
THE HRB has developed a National Drug - Related Deaths Index (NDRDI) and has published data for the 
period 998 - 2005, (see chapter 4). This data collection mechanism complies with the requirements of the 
EMCDDA. 
89   European School survey Project on Alcohol and other Drugs (ESPAD): 
The survey is carried out every 4 years in 40 European countries. 
90   Health Behaviour in School aged Children (HBSC):   A World Health 
Organisation (WHO) collaborative cross national study.
9   SLÁN is a national survey (carried out by the Department of Health 
& Children) of the lifestyle, attitudes and nutrition of people living in 
Ireland.  The most recent survey was carried out in 2007.  It includes 
questions on alcohol and the use of licit and illicit drugs. 
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5.7    Substantial progress is, therefore, evident 
in developing data.  A key constraint in 
enhancing current data collection is the lack 
of a unique identifier that, with a patient’s 
consent, would allow the system to track 
individual histories and permit the calculation 
of numbers treated for specific drugs in the 
population.  Issues around data protection 
legislation constitute a major difficulty in 
overcoming this problem.
5.8    Data gaps have also been identified under the 
prevention and rehabilitation pillars, as well 
as in regard to harm reduction (which include 
needle exchange and social care services). In 
relation to the latter, the Dublin Addiction 
Information System has been collecting data 
on needle exchange in the northern and 
east coast HSE areas.  In this context, it is 
recognised that there is a need to develop a 
national harm reduction database that can 
be maintained alongside the NDTRS, and the 
HSE is considering how best to progress this 
matter.
5.9    The primary focus of the current NDS has 
been on developing data in relation to 
prevalence, treatment and drug - related 
deaths. Much work has also been undertaken 
in the justice area in the development of 
information systems.  Examples of this include 
the development of Pulse (Garda information 
system), the role of the Central Statistics 
Office (CSO) in reporting crime statistics and 
Irish youth Justice and Irish Prison Services’ 
information systems.  
5.10    Some exploratory work has been conducted 
by the lead agencies to progress action 4 of 
the current NDS relating to the collation of 
data on the progression of offenders with 
drug - related offences through the criminal 
justice system (arrests, prosecutions etc.). 
However, significant technical and resource 
issues continue to prevent the compilation 
of such information.  The Steering Group 
considers that the availability of such a 
system to track offenders with drug - related 
offences is a critical element of designing 
and establishing policy in the area of law 
enforcement as it relates to supply reduction. 
(See 2.39)
5.11    There are significant levels of prevention 
activity across the statutory, community and 
voluntary sectors, ranging from school - based 
actions to actions and activities through 
community and voluntary organisations 
(particularly among youth and sporting 
organisations).  However, it is noted that the 
reporting of outcomes, and the establishment 
of the impacts of initiatives undertaken is 
under - developed.  The Steering Group 
considers that the recent consolidation of 
youth affairs within the OMCyA and the 
evaluation of DEIS initiatives, affords an 
opportunity to develop reporting systems and 
to look holistically at prevention strategies 
aimed at both the general youth population 
and youth most at risk.        
Research
5.12    The NACD has published 70 reports8692 since 
it was established and has substantially 
completed the actions identified in the NDS:
n	 it has published, or is about to publish, 
reports on at risk groups identified in the NDS 
- the homeless, Travellers, sex workers and 
early school leavers; 
n	 It also commissioned a longitudinal study on 
treatment outcomes (Research Outcomes 
Study in Ireland - ROSIE) under which it has 
published seven reports on outcomes to 
date; and  
n	 it has published a report on Harm Reduction 
Approaches in Ireland, incorporating 
international evidence (action 00 refers).
5.13    The 2005 MTR of the current NDS identified 
an additional action relating to the 
monitoring of the implementation of NACD 
recommendations.  To date, no formalised 
procedure has been put in place to monitor 
implementation but the progress of NACD 
reports are routinely discussed at IDG 
meetings.  
5.14    The ADRU of the HRB, has undertaken 
and disseminated research in relation to 
drugs through its trend paper series (NDTRS 
and NDRDI), overview series, research 
publications and its quarterly newsletter - 
Drugnet Ireland. The ADRU also manages the 
National Documentation Centre on behalf 
of the Department of Community, Rural 
and Gaeltacht Affairs.  This is a significant 
information resource for researchers, policy 
- makers and people working in the areas of 
drug or alcohol use and addiction, or related 
fields.  
5.15    Research has also been undertaken 
independently or jointly by a number of 
Departments and agencies. The joint NACD 
and NDST reports on Cocaine and on Needle 
Exchange8793, which were based on data and/
92   Details of publications by the National Committee on 
Drugs can be found on www.nacd.ie.
93   An Overview  of  Cocaine Use in Ireland II:  National Advisory 
Committee on Drugs & National Drugs Strategy Team, 2007. 
Needle Exchange Provision in Ireland: National Advisory 
Committee on Drugs & National Drugs Strategy Team, 
2008.
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or research produced by the HSE, ADRU, 
ESRI, An Garda Síochána and the Irish Prison 
Service, are good examples of this. A report 
on crack cocaine8894, undertaken by ADRU, 
was jointly financed by the Department of 
Justice, Equality & Law Reform and the 
HSE.  A promising feature of this research 
has been the level of inter - agency and inter 
- departmental engagement on mutually 
beneficial initiatives.  
5.16    Drugs Task Forces have sought to develop 
local data sources to facilitate needs analysis 
and planning, and they have also undertaken 
a number of research projects over the lifetime 
of the current Strategy.  Drugs Task Forces 
also tap into any information that is available 
through their statutory representatives. 
Analysis of the LDTF strategic planning 
process, undertaken in 2008, found that, 
while the LDTFs presented a comprehensive 
picture of drug prevalence using data from a 
number of different sources, there is an issue 
of a lack of consistent reliable local data in 
a useable form.  The difficulty in developing 
local data sources was also highlighted in the 
NACD’s Community Indicators Study which 
explored the development of a Community 
Indicator for Problem Drug Use8995. 
5.17    Three systematic reviews9096, funded by the 
NACD, have been completed by the National 
Medicines Information Centre on the use of 
naloxone, lofexidine and buprenorphine in 
the management of problem opiate users. 
The Department of Health & Children 
published a review of benzodiazepine use997, 
in 2002, as well as good practice guidelines 
for clinicians to ensure more appropriate 
prescribing of these drugs.   These publications 
were developed under the aegis of the NDS 
and, along with other NACD and HRB 
publications, were disseminated to a wide 
audience including policy makers.
94   Crack Cocaine in the Dublin Region, An Evidence Base 
for Crack Cocaine Study:  HRB Research Series 6, Health 
Research Board, 2008. 
95   A Community Drugs Study:  Developing Community 
Indicators for Problem Drug Use, National Advisory 
Committee on Drugs, 2006. 
96   The Use of Naloxone in the Management of Opiate 
Dependence Syndrome, National Committee on Drugs, 2003. 
The Use of Lofexidine in the Management of Opiate 
Dependence Syndrome, National Committee on Drugs, 2003. 
Report on the Use of Buprenorphine as an Intervention in 
the Treatment of Opiate Dependence Syndrome, National 
Committee on Drugs, 2002. 
97   Report of the Benzodiazepine Committee, Department 
of Health & Children, 2002.
5.18    With respect to research developed outside 
the remit of the NDS, an internal analysis 
which was undertaken by the HRB identified 
69 peer - reviewed drug - related publications 
produced in 200/2002 and 2005/2006 (i.e 
69 publications over a total of 4 years). These 
were classified into three main categories: 
n	 the nature and extent of drug use and its 
consequences (most common);
n	 clinical publications on aspects of problem 
drug use; and 
n	 a small number of harm reduction reports.  
5.19    Overall, it is clear that a significant amount 
of research has been undertaken and that 
the results of this research have been widely 
disseminated.  It is noted that this would 
have influenced policy formulation at least 
informally.  
ASSeSSmeNTOfimPACTPrOgreSS
AgAiNSTKPis-quANTiTATive
ASSeSSmeNTOfimPACT
5.20    The KPIs identify 3 important outputs in 
relation to the research pillar:
n	 Eliminate all identified gaps in drugs research 
by mid - 2008; 
n	 Publish an annual report on the nature 
and extent of the drug problem in Ireland, 
drawing on available data; and 
n	 Publish a report on progress being made 
in achieving the objective and aims 
set out in the Strategy every two years. 
 
In relation to the first indicator, there has been a 
significant increase in the knowledge of the drug 
problem in Ireland arising from commissioned 
research and data improvements.   Given 
the evolving nature of the drug problem, 
however, it is unrealistic to expect that 
commissioned research has bridged all research 
gaps as these become evident over time. 
 
On the second indicator, an annual report is 
prepared by the ADRU, as the Reitox National 
Focal Point, for the EMCDDA. This is a substantive 
report on the drugs situation in Ireland, and 
our responses to it.  This National Report 
has been available to the public since 2005. 
 
The third indicator, which was added in the 
MTR of the Strategy, has not been progressed 
in a formal way.  
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5.21  The current KPIs do not seek to outline how 
effective the data and research has been in 
influencing and shaping the development 
of policy and practice on a routine basis at 
national, regional and local level.  It is clear, 
however, that research has provided much 
important information which has influenced 
decision - making.
5.22    There is strong evidence that NACD and 
HRB (ADRU) reports and bulletins are widely 
disseminated and have an impact.  They 
contribute to creating a climate for change 
in the NDS, examples include a number of 
NACD reports, below:  
n	 Drug Use Prevention – Overview of Research 
(November 200) was routinely referred to by 
practitioners; 
n	 The Use of Buprenorphine as an Intervention 
in the Treatment of Opiate Dependence 
Syndrome (October 2002) was well - received 
internationally and has helped to inform the 
Department of Health & Children’s response 
and discussion at local level with GPs; 
n	 Drug Use among the Homeless Population 
(April 2005) has added credibility to the work 
of the homeless agencies and was specifically 
used to develop the case for drug workers in 
this field; 
n	 An Overview of the Nature and Extent of Illicit 
Drug Use amongst the Traveller Community 
– an Exploratory Study (October 2006) has 
also given credibility to their needs;  
n	 Needle Exchange Provision in Ireland 
(December 2008) reinforced the need for 
access to services; and 
n	 The Role of Family Services in Drug Prevention 
(November 2004) helped to bolster the efforts 
of the Family Support Network.  
5.23    On the other hand, the “Vision for Change” 
(Mental Health Strategy – see chapter 4) 
excluded addiction services from mental 
health services, contrary to the views 
documented in the dual diagnosis report9298 and 
contrary to general international practice.  
98   The Management of Dual Diagnosis in Mental Health 
and Addiction Services in Ireland:  National Advisory 
Committee on Drugs, 2004.
KeyfiNDiNgSfrOmTheCONSulTATiON
PrOCeSS
5.24    While research did not figure prominently in 
the public consultations, the need for better 
information systems and more research was 
included in some submissions. It was also 
captured and articulated in the submissions 
from the organisations that are more centrally 
involved in this area.   The conclusions and 
priorities for the future NDS outlined below 
take on board the findings from the overall 
consultation process. 
CONCluSiONSANDPriOriTieSfOrThe
fuTureDrugSSTrATegy
Information
5.25    Much more is now known about the drugs 
situation in Ireland than was the case in 200, 
with significant progress made in regard to 
4 of the 5 key epidemiological indicators 
identified by the EMCDDA: 
n	 prevalence and patterns of drug use among 
the general population;
n	 prevalence and patterns of problem drug 
use;
n	 demand for drug treatment; and 
n	 drug - related deaths and mortality of drug 
users.
Limited progress has been made in respect of 
the drug - related infectious diseases indicator. 
5.26    The Steering Group considers that the 
continuation of the All - Island National 
Prevalence Survey in 200/20 and 204/5 
is a prerequisite for monitoring the prevalence 
of problem drug use in our society.  The 
Group considers that alcohol use also needs 
to be monitored in a more comprehensive 
way and is of the view that the Prevalence 
Survey should be amended to include survey 
questions on alcohol. This would allow for 
a deeper understanding of the changing 
prevalence and patterns of alcohol use in 
the general population.  While it is agreed 
that the ESPAD Survey should continue 
to be the primary estimator of substance 
misuse among those under 8, it is also 
acknowledged that as a school - based survey 
it will not fully capture the level of misuse 
among the youth population most at risk. 
Consideration needs to be given, therefore, 
as to how to effectively monitor changes in 
the prevalence of substance misuse among 
this cohort.  The Steering Group believes 
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that the development of such a monitoring 
system should be informed by the research 
currently being completed by the NACD on 
early school leaving and substance misuse 
5.27    While the information provided through 
reporting systems, such as the NDTRS and 
the CTL, and through research projects such 
as ROSIE, provide significant insights into the 
patterns of problem drug use and into those 
engaged in treatment, the issue of estimating 
the prevalence of heroin, cocaine and 
emerging trends in new drugs is much more 
problematical.  There is a need to develop 
our data sources to estimate the overall 
prevalence of problem drug use. Critical in 
this regard is the putting in place of a unique 
identifier, as outlined in paragraph 5.7 above. 
Without such an identifier, it is unlikely that 
further significant progress can be made.  It is 
also important that an ethnic identifier, where 
appropriate, is further developed, particularly 
in the area of treatment and rehabilitation. 
5.28    The system of monitoring changing trends 
needs to be further developed with a view 
to ensuring full participation in the EU 
Early Warning System9399.  In this regard, the 
recommendations of the NACD’s Report9400 
on the role of laboratory stakeholders might 
be considered further.  
5.29    A system for monitoring cases of problem 
substance use (including alcohol) presenting 
to hospital Emergency Departments should 
be introduced and this is discussed in chapter 
4.  This could be done through the inclusion 
by hospitals of a small number of questions 
on alcohol and drug abuse in their generic 
data collection systems. 
5.30    The Steering Group considers that the 
introduction of a Drugs Trend Monitoring 
System should be considered by the Office 
of the Minister for Drugs (see chapter 7), 
in its first year of operation, in the light 
of developments regarding research and 
information under the new NDS.
5.31    While there have been improvements in the 
development of information systems in the 
justice area, their use is under - developed 
within the context of the NDS.  For example, 
PULSE data is not routinely available to 
the ADRU for reporting purposes to the 
EMCDDA.  
99   EU Early Warning System as established by EU Council 
Decision 2005/387/JHA.
00   Report on the Role of the Laboratory Stakeholders on 
the Early Warning and emerging Trends Committee, 
this was an internal report carried out by the National 
Committee on Drugs and was submitted to the IDG for 
their consideration in December 2007.   
5.32    The development of a real time National 
Substance Reporting System (NSRS) that 
is timely and monitors treatment and 
rehabilitation outcomes is considered to be 
crucial.  This would integrate the NDTRS, 
CTL, DAIS and HPSC (in respect of BBVs) 
information relating to IDUs and related 
reporting systems (e.g. prison treatment 
services, homeless treatment services, 
National Psychiatric In - patient Reporting 
System and the Hospital In - Patient Enquiry 
(HIPE) System, NDRDI and general mortality 
register) into a single reporting framework 
to monitor the outcomes of treatment and 
rehabilitation services.   Essential to this is 
the need to develop a unique identifier that 
while, respecting the privacy of individuals, 
facilitates the tracking of treatment outcomes. 
A unique identifier would allow the NDTRS 
to track individuals through treatment 
and social re - integration and to identify 
factors associated with positive and negative 
treatment outcomes. 
5.33    The Steering Group believes that there is 
also a need to further improve information 
in relation to a number of at risk groups 
including the following:
n	 BBVs: no national estimate of prevalence of 
BBVs, particularly Hepatitis C, among the 
drug - using population is available.  Risk 
factor data should be provided by all relevant 
organisations as an automatic element of the 
data to be notified to the HPSC;  
n	 the prevalence of psychiatric co - morbidity 
among drug and alcohol users is unknown; 
and  
n	 problem drug/alcohol use among the prison 
and homeless populations – a repeat of 
earlier research should be considered.  
5.34    The continued development of the National 
Drugs - Related Death Index is an important 
aspect of the development of our data sources. 
There is a need for this information to be 
available in a more timely manner but this 
is dependent on the implementation of the 
recommendations of the Coroners Report950. 
It is noted that an implementation team 
has been established in the Department of 
Justice, Equality & Law Reform in this regard.
0   Report of the Working Group on the Review of the 
Coroner Service:  Department of Justice, Equality & 
Law Reform, 2000. 
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5.35   The EMCDDA has identified three areas 
- harm reduction, drugs & crime and public 
expenditure - where they consider new 
indicators at EU level should be developed. 
The Steering Group notes that the work on 
these is still at an early stage.  While it is 
acknowledged that the development of these 
indicators present significant challenges, the 
Group is of the view that they would provide 
further useful insights into the drugs issue 
and that Ireland should be at the forefront of 
the development of some, or all, of them. 
reSeArCh
5.36   A number of important research initiatives 
with respect to treatment and rehabilitation 
have been identified in chapter 4.  These 
relate to: 
n	 the factors influencing indirect drug deaths;
n	 harm reduction approaches, based on 
an evidence - based approach covering 
developments internationally; and  
n	 the effect of alcohol and drugs on the Irish 
health and justice systems.
It is noted that research recommendations 
were also made in the Report of the Working 
Group on Drugs Rehabilitation, as outlined in 
chapter 4.  
Such research proposals should be assessed and 
reviewed annually to facilitate implementation, 
as appropriate, over a phased period.
 
5.37   The Steering Group believes that clinical 
research is underdeveloped in Ireland.  The 
Group is of the view that the programme of 
research, to be developed, should include 
research into the following, on a priority basis 
subject to annual review: 
n	 the psychosocial adjustment and quality of 
life of patients on long - term methadone 
maintenance treatment; 
n	 the evidence of the effectiveness of the 
progression of clients from substitute 
maintenance treatments to abstinence; 
n	 the misuse and prolonged use of psychotropic 
drugs; and
n	 new developments in treatments for drugs.  
5.38   The Group also considers that research into 
the impact of prevention programmes aimed 
at youth at risk should be undertaken to 
establish the outcomes being achieved.  This 
should include examination of the range of 
youth services being provided, such as those 
through yPFSF, SPy and the Garda youth 
Diversion programmes.
5.39   With respect to research broadly, the 
Steering Group considers an annual research 
programme should be agreed by the Minister, 
the Office of the Minister for Drugs (see 
chapter 7) and the NACD, as early as is 
feasible after the commencement of the 
new Strategy.  The development of this 
work programme should take cognisance 
of the need to develop reporting systems 
and indicators on the extent and nature of 
problem drug use in Ireland as discussed 
above.  In this context, the Steering Group 
considers that the following areas, among 
others, should be considered in the finalisation 
of the programme: 
n	 Research recommended in the Report of the 
Working Group on Drugs Rehabilitation;
n	 Harm reduction approaches, founded on 
an evidence - based methodology covering 
international developments;
n	 The evidence of the effectiveness of the 
progression of clients from substitute 
maintenance treatments to abstinence;
n	 Psychosocial adjustment, and quality of 
life, of patients on long - term methadone 
maintenance treatment;   
n	 The misuse and prolonged use of psychotropic 
drugs;
n	 Factors influencing deaths that are indirectly 
related to drugs;
n	 New developments in treatments for drugs;
n	 The impact of alcohol and drugs on the Irish 
health and justice systems;
n	 Further research on psychiatric co - morbidity 
among drug users;
n	 Prevalence patterns of problem substance 
use among prisoners and homeless people; 
and 
n	 Exploration of the feasibility of developing 
an indicator to monitor changes in the 
prevalence of substance misuse among youth 
at risk.   
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5.40    The Steering Group considers that the 
NACD should seek to develop a framework 
through which it can influence research 
carried out into problem substance use in 
Ireland, whether at a national (including 3rd 
level institutions), regional or local level, 
and whether within or outside the NDS 
organisational framework.  The aim would 
be to influence the areas in which research is 
carried out, to promote the improvement of 
research standards in the substance misuse 
area, to increase interest and expertise in 
such research and to strengthen links with 
other research bodies. 
5.41    It is noted that a significant body of 
knowledge on evidence - based best practice 
in relation to dealing with problem drug use 
has been built up.  However, a key challenge 
is to disseminate best practice among service 
providers to ensure that it is applied.  The 
increased collaboration between Drugs Task 
Forces, the NACD and the HRB has been 
helpful in this regard, as has the development 
of the NATP by the HSE, as outlined in 
chapter 4.  The National Documentation 
Centre of the HRB can play an important role 
also.  An important aspect of this will be the 
strengthening of links between research and 
training provision at national and local level. 
PriOriTieS
5.42    The Steering Group has identified the 
following priorities in relation to research and 
information under the new NDS: 
n	 Continue to develop indicators and reporting 
systems on the extent and nature of problem 
substance use in Ireland (seeking to remove 
barriers to the development of these reporting 
systems and indicators);    
n	 Develop a prioritised research programme, to 
be reviewed annually;
n	 Continue the Drug Prevalence and the ESPAD 
Surveys; and 
n	 Develop a research management framework 
and disseminate research findings and models 
of best practice.
5.43    These issues are returned to in chapter 7 
where actions in relation to the new strategy 
are identified.
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CHAPTER 6 
INSTITUTIONAL 
STRUCTURES
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ChApTEr 6 
iNSTiTuTiONAlSTruCTureS
iNTrODuCTiON
6.1    A wide range of statutory, community and 
voluntary sector organisations are currently 
involved in delivering the NDS at national, 
regional and local levels. As a cross - cutting 
area of public policy and service delivery, 
the implementation of the NDS represents, 
therefore, a significant institutional challenge. 
Ultimately, its overall effectiveness is closely 
linked to how well the institutional and co - 
ordination arrangements work.  
6.2    This chapter provides an overview of the key 
elements of the co - ordination framework. It 
assesses progress in achieving NDS actions, 
as revised by the MTR in 2005, examines the 
effectiveness of the overall framework and 
makes recommendations for the new NDS. 
Co - ordination framework - key features
6.3    Table 6.1 - key strategic aim and objective of 
the co - ordination framework.
National Drugs Strategy 2001 - 2008  
– Co - ordination framework 
Strategic Aim
n	 To strengthen existing partnerships in 
and with communities and build new 
partnerships to tackle the problems of 
drug misuse
Strategic Objective
n	 To have in place an efficient and effective 
framework for implementing the National 
Drugs Strategy
6.4    The institutional arrangements that support 
cross - agency working are an important 
element in the success of the implementation 
of the NDS. The MTR acknowledged that 
the effective implementation of the NDS as 
a whole was closely linked to the working of 
these arrangements. 
6.5    The key co - ordination mechanisms in the 
current NDS include:
n		 Department of Community, Rural and 
Gaeltacht Affairs (Drugs Strategy Unit - DSU);
n		 The National Drugs Strategy Team (NDST); 
n		 The Inter - Departmental Group on Drugs 
(IDG); 
n		 Local and Regional Drugs Task Forces; and 
n		 Cabinet Committee on Social Inclusion, 
Children & Integration. 
6.6    Arising from the First Report of the Ministerial 
Task Force on Measures to Reduce the Demand 
for Drugs, the NDST was established as a cross 
- departmental team on the lines envisaged 
in the Strategic Management Initiative in the 
Public Service. The core mandate of the Team 
was threefold (i) to effectively oversee the 
operation of the Local and Regional Drugs Task 
Forces (ii) to ensure effective co - ordination 
between Departments and agencies and (iii) to 
identify and consider policy issues and ensure 
that policy is informed by the work and lessons 
from the Task Forces, through joint meetings 
with the IDG.  
6.7    An important achievement of the NDST - 
and the other NDS co - ordination structures 
- is that they have stimulated and promoted 
inter - agency working in a difficult cross 
- cutting policy and service area. Relevant 
Departments and statutory agencies – as 
well as representatives of the community and 
voluntary sectors - are represented on the 
NDST, the IDG and the Task Forces. 
ASSeSSmeNT Of PrOgreSS uNDer The
CurreNTNDS
6.8    The MTR found that most of the 22 co - 
ordination actions in the Strategy had 
been implemented, with only 2 requiring 
“considerably more progress”.  Arising from the 
MTR, 5 of the 22 co - ordination actions were 
replaced or amended with no new actions 
being recommended.
6.9    The MTR identified three priorities in relation 
to the co - ordination pillar, which the adjusted/
replaced actions were designed to address in 
particular:
n		 Addressing the membership and operation 
of the NDST (action 83) - these have been 
substantially progressed; 
n		 Strengthening the operation of the IDG 
and specifying its modus operandi and 
membership (action 79) -  actions progressed; 
and 
n		 Engagement with the Oireachtas Committee 
on Arts, Sport, Tourism, Community, Rural 
and Gaeltacht Affairs (action 77) – action on 
- going.
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6.10    The actions under the co - ordination pillar 
of the current Strategy can be separated into 
a couple of areas. In the main, they relate to 
the work of the (i) the DSU (ii) the NDST and 
(iii) the IDG.  
(i)    The actions relating to the DSU were primarily 
concerned with co - ordinating the overall 
implementation of the Strategy in partnership 
with other Departments and agencies, as well 
as working through the IDG to establish the 
cost effectiveness of the various elements of 
each pillar of the NDS.  
(ii)    The actions relating to the NDST were, 
in the main, focused on their work in 
relation to the Local and Regional Drugs 
Task Forces and disseminating models of 
best practice arising from that work.   The 
NDST also had a role, through engagement 
with relevant interested partners, in capacity 
building within communities, particularly in 
developing community representation, and in 
disseminating good practice.  
(iii)    In relation to the IDG, it was tasked with 
addressing operational difficulties in relation 
to the on - going implementation of the NDS. 
Other actions related to its membership, joint 
meetings with the NDST and reporting by 
Departments, Agencies and other relevant 
organisations, as required. 
All of these actions have, in the main, either 
been completed or are ongoing tasks.  
6.11    Overall, the achievements made through the 
NDST and Drugs Task Forces since the 990s 
have been considerable.  The structures put 
in place, responding initially in the main to 
an opiate problem in Dublin, were innovative 
and broadly effective.  Among the areas of 
achievement under the stewardship of the 
NDST were the following: 
n		 a real focus on the drugs problem;
n		 the establishment of Local and Regional 
Drugs Task Forces throughout the country;
n		 prominent placing of the drugs problem in 
the social inclusion sphere;
n		 a targeted response to drugs issues as they 
affected people on the ground;
n		 structures that engaged communities and 
fostered commitment;
n		 encouragement of ownership of issues and 
voluntary involvement;
n		 upskilling and empowerment of people on 
the ground;
n		 training initiatives and promulgation of a 
standards and accreditation framework;
n		 dissemination of models of good practice; 
n		 co - operation between the statutory, 
community & voluntary sectors; and 
n		 structures that encouraged inter - agency 
working at NDST and Drugs Task Force 
level.
6.12    The focus for the new NDS is, therefore, 
to build on the achievements to date 
and put structures in place that will best 
facilitate tackling problem substance misuse 
nationwide over the coming seven years.
PrOgreSSAgAiNSTTheCurreNTKPis
6.13    The current NDS identified 4 KPIs to assess 
the efficiency and effectiveness of the 
framework for implementing the NDS:
Table 6.2 kpis and summary of progress
KPi Progress
Establish an effective regional 
framework to support the 
measures outlined in the 
Report by end 200.
RDTFs now established 
in 0 regions throughout 
the country (and with 
LDTFs provide full national 
coverage).
Complete an independent 
evaluation of the 
effectiveness of the overall 
framework by end 2004.
This was an integral part of 
the MTR of the NDS which 
was completed in 2005.
Each agency to prepare 
and publish a Critical 
Implementation Path (CIP) 
for each of the actions 
relevant to their remit by 
end 200.
CIP was completed and 
updated in 2005.  
Review the membership, 
work - load and supports 
required by the NDST 
to carry out its terms of 
reference by end September 
200.
Additional resources secured 
for NDST.
6.14    Significant progress has been made in 
developing the actions and in reaching the 
agreed KPIs.  The Steering Group considers, 
however, that more meaningful indicators 
are required in the new NDS to assess the 
efficiency and effectiveness of the overall 
co - ordination framework over the coming 
years.   The development of a performance 
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management framework is also relevant in 
this context and this issue is examined later 
in this chapter. 
CAPACiTyTODevelOPANDimPlemeNT
STrATegy
6.15   Despite the progress made, the Steering Group 
believes that there are a number of areas 
where the current NDS could be improved 
to better tackle problem substance use over 
the period until 206 and ultimately, to better 
enhance the overall capacity to develop and 
implement strategy.  These areas include:
n		 	influencing the prioritisation and  provision of 
mainstream services;
n		 accounting for expenditure; 
n		 governance; 
n		 the roles and responsibilities of the DSU and 
the NDST;
n		 mainstreaming; 
n		 capacity of services to meet clients needs; 
and
n		 monitoring/evaluation.  
These areas are addressed in detail below. 
Influencing priorities and mainstream service provision 
6.16    One of the key challenges for the NDS is 
its ability to influence the priorities of key 
agencies who are involved in delivering 
relevant services at national, regional and 
local level. While considerable progress has 
been made in implementing the actions in 
the NDS, this tended to be most successful 
where one Department, agency or Drugs 
Task Force was involved in implementing 
an initiative, rather than where a number of 
agencies were involved, with the potential for 
organisational problems and inconsistent levels 
of commitment. In this context, it is noted 
that co - ordinating structures depend on their 
ability to influence - rather than their authority 
to secure implementation of the NDS.   
6.17    The level of capacity to influence mainstream 
service provision can make it particularly 
challenging for the Minister of State with 
responsibility for the NDS to ensure that 
services are delivered in line with the strategic 
priorities of the Strategy. This is particularly 
so given the often competing social inclusion 
(and other) priorities of Departments and 
agencies.
6.18    In this context, it is noted that problem 
drug use may not be sufficiently high on 
other Departments/agencies agendas when 
considered purely from the perspective of their 
own responsibilities and concerns. However, it 
may warrant a more prominent role when 
viewed from a broader societal angle.
6.19    As identified in chapter 4, another structural 
concern within the health sector is the 
need to factor in the implications of the 
roll - out of the “Vision for Change” mental 
health services for the development of HSE 
addiction services. This primarily relates to 
the need to realign those elements of mental 
health services, currently dealing with drug 
and alcohol issues, to its addiction services. 
6.20    The challenge, therefore, is to put a structure 
in place that optimises the chances to 
influence policy formulation and programme 
implementation across the various agencies 
involved.   
6.21    The Group also notes that the Cabinet 
Committee on Social Inclusion, Children and 
Integration deals with a wide range of social 
inclusion policy areas, of which drugs is 
one issue.  While the scope for routine 
debate on drugs is limited, therefore, the 
Group acknowledges that addressing the 
broader social inclusion agenda ensures that 
the drugs issue is taken into consideration, 
as it is an integral aspect of many of the 
social inclusion priorities.  The fact that the 
proposed National Substance Misuse Policy 
(drugs and alcohol) is to be developed, regular 
engagement by the Cabinet Committee in 
this area is considered vital and it is the view 
of the Steering Group that substance misuse 
should be a formal agenda item at meetings 
at least twice a year. 
Accounting for expenditure 
6.22    While it is not difficult to identify annual 
expenditure across Departments and agencies 
in relation to the provision of core services 
for problem drug users, identifying monies 
expended on generic services provided for 
the general public remains a difficulty.   While 
it is estimated that approx €276m was spent 
on these services in 2008 – see table 6.3 
below - this figure excludes the cost of some 
generic services, as indicated above, and 
so understates total expenditure.  While 
bringing more clarity to NDS expenditure 
across all departments and agencies presents 
significant challenges, efforts to improve 
on the financial information available will 
continue and, accordingly, help to track 
trends in this regard more effectively.  
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Table 6.3 - 2008 expenditure by departments 
and agencies that is directly attributable to drugs 
programmes
Department/Agency 2008expenditure(€m)
Department of Community, Rural and 
Gaeltacht Affairs
e65.207
Department of Health and Children e.033
Health Service Executive e0.867
FÁS e8.8
Department of Education and 
Science
e2.386
Department of Environment, Heritage 
and Local Government
e0.496
Department of Justice, Equality and 
Law Reform
e8.79
The Probation Service e2.897
Irish Prison Service e5.00
An Garda Síochána e44.4
Revenue’s Customs Service e4.9
Total €275.776
Source – Department of Community, Rural and Gaeltacht Affairs 2009 
6.23    The Steering Group notes that the EMCDDA 
also recognises the importance of more 
clarity in public expenditure in the drugs area 
and that they are developing guidelines to 
support the development of an indicator in 
this regard.  
Organisational Governance  
6.24    The current co - ordination framework, which 
was designed to encourage effective inter 
- agency working relationships, is complex.  It 
is felt that further development is needed in 
the area of organisational governance and in 
particular, it is noted that: 
n		 	The Minister of State has overall political 
responsibility for the NDS but his authority to 
ensure implementation of NDS actions across 
all pillars is considerably constrained. The 
key pillar organisations involved in service 
delivery are accountable to the Accounting 
Officer of their respective Departments/
agencies and to their respective Ministers for 
all expenditure, priorities and actions;  
n		 The Secretary General of the Department 
of Community, Rural and Gaeltacht Affairs 
is ultimately accountable to the Public 
Accounts Committee for all expenditure 
incurred by his Department, including that 
incurred in respect of services funded by his 
Department through the Drugs Task Force 
process. However, this is not underpinned 
by sufficiently robust reporting arrangements 
from these organisations to the Department; 
n		 Drugs Task Force Co - ordinators are employed 
by the HSE, while development workers and 
administration staff are employed mainly by 
Area Partnerships Companies, in the case 
of the RDTFs, and through various hosting 
agencies in the case of the LDTFs. This has led 
to inconsistency in reporting arrangements in 
Drugs Task Forces between chairpersons, co 
- ordinators and other personnel; 
n		 There are some concerns about the adequacy 
of the monitoring arrangements of interim 
- funded projects, though it is acknowledged 
that the NDST has played a significant role 
in supporting the Drugs Task Forces through 
the introduction of agreed monitoring and 
evaluation processes; and    
n		 The development and implementation of 
agreed standards of clinical governance at 
national level is a priority within the HSE. 
This is a complex and challenging task, 
involving the harnessing of the expertise, 
knowledge and resources to commission 
the mix of services that incorporate best 
practice and meet evidenced - based need. 
The development of such a structure for 
treatment and rehabilitation services will be 
of significant assistance to Drugs Task Forces 
in regard to their roles in commissioning, 
promoting, providing and delivering services 
to respond to the needs of their populations. 
Drugs Strategy Unit (DSU) & National Drugs 
Strategy Team (NDST)
Roles & responsibilities 
6.25    The Steering Group found that both the DSU 
and the NDST have co - ordination, policy 
and strategy roles.  The NDST was originally 
established in 996/97 under Department 
of the Taoiseach and subsequently moved 
to the Department of Tourism, Sport and 
Recreation, where the DSU was put in place 
in 998/9.  Responsibility for the drugs area 
moved again in June 2002 to the newly 
established Department of Community, Rural 
& Gaeltacht Affairs. The operational and 
managerial role of the NDST has increased in 
recent times due to the increase in the number 
of Drugs Task Forces and the increase in the 
number of projects at Drugs Task Force level. 
As outlined in para 6.6 above, the NDST has 
also had a policy role, which was informed by 
the work of the Drugs Task Forces.
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6.26    The core role of the DSU is to co - ordinate 
the work of agencies, to provide resources to 
channels of funding, Drugs Task Forces and 
others, and to manage the development of 
policy. However, its focus has predominantly 
been on co - ordination and managing 
funding, with its policy role being under - 
developed.
6.27   Overall, this has led to some confusion for 
Drugs Task Forces and a perception has 
emerged of a double layer of administration, 
and a lack of clarity around the role and 
responsibilities of the NDST vis - à - vis that of 
the DSU.
6.28    There is also a perception in the Drugs Task 
Forces and the NDST that more incremental 
funding processes have been put in place since 
the last area - based plans were developed 
(in 2002 for LDTFs and 2005 for RDTFs). 
This arises from funding having been made 
available to address more nationally identified 
needs, such as cocaine and rehabilitation. 
While these funding streams were welcomed, 
concerns have been expressed that they were 
not based on the principle of priorities being 
directed only from a local level, involving 
the development of projects exclusively 
identified by, and specific to, local needs. 
The latter process was also seen to foster 
local ownership of both strategic plans and 
action - based responses. 
6.29    While there has been a focus on planning 
from the local level upwards, it is recognised 
that there is also a need for a national 
perspective in regard to the development 
of policy and services. Furthermore, the 
national perspective sits within an EU, and 
a wider international, perspective on the 
overall global drugs problem. 
6.30    The Steering Group notes that both cocaine 
and rehabilitation were identified as national 
concerns after extensive consultation.  The 
former came into clear focus as a result of a 
joint NACD and NDST Report on cocaine9602, 
which was based on data from the HSE, 
the HRB, the Gardaí, Revenue’s Customs 
Service and international evidence.  The 
latter was highlighted during the 2005 MTR 
of the NDS, which identified the under - 
developed response to rehabilitation as a 
key gap in the Strategy.  These examples 
illustrate the advantages of “marrying” the 
national and local perspectives, and, indeed, 
the international perspectives in developing 
policy. 
02   An Overview of Cocaine Use in Ireland II:  National 
Advisory Committee on Drugs & National Drugs 
Strategy Team, 2007.
6.31   In the future, the Steering Group considers 
that the combination of local, national 
and international perspectives should be 
utilised, as appropriate, in the planning 
and development of initiatives and in the 
allocation of resources.  For example, in the 
area of treatment and rehabilitation where a 4 
- tier model is to be utilised, the development 
of tier 3 and tier 4 initiatives should normally 
be best taken from a national perspective 
but informed by local input and international 
trends.  Similarly, addressing the needs of 
specific groups (new communities, homeless 
people and others (as outlined in chapter 4) 
would usually involve an integrated national 
approach.  
Mainstreaming 
6.32   A key achievement under the NDS has been 
the development of a range of established 
services in LDTF areas and of newer services 
in RDTF areas.  The original principle was 
to mainstream projects after evaluation to 
the appropriate Department/agency and this 
occurred in respect of the first tranche of 
projects in 200.
6.33   Mainstreaming of a second tranche of projects 
is currently being progressed following the 
evaluation carried out in 2007/08.  It is noted 
that difficulties have arisen in completing the 
transition to mainstreaming, which include 
establishing “best fit”, and concerns about the 
lack of clarity regarding roles, responsibilities 
and funding for mainstreamed projects. 
6.34   The large number of interim projects that 
are currently operating under the Task Force 
structure can also have the effect of diverting 
Task Forces from their broader strategic and 
co - ordinating role in relation to drugs issues 
in their areas of operation. 
6.35   The Steering Group considers it to be 
important to ensure that appropriate agreed 
clinical and organisational governance is put 
in place from the outset with respect to 
the further development of treatment and 
rehabilitation services. Also, future prevention 
should generally be integrated within the 
broader framework of prevention initiatives 
applying at a particular time. 
6.36   Drugs Task Forces, while generally performing 
well, are of the view that they face a number 
of difficulties in optimising their input.  The 
areas of difficulty include:
n	 continuing to improve data for needs analysis 
to  provide a better evidence base;
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n	 inconsistency of responses by Departments 
and statutory agencies;
n	 achieving greater engagement by local 
elected representatives in some areas; and 
n	 Drugs Task Force boundary issues (e.g. the mix 
of DTFs, Local and Regional in Dublin; and the 
geographical area covered by some RDTFs). 
Capacity to deliver services to meet client needs
6.37   A wide range of statutory, voluntary sector and 
community sector organisations are involved 
in delivering the NDS at national, regional 
and local level, with the statutory agencies 
critical in terms of core service provision. 
While the structures are designed to promote 
inter - agency working, and have been largely 
successful, this continues to be a key challenge 
for the NDS. Primary agencies responsible for 
mainstream pillar services have developed their 
individual capacity to deliver services using the 
partnership approach with evident progress 
(as outlined in chapters 2–5). However, there 
is still room for improvement.  For example, 
in regard to treatment and rehabilitation, a 
key aim is to provide a seamless continuum of 
care based on the needs of an individual.  In 
this regard, the Steering Group notes that it is 
important that the NDS continues to progress 
from a service - led model to a client centred 
model of care (incorporating the needs of 
families and communities) over the lifetime of 
the new Strategy. 
Monitoring and evaluation
6.38   Evidence shows that monitoring and 
performance frameworks can be an important 
lever in stimulating implementation 
of policies by putting a sharper focus on 
performance.  While the collection of data 
has advanced considerably in recent years, 
thus providing many of the core elements for 
such frameworks, this work is not sufficiently 
co - ordinated and timely to facilitate the 
effective assessment and monitoring of 
progress.  A performance management 
framework could also be an important lever 
in influencing progress.  Given the range of 
agencies involved in implementing the NDS, 
the Steering Group believes that a developed 
performance management framework would 
be an important tool to aid the focus on 
implementation. 
6.39   In this context, the Group also notes 
that under the EU Action Plan on Drugs 
2009–202, one of the five priority areas 
identified is “Information, Research and 
Evaluation”.  Within this priority, the need to 
further develop instruments to monitor the 
effectiveness of responses to problem drug 
use has been identified as an objective that 
Member States must progress. The need to 
ensure the ongoing evaluation of national 
drugs policies using improved indicators and 
reporting mechanisms is also highlighted.  
6.40   The Steering Group notes that the majority of 
evaluations carried out to date have tended to 
be around processes and outputs achieved by 
individual elements and projects of the NDS, 
rather than assessments of overall outcomes 
being achieved in tackling the drug problem. 
While the former will continue to be an 
important part of the evaluation approach 
into the future, the Steering Group believes 
that there is a need to evaluate services in a 
more comprehensive way that assesses not 
only services being developed and provided 
under the NDS framework, but also closely 
related services provided in the broader 
social inclusion context.  
6.41  Overall, therefore, the Steering Group believes 
that the significant progress to date needs to 
be built upon by strengthening the capacity 
of the current co - ordination structures to 
effectively support the delivery of the new 
NDS.  
CONCluSiONSANDPriOriTieSfOrThe
NewNDS
6.42   As outlined earlier in the chapter, an 
important achievement of the current NDS 
co - ordination structures is that they have 
stimulated and promoted inter - agency 
working in a difficult cross - cutting policy 
and service area.  While recognising the 
importance of maintaining and building 
on this under the new NDS, the Steering 
Group also found that there are capacity and 
structural limitations that are affecting their 
ability to support the implementation of the 
NDS.  
6.43   As a result, the Group believes that a new 
structure will need to:
n	 continue to address the existing and 
emerging needs of problem substance users, 
their families and their communities through 
measurable outputs and outcomes; 
n	 facilitate the Minister of State who is given 
responsibility by Government for the NDS to 
effectively fulfill that role;
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n	 provide the necessary assurances to the 
Secretary General of the Department  of 
Community, Rural & Gaeltacht Affairs, and 
his counterparts in other Departments, in 
regard to their roles as Accounting Officers;
n	 streamline administration;
n	 reflect problem substance use as a global 
issue that must be tackled on a world - wide, 
EU, national and regional/local basis;
n	 facilitate co - ordination across statutory, 
community and voluntary sectors;
n	 build upon the partnership process that is 
already in place; and 
n	 marry the bottom - up approach to a top 
- down perspective to achieve and deliver 
a comprehensive and effective response to 
problem substance use.
6.44   Accordingly, the Steering Group recommends9703 
that an Office of the Minister for Drugs 
(OMD) be established to facilitate greater 
coherence in policy - making and service 
delivery. 
6.45   The new OMD will incorporate the work 
and functions which, under the structures 
of the current NDS was carried out by the 
DSU and the NDST and it will also impact on 
the role of the IDG.  Critically, it will support 
and drive the ongoing implementation of 
the NDS, while respecting the various lead 
roles and statutory responsibilities of the 
Departments/agencies involved.  Overall, 
the Steering Group believes that the OMD, 
by building on the significant achievements 
to date, will provide a more cohesive and 
integrated framework that promotes closer 
co - operation and accountability between 
the different players, as well as greater 
transparency for expenditure.  
6.46   The new Office, and the simplification of the 
overall structural framework, will also provide 
a clear hierarchy and a greater transparency 
of the roles from the Government and Cabinet 
Committee on Social Inclusion, Children & 
Integration to the local project level – see 
Table 6.4 below.  
gOverNmeNT
DrugsTaskforces
minister/Officeof
theminister
forDrugs
CabinetCommitteeonSocialinclusion,
Childrenandintegration
Oversightforum
onDrugs
National
Advisory
Committeeon
Drugs
Table6.4-NationalDrugsStrategy2009-2016OrganisationalStructure
*[Note:  the work of the National Drugs Rehabilitation Implementation Committee will also be closely linked to the OMD]
03  Community sector representatives do not endorse this recommendation.
Statutory
Agencies
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6.47   The new Office will continue to reflect the 
following principles: 
n	 Local responses to local need, based on local 
planning and decision making;
n	 Community representation and involvement;
n	 Partnership between community, voluntary 
and statutory sectors;
n	 Direct linkages between local and national 
structures; and  
n	 Direct linkages between local and national 
policy.  
KeyfeATureSOfTheNewOffiCe
(i) Roles & responsibilities 
6.48   The Steering Group recommends that the 
OMD should have the following key roles and 
responsibilities:
(a) National co - ordination
n	 to advise and support the Minister of State in 
the OMD; 
n	 to co - ordinate the overall implementation 
of the NDS at local, regional and national 
levels;
n	 to ensure effective co - ordination between 
Departments and agencies;
n	 to provide an over - arching cross - sectoral 
framework to address policy development and 
operational issues in relation to the Strategy, 
while respecting the various lead roles and 
statutory responsibilities of Departments/
agencies involved; and 
n	 to ensure the timely and effective input 
of relevant Departments and agencies into 
operational and policy developments, as 
appropriate. 
 (b) Policy Development 
n	 to identify and progress policy issues that 
impact on the implementation of the NDS, 
in the context of the drugs problem being a 
major national challenge, using a partnership 
approach; 
n	 to ensure that policy is informed by the work 
of the Local and Regional Drugs Task Forces, 
the NACD and the NDRIC; 
n	 to take on board key reports and plans 
identified by partner agencies;
n	 to advise the Cabinet Committee on Social 
Inclusion, Children & Integration on critical 
matters of a public policy nature relating to 
the NDS; and 
n	 to identify appropriate matters for 
consideration by the Minister of State for 
submission to Government for decision or 
information, as appropriate. 
(c) Supporting the work of Drugs Task Forces 
n	 to oversee the work of the Local and Regional 
Drugs Task Forces;
n	 to act in a liaison role with the Drugs Task 
Forces and to assist their ongoing work by: 
 q		 drawing up guidelines for the development 
of local/regional action plans; 
 q			evaluating local/regional plans and making 
recommendations regarding funding of 
the plans;
 q			monitoring developments at local/regional 
level to ensure that problems and priorities 
of communities are addressed at national 
level;  
 q		c ontributing to the development of 
government policy on drugs; and 
 q			developing the capacity of Drugs Task 
Force projects.
n	 to ensure effective co - ordination between 
statutory representatives and the community 
& voluntary sectors in the OMD in delivering 
on the objectives of the Task Forces;
n	 to be accountable for the expenditure 
and activities of the projects funded by 
the Department of Community, Rural and 
Gaeltacht Affairs through the Drugs Task 
Force network; and 
n	 to promote and support the process of 
mainstreaming projects to Departments and 
agencies. 
(d) Supporting the work of the NACD 
n	 to support the work of the NACD in the on 
- going implementation of its agreed work 
programme;
n	 to be accountable for expenditure arising 
from that work; and
n	 to widely disseminate information on drugs 
issues and on best practice models.
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(e)   Supporting the community and voluntary 
Sector 
n	 To facilitate and support the engagement of 
the community & voluntary sectors in their 
roles in the NDS.
(f)   International Links
n	 To co - ordinate Ireland’s input to the EU, the 
UN and other international fora regarding 
drugs issues. 
(ii)   Staffing 
6.49   The new Office will be headed by a Director 
and staffed by the Department of Community, 
Rural and Gaeltacht Affairs.  The allocation of 
staff to different areas of work will reflect the 
ongoing role, responsibilities and priorities of 
the new Office that will be developed as part 
of its work programme.  The Steering Group 
recommends that the Director’s post should 
be filled by open competition. 
6.50   The Steering Group acknowledges the 
concerns of some members and of the Drugs 
Task Forces regarding the loss of knowledge 
and experience associated with the closure 
of the NDST.  However, it is also noted 
that detailed transitional arrangements to 
facilitate the smooth transfer of functions 
to the new Office have been drawn up 
by the Department of Community, Rural 
and Gaeltacht Affairs and will be rolled 
out.  These cover a broad range of issues 
covering financial matters, role of the interim 
Advisory Group, liaison with the Drugs Task 
Forces, role of the statutory and community 
& voluntary representatives, progression of 
“live” issues in the NDST workplan, as well as 
day - to - day administrative issues.  
(iii)   Cross - Departmental/Agency and Community 
& Voluntary input 
6.51   Involvement of the statutory sector in co - 
ordination structures has been a key feature 
of the current NDS and reflects their critical 
role in delivering services.  To retain and 
deepen the cross - Departmental input, 
the Steering Group recommends that, as 
currently operates, an officer at AP level (or 
equivalent) should be assigned to the OMD 
on a half - time basis, for a minimum of 3 
years at the outset (subject to the exigencies 
of the Public Service), from:
n			An Garda Síochána; 
n	 Department of Justice, Equality & Law 
Reform; 
n	 Department of Health & Children; 
n	 HSE; 
n	 Department of Education & Science;
n	 FÁS; 
n	 	Department of Environment, Heritage & Local 
Government; and 
n	 Department of the Taoiseach.
It is noted that all of these organisations were 
represented on the NDST.
6.52  In addition, the Steering Group recommends 
that the following organisations should be 
represented in the new Office on a similar 
basis:
n	 	Customs Service of the Office of the Revenue 
Commissioners; 
n	 Department of Social & Family Affairs, through 
the Family Support Agency;
n		 Irish Prison Service; and 
n		 The Probation Service. 
6.53   As part of their role within the OMD, the 
statutory sector representatives will have 
responsibility for driving the implementation 
of the new Strategy, primarily at local and 
regional levels.  They will work with the 
Director and staff of the OMD and protocols 
to reflect their on - going roles will be 
drawn up.  In addition, they will continue to 
work within their parent Departments and 
agencies to seek to positively influence policy, 
programme activity and resource allocation 
in regard to drugs issues.  
6.54 At a more national level - particularly in terms 
of influencing policy and budgets - the Steering 
Group recognises that the representatives will 
need to be strongly supported by their more 
senior Department/agency personnel who 
will be represented on the Oversight Forum 
on Drugs (see paragraphs 6.65 - 6.70).  The 
Steering Group considers that the OFD will 
have an important influencing role with regard 
to the ongoing implementation of the NDS. 
6.55 The community and voluntary sectors have 
played a key role in the current NDS. The 
Group believes that it is vital that the input, 
expertise and participation of these sectors 
be maintained under the new co - ordination 
arrangements.  Accordingly, it is recommended 
that funding at current levels be provided by 
the OMD to support the active participation 
of the two sectors in the work of the Office 
for an initial period of three years.  Protocols 
will be developed in this regard.  The Steering 
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Group notes that support along broadly similar 
lines is provided to community & voluntary 
pillar organisations by the Department of 
Community, Rural and Gaeltacht Affairs to 
support their participation in the Towards	
2016 process.  
6.56 To secure collective commitment for the 
implementation of the NDS, the Steering 
Group recommends that an Advisory Group 
of the OMD, comprising representatives 
of the statutory (including D/CRGA) and 
community & voluntary sectors – as set out 
above - should be established.  The function 
of the Group will be to advise the Minister on 
operational and policy matters relating to the 
NDS.  In this way it is intended that progress 
in advancing the Strategy will be supported, 
and issues and/or blockages arising will be 
identified and addressed. Upon appointment, 
the Director will chair the Group. In the 
interim period, the Minister of State will 
chair the Group which will meet regularly. As 
happens at present, the Minister of State will 
ultimately be the final decision maker. 
6.57   The Steering Group recommends that the 
OMD should consider how best to promote 
service user involvement in the new NDS. 
They further recommend that protocols be 
developed in an appropriate and timely 
manner to support such engagement. 
(iv)  OMD Budget 
6.58 While recognising the importance of the 
independence of the new Office, the 
Steering Group recommends that the budget, 
including the allocations to support the work 
of the Drugs Task Forces, should remain, 
for the time being at least, within the Vote 
of the Department of Community, Rural & 
Gaeltacht Affairs, where it would have a 
separate subhead. 
 (v)  Other key features
6.59In order to strengthen and consolidate the 
role of the new Office - particularly in the 
areas of governance and accountability - the 
Steering Group recommends that: 
n	 an overall performance management 
framework should be developed by the OMD, 
in consultation with relevant Departments 
and agencies to assess and monitor progress 
across the NDS;
n	 a mechanism should be put in place whereby 
relevant Departments and agencies outline 
their proposed budgets for drug - related 
initiatives to the Minister of State, in the 
context of the annual Estimates process.  
 This should be done with a view to ensuring 
that there is appropriate and adequate focus 
on addressing the key priorities in regard to 
problem substance use - as outlined in this 
Strategy - across relevant Departments and 
agencies.  
n	 Departments and agencies should report to 
the OMD on their expenditure, outputs and 
outcomes twice a year, in an agreed format; 
n	 Departments and agencies should incorporate 
their envisaged contribution to the work of 
the NDS in their Statements of Strategy and 
Business Plans and should report on the 
associated outputs and outcomes in their 
Annual Reports; 
n	 Drugs Task Forces should report to the OMD 
for expenditure and activity relating to their 
projects twice a year.  In addition, they should 
produce an annual statement, in an agreed 
format, giving an assessment of the work and 
outputs of their projects – and their broader 
strategic and co - ordinating work - in the 
previous 2 months;  
n	 The OMD should establish on - going liaison 
with Drugs Task Force projects in regard to 
their overall work and activities, as well as 
their channels of funding; and
n	 The OMD should produce (i) an annual report 
of progress of the services and structures 
under its direct influence and (ii) a report of 
the progress of the overall Strategy every two 
years.
6.60  In addition, in order to keep a focus on drug - 
related issues and the broader implementation 
of the NDS, the Group recommends that twice 
a year:
n	 The Minister of State with responsibility for 
the OMD should meet bilaterally with the 
Ministers for Justice, Equality & Law Reform, 
Education & Science, and Health & Children; 
n	 The Minister of State and the OMD Director 
should also meet with: 
 q		the Garda Commissioner; 
 q			the Secretary Generals of the Departments of 
(i) Justice, Equality & Law Reform, (ii) Health 
& Children, (iii) Education & Science, 
 q			the Chairman of the Revenue 
Commissioners; 
 q		the relevant senior official in the HSE;  
 q			the Director General of the Irish Prison 
Service, the Director General of FÁS, the 
Directors of the Probation Service and the 
OMCyA.
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n	 Given the on - going key role of the Drugs 
Task Forces under the new Strategy, it is also 
recommended that the Minister of State and 
the OMD Director should meet with the chairs 
and co - ordinators of the Local & Regional 
Drugs Task Forces at least twice a year; 
n	 Given the key role that rehabilitation will 
play in the new Strategy, the OMD will have 
close and formal links with the work of the 
Senior Rehabilitation Co - ordinator (SRC), 
and will be represented on the National Drug 
Rehabilitation Implementation Committee 
(NDRIC). Accordingly, two meetings a year 
should take place between the Minister of 
State, the OMD Director and the SRC.
n	 The Minister of State and the OMD Director 
should also meet twice a year with: 
 q		 the Chairperson and Director of the 
NACD; and 
 q			representatives of the Family Support 
Network. 
6.61Members of the OMD Advisory Group (as 
outlined above) could also be invited to 
attend these meetings, as appropriate. 
6.62   In addition, the Steering Group recommends 
that:
n	 Drugs should be an agenda item on the 
Cabinet Committee for Social Inclusion, 
Children & Integration at least twice a year – 
following on from the meetings between the 
Minister of State and the relevant Ministers; 
n	 The OMD and the Minister should report 
directly to the Cabinet Committee on 
Social Inclusion, Children & Integration as 
appropriate, and to Government through the 
Minister for Community, Rural & Gaeltacht 
Affairs; 
n	 The OMD Director should have the right to 
attend MAC meetings in the Departments 
of Justice, Equality & Law Reform, Health 
& Children and Education & Science, when 
agenda items in relation to drugs issues are 
being discussed; and
n	 The Director of the OMD should be a 
member of the Senior Officials Group on 
Social Inclusion, Children & Integration.  
6.63The Steering Group believes that liaison 
and interface with the OMCyA is key with 
regard to the development of services for 
young people involved or at risk of becoming 
involved in substance abuse.  This is with a 
view to ensuring that the OMCyA continues 
to address these young people as a priority.  
6.64Furthermore, it is felt that the OMD 
should address the needs of specific at risk 
communities and groups (as identified in 
chapter 4), working with their representative 
fora and/or other services addressing their 
needs and with local/regional input, as 
appropriate. 
rOleOfTheiDgiNTheNewOffiCe
6.65The Inter - Departmental Group on Drugs 
(IDG) has played an important role in the 
formal NDS co - ordination structures in 
securing effective inter - agency working. It 
is currently chaired by the Minister of State 
and the Department of Community, Rural 
& Gaeltacht Affairs provides the secretariat. 
While representation on the Group was 
pitched at Assistant Secretary level, by and 
large this did not happen.  While the Steering 
Group notes that this is a capacity issue 
common to many co - ordinating structures, 
it may have undermined the effectiveness of 
the Group in some NDS areas.
6.66One of its main roles is to resolve emerging 
operational difficulties in implementing 
the NDS.  Its role and composition were 
strengthened arising from the MTR and, in 
this context, the Steering Group believes 
that it has become more valuable in terms of 
monitoring progress of mainline services.
6.67Overall, it is considered that there is merit in 
retaining a group that has an oversight role in 
monitoring the implementation and roll - out 
of the Strategy.   Equally, a group that has the 
power to influence and free up blockages in 
the system is also considered very important 
to the effective functioning of the new Office. 
Accordingly, it is recommended that the IDG 
be re - constituted as the Oversight Forum 
on Drugs (OFD).  The new Forum should 
meet quarterly and its primary role should be 
the high - level monitoring of progress being 
achieved across the Strategy and to agree on 
the appropriate way forward where issues 
are blocked or progress is being impeded. It 
is recommended that the OFD should also 
provide a forum for discussion and feedback 
on issues relating to problem drug use that 
arise in EU and international arenas (see 
paragraphs 6.92 - 6.00).  
6.68The Minister of State will continue to chair 
the OFD and the OMD will provide the 
secretariat.  The aim of having representation 
on the OFD at Assistant Secretary, or 
equivalent, level will continue, particularly 
with a view to maximising the influencing 
role of the group. Again, the community 
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and voluntary sectors will each be given the 
opportunity to nominate a representative 
to the OFD.  The chairperson of the NACD 
should also be a member of the Forum. 
6.69Accordingly, the Steering Group recommends 
that the OFD should have the following terms 
of reference: 
n	 To examine the progress of the NDS 2009 - 
206 across the five pillars of supply reduction, 
prevention, treatment, rehabilitation and 
research in the context of the aims, priorities, 
actions and key performance indicators set 
out therein; 
n	 To address operational difficulties and 
blockages in implementing the NDS and agree 
on appropriate ways forward to overcome 
these difficulties;
n	 To monitor progress on associated mainline 
services with a view to influencing 
outcomes;
n	 To provide any reports on existing actions 
and details/rationale of future plans sought 
by the Minister of State, as chairperson of the 
Forum;  
n	 To consider developments in drugs policies, 
and in dealing with problem drug use 
generally, at EU and international level; and 
n	 To discuss and agree, as far as possible, on 
the approach to drugs issues at the Cabinet 
Committee on Social Inclusion, Children and 
Integration.
6.70The Steering Group also recommends that 
the terms of reference for the OFD should be 
reviewed in the context of the development 
of a National Substance Misuse Policy. 
rOleOfTheNACDiNTheNewOffiCe
6.71As outlined in Chapter 5, the NACD is the 
research arm of the NDS and representatives 
of all the relevant Departments, agencies and 
sectors relating to problem drug use sit on 
the Committee.  Its main function is to advise 
the Government in relation to the prevalence, 
prevention, treatment and consequences of 
problem drug use in Ireland.  The Steering 
Group notes that since early February 2009, 
the NACD Director post has been filled on 
secondment by a Principal Officer from the 
Department of Community, Rural & Gaeltacht 
Affairs. The Group recommends, however, 
that the post should be filled through open 
competition, as soon as possible. 
6.72While the NACD does not play a direct role 
in co - ordinating the implementation of the 
NDS, it is a critical element of the overall 
drugs policy in Ireland and research will 
continue to be a pillar in the new NDS.  
6.73In these circumstances, the Steering 
Group recommends that Director of the 
NACD should be a member of the senior 
management team of the new OMD and 
should, ultimately, report to the Director of 
the OMD.   Independence in regard to the 
research work of the NACD will be fully 
maintained.
6.74While again recognising and stressing 
this independence of the NACD, it is also 
recommended that the Director and staff of 
the NACD should be located in the same 
building as the new OMD.  Having the NACD 
as part of the new Office should also help to 
better address the issue of linkages between 
policy development and research. 
6.75The Steering Group notes that the decision 
to have a National Substance Misuse Strategy 
may have implications for the membership 
and work programme of the NACD.  This is an 
issue that will need to be considered by the 
new Steering Group tasked with developing 
that Strategy. In the meantime, the Group 
recommends that the NACD should 
continue to progress the work programme 
recommended in this Report.  
TheOmDANDTheDrugSTASKfOrCeS
6.76 The Steering Group recognises the key role 
that the Local and Regional Drugs Task Forces 
have played in addressing the drug problem 
in Ireland in recent years. The Group believes 
that the Drugs Task Forces will continue 
to play a strong role in the coming years in 
addressing the drug problem in Ireland and 
they should continue to have a focus on:
n	 monitoring the implementation of projects and 
evaluation with a view to mainstreaming;
n	 preparing updated action plans; 
n	 identifying emerging strategic issues and 
developing proposals on policies or actions 
needed to address them; and 
n	 providing for the implementation of a local/
regional drugs strategy.   
6.77As outlined above, the OMD will continue to 
support the work of the Drugs Task Forces 
and their projects through regular liaison 
and contact, as provided heretofore by the 
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NDST.  In line with the over - arching role 
envisaged for the OMD, the Steering Group 
recommends that Drugs Task Forces should 
report to the Office for the activities, outputs 
and expenditure of projects under their remit 
– as well as for their broader strategic and co 
- ordinating work - on an on - going basis, in 
an agreed manner. Conditions of the funding 
of projects should be such as to ensure co 
- operation from projects in this regard. 
6.78 The Drugs Task Force Co - ordinator will have 
a key role to play in this regard and will be the 
principal point of contact with the OMD.  
6.79 The Steering Group also notes that 
approximately 600 projects are currently in 
place through the Drugs Task Forces. The 
project approach was designed to deliver 
speedy and relevant services to Drugs Task 
Force communities in response to needs at 
a point in time. At this stage, the multiplicity 
of projects has added a layer of reporting 
complexity that needs to be further addressed. 
The Group recommends that the reporting 
and accountability arrangements for projects 
be considered by the OMD as a matter of 
priority, with a view to simplification of the 
reporting arrangements.  
6.80 As outlined earlier in this chapter, difficulties 
exist in the arrangements that are currently 
in place regarding the employment and 
management of Task Force staff.  These 
difficulties impact on governance and on the 
overall effectiveness of the Task Forces.  In 
this context, the Steering Group considered a 
number of options, including:
n	 setting up of Drugs Task Forces as limited 
companies to employ all members of staff;   
n	 development of a single agency - under 
the direction of the OMD – to act as the 
employer for the staff involved; 
n	 where co - ordinator vacancies arise, they 
would be employed in line with other Drugs 
Task Force staff i.e. employed directly by the 
Task Force or by a hosting agency. 
6.81 Overall, the Steering Group has not reached 
a clear consensus on the best way forward 
to address the complex human resource, 
and other, issues involved.  Accordingly, the 
Group recommends that the feasibility of 
achieving the optimum structure for the 
employment arrangements of the Drugs Task 
Force personnel be examined by the OMD 
once it becomes operational over the coming 
months. This examination should feed into the 
development of the new National Substance 
Misuse Strategy and the consideration of the 
appropriate structures for its delivery.  In the 
interim, the Steering Group recommends that 
current employment arrangements should 
remain in place.  
6.82 The Steering Group is also of the view 
that the commitment and participation of 
members of Drugs Task Forces needs to be 
reviewed and renewed given the perceived 
inconsistency of responses by Departments 
and statutory agencies and to achieve greater 
engagement by local elected representatives 
in some areas.
6.83 The Steering Group believes that greater 
engagement by Departments/agencies would 
be achieved by: 
n	 providing suitable inductions for local staff 
to effectively contribute to the work of the 
Drugs Task Forces;  
n	 ensuring representatives have appropriate 
decision making authority; 
n	 bringing relevant information regarding 
developments at local, regional and national 
levels within their organisations that impact 
on progressing actions in the NDS; and  
n	 activating their monitoring role regarding 
Drugs Task Force projects.
6.84 Equally, representatives need to ensure that 
their parent organisations are kept informed 
of developments at Drugs Task Force level 
and how these might impact on their 
agencies. In order to reinforce the principles 
of partnership working and the sharing of 
good practice, the OMD reps from various 
statutory bodies should convene meetings of 
their RDTF and LDTF reps twice annually.
6.85 With respect to elected representatives, 
particularly in RDTF areas, the Steering Group 
considers that these reps should come from 
across the local authority spectrum i.e. city 
and county councils as well as local municipal 
authorities.
6.86 The Steering Group also notes that a handbook 
for the operation of LDTFs was developed in 
2000 and that work on up - dating it for RDTFs 
is being progressed. The handbook outlines 
the roles and responsibilities of all members 
of the Drugs Task Force process, including 
their membership and operational workings. 
It is recommended that the handbook should 
be updated to take account of the new 
structural arrangements proposed in this 
Report.  The Steering Group also recommends 
that guidelines on mainstreaming should be 
included in the handbook.   
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6.87In addition, the Group believes that, in the 
interests of bringing fresh ideas and approaches 
to the work of Drugs Task Forces, the position 
of chairperson should be reviewed every 3 
years.  
DeDiCATeDTreATmeNTAgeNCy
6.88 Treatment and rehabilitation are two of the 
key pillars of the NDS and as well as the 
statutory sector, there are a wide range 
of voluntary and community organisations 
providing services in this area.  This is 
reflected in the substantial funding that is 
being provided annually across all the sectors 
to support the provision of such services. 
6.89 From the perspective of achieving better co 
- ordination and value for money across such 
services, the Steering Group considers that 
the question of the need for/desirability of a 
dedicated treatment agency, along the lines 
of the National Treatment Agency (NTA) 
model used in England and Wales should 
be explored.  Under the NTA, all addiction 
services (excluding those related to prisons 
- although there is strong interaction) are 
funded through the NTA who are charged 
with overseeing and monitoring performance. 
In the main, services continue to be provided 
by the NHS, but with a significant role 
for community & voluntary sectors. A key 
strategic consideration in the setting up of 
the NTA was the fact that treatment of those 
with problem drug use was not sufficiently 
high on the agenda when considered from 
a purely health perspective, whereas it was 
seen as more important when viewed from a 
broader societal perspective.  The NTA has a 
dedicated budget for the provision of services 
throughout England and Wales.  
6.90 Given current financial and other constraints, 
the Steering Group recognises that setting 
up a dedicated treatment agency is not 
likely to be feasible at present.  However, the 
Group recommends that this issue should be 
examined by the OMD within the context of 
the development of the National Substance 
Misuse Strategy. Such an examination 
should also have regard to other examples of 
international best practice, in addition to the 
NTA model.  
6.91 The Steering Group also notes the Report 
of the Office of the Comptroller & Auditor 
General in relation to drug treatment and 
rehabilitation in Ireland, which was published 
in June 2009.  This examination looked at all 
of the main publicly - funded treatment and 
rehabilitation services provided for persons 
with drug problems. It is focused, in the 
main, on service provision in the period 200 
to 2007 and looked at the contribution to 
treatment and rehabilitation services by all of 
the agencies involved, e.g. HSE, Drugs Task 
Forces, the IPS, FÁS and the community & 
voluntary sectors.  
 
rOleOfTheOmDiNrelATiONTO
iNTerNATiONAlCO-OPerATiON
6.92 Drug misuse is an international problem 
and the Steering Group notes that it is vital 
that the national and international aspects 
of it are tackled in a co - ordinated way. 
In this context, the nature of the problem 
calls for regional, international, bilateral and 
multilateral approaches.
6.93 By virtue of its membership of the European 
Union and institutions such as the United 
Nations, Ireland has a number of international 
obligations that must be supported and 
serviced.  Participation in international fora 
should be seen as an opportunity.  On the 
one hand, we have a duty to share our 
experience with our international partners, 
while on the other, Ireland can learn from the 
experiences of many countries, especially 
those with much experience in dealing with 
drugs problems over many years.  Properly co 
- ordinated international co - operation can, 
and will, add value to the new NDS.  
6.94 International co - operation activities in which 
Ireland are engaged aims to:
n	 help the overall efforts to address the drugs 
problem, particularly in the EU, but also 
globally;
n	 achieve a high level of public safety by 
tackling international drug trafficking: 
n	 access information on the initiatives taken 
in other countries with the aim of applying 
potentially effective ideas to our problems at 
home;
n	 share our experiences and the outcome of 
our efforts with others for their benefit; and 
n	 establish contacts and relationships to the 
mutual benefit of different jurisdictions.  
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6.95 The Steering Group notes that officials from 
various Departments represent Ireland at a 
number of fora.  Table 6.5 (below) sets out 
the key groups in this regard: 
6.96 As well as the working groups mentioned 
above, Ireland co - operates internationally 
in many other ways.  A good example of 
multilateral co - operation is the Maritime 
Analysis and Operations Centre - Narcotics – 
MAOC - N.  An Garda Síochána, the Customs 
Service of the Revenue Commissioners, the 
Naval Service and the Department of Justice, 
Equality & Law Reform worked closely with 6 
other countries on its establishment in 2007. 
Currently, a Garda and a Customs Liaison 
Officer are working at the Centre in Lisbon, 
sharing and receiving intelligence and other 
information primarily regarding cocaine being 
shipped into the European Union.  Also, An 
Garda Síochána and the Customs Service 
have a number of Liaison Officers working 
in a number of European cities, as well as at 
Europol and Interpol.
6.97 Revenue’s Customs Service also attend 
first Pillar Precursor related Conferences/
Workshops and various other meetings 
dealing with drugs topics, with representation 
being decided on a case by case basis (e.g. 
meetings dealing with controlled deliveries, 
or with Europol). 
6.98 Ireland fulfils its role in all of these fora in 
an active manner.  However, a lot of the 
activity takes place within the area of work 
of a given Department, with little focus on 
communicating information on the activities 
of various committees, the Irish input being 
made and the outcomes of the deliberations. 
Overall, the Steering Group believes that 
there is much to be gained from better co 
- ordination of the overall Irish effort, more 
sharing of Irish positions on issues and an 
inter - departmental input into strategies for 
important areas. Departments and agencies 
need to co - ordinate more effectively and 
develop national positions in a more timely 
manner on issues arising at the various 
international institutions.  
6.99 In the context of a lead agency for each 
relevant international forum, actual 
participation at individual meetings should 
also relate to the issues being discussed, as 
well as to the Departmental ownership of the 
particular group involved. 
6.100The Steering Group recommends that the 
OMD should take on the lead role in this co 
- ordinating process.  The more hands - on 
co - ordination role of the OMD would not 
affect the primary responsibility of the other 
Departments (and Ministers) in regard to 
their lead areas.  Given that virtually all the 
Table 6.5  - Eu and Other groups & Committees and irish representation
group/Committee Attendedby:
Horizontal Working Party on Drugs (HDG – EU Group) Department of Community, Rural & Gaeltacht Affairs
Department of Justice, Equality & Law Reform 
Department of Foreign Affairs
Department of Health & Children
Commission on Narcotic Drugs (CND - United Nations) Department of Foreign Affairs
Department of Justice, Equality & Law Reform
Department of Health & Children
Department of Community, Rural & Gaeltacht Affairs
European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA – EU Institution based in Lisbon) 
Department of Health & Children (Board Meetings)
EMCDDA National Focal Point: HRB (Alcohol and Drug 
Research Unit) 
The Pompidou Group (and associated Platform Groups)
(Council of Europe Co - operation Group to combat drug 
abuse and drug trafficking)
Department of Health & Children
Health Research Board
Revenue’s Customs Service
Drug Treatment Centre Board
EU National Drugs Coordinators Network Department of Community, Rural & Gaeltacht Affairs
British - Irish Council Intersectoral Group on Drugs
(Chaired by Ireland, this is one of 8 intersectoral groups under 
the East - West dimension of the Good Friday Agreement)  
Department of Community, Rural & Gaeltacht Affairs 
Other Departments and agencies as appropriate
Civil Society Forum on Drugs 
(Set up in 2007 to facilitate the involvement of civil society in 
the implementation and development of the EU Drug Strategy 
and Action Plan.) 
Community & Voluntary Sectors
Multidisciplinary Group (MDG) on Organised Crime
(Council of Europe)
Department of Justice, Equality & Law Reform, 
An Garda Síochána, 
Revenue’s Customs Service
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relevant Departments will be represented in 
the new Office, such co - ordination should be 
easier to achieve and should become an on 
- going feature of their work.  As well as this 
on - going interaction, the new arrangements 
should include:
n	 circulation among relevant Government 
Departments of draft speeches and 
briefings to be presented internationally (for 
observations);
n	 quarterly meetings involving key officials from 
the relevant Departments (or as needs arise);
n	 an annual meeting chaired by the Minister of 
State to plan our broad approach across the 
various issues and fora; and 
n	 more regular up - dates at OFD level (6 
monthly or a needs arising basis).
PriOriTieS
6.101As outlined above, the following key priorities 
have been identified by the Steering Group:
n	 The establishment of an Office of the Minister 
for Drugs to co - ordinate, support and drive 
the on - going implementation of the NDS 
2009 – 206;  
n	 The re - constitution of the Inter - Departmental 
Group on Drugs as the Oversight Forum on 
Drugs with revised terms of reference;
n	 The development of an overall performance 
management framework across all relevant 
Departments and agencies to facilitate the 
effective assessment and monitoring of 
progress;
n	 The renewal of the participation and 
commitment by all sectors to the Drugs Task 
Force process to ensure more effective and 
consistent engagement;
n	 The promotion of more active engagement 
by service users and services working with 
specific identified at risk groups in the design 
and planning of interventions under the 
NDS; 
n	 Building on existing work, the establishment 
of a more co - ordinated approach to fulfilling 
Ireland’s international role and responsibilities 
with respect to problem substance use. 
6.102These issues are returned to in Chapter 7 
where actions in relation to the new Strategy 
are identified.
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7.   NATiONAl drugS 
STrATEgy 2009 – 2016
7.1 In light of the analysis, conclusions and 
priorities identified in chapters  – 6 above, 
the Steering Group recommends that the 
Government adopts the following, objectives, 
key performance indicators and actions across 
the five pillars of supply reduction, prevention, 
treatment, rehabilitation and research. A 
number of recommendations are also made 
in relation to the co - ordination structures, in 
particular, relating to the establishment of a 
dedicated Office of the Minister for Drugs.  In 
total, 63 actions are recommended and these 
are set out below. 
7.2 As outlined in chapter , this Report is an 
interim Strategy pending the development of 
a National Substance Misuse Strategy.  This is 
due to be developed by the end of 200 and 
will incorporate this Report.  
7.3 Departments and agencies will be asked to 
prepare a report by the end of 2009 detailing 
how each of their actions will be implemented 
with indicative timelines.  
OverAllSTrATegiCOBJeCTive
7.4 The overall strategic objective for the National 
Drugs Strategy 2009 – 206 is:
n		 To continue to tackle the harm caused to 
individuals and society by the misuse of 
drugs through a concerted focus on the 
five pillars of supply reduction, prevention, 
treatment, rehabilitation and research. 
OverAllSTrATegiCAimS
7.5 The following are the overall strategic aims of 
the Strategy:
n	 To create a safer society through the reduction 
of the supply and availability of drugs for illicit 
use;
n	 To minimise problem drug use throughout 
society;
n	 To provide appropriate and timely substance 
treatment and rehabilitation services (including 
harm reduction services) tailored to individual 
needs; 
n	 To ensure the availability of accurate, timely, 
relevant and comparable data on the extent 
and nature of problem substance use in 
Ireland; and 
n	 To have in place an efficient and effective 
framework for implementing the National 
Drugs Strategy 2009 – 206.
7.6 Across the 5 pillars, the following objectives 
and key performance indicators are 
recommended: 
SuPPlyreDuCTiON
Objectives 
n	 To significantly reduce the volume of illicit 
drugs available in Ireland; 
n	 To prevent the emergence of new markets 
and the expansion of existing markets for illicit 
drugs; 
n	 To disrupt the activities of organised criminal 
networks involved in the illicit drugs trade in 
Ireland and internationally and to undermine 
the structures supporting such networks; 
n	 To target the income generated through illicit 
drug trafficking and the wealth generated by 
individuals involved in the illicit drugs trade; 
and
n	 To tackle and reduce community drug 
problems through a co - ordinated, inter - 
agency approach. 
Key Performance Indicators 
n	 Increase of 25% in the number of supply 
detection cases by 206, based on 2008 
figures; 
n	 Increase of 25% in the volume of drugs seized 
that are considered to be intended for the Irish 
market by 206, based on 2008 figures; and
n	 Twenty Local Policing Fora established and 
operating by 202. 
PreveNTiON
Objectives
n	 To develop a greater understanding of the 
dangers of problem drug/alcohol use among 
the general population; 
n	 To promote healthier lifestyle choices among 
society generally; and  
n	 To prioritise prevention interventions on those 
in communities who are at particular risk of 
problem drug/alcohol use.
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Key Performance Indicators
n	 Decrease in the number of opiate users in the 
Dublin area and stabilisation of opiate users 
in the rest of the country by 209804;
n	 Stabilisation in recent, and reduction in the 
current, prevalence of illicit drugs in 5 - 34 
year old population (Drug Prevalence Survey 
200/20); 
n	 Reduction in numbers engaged in poly - drug 
use (Drug Prevalence Survey 200/20);
n	 Reduction of the level of drug misuse reported 
by school students (regular survey results and 
ESPAD Survey 20);
n	 Delaying the age of first use of illicit drugs 
(ESPAD Survey 20); 
n	 Delaying the age of first drink and reduction in 
binge drinking among young people (ESPAD, 
National Prevalence Survey, HBSC Surveys); 
and 
n	 Reduction in ESL figures from .5% (2007) to 
0% by 202, utilising the widely recognised 
definition of ‘early school leaver’ used by 
Eurostat9905.   
TreATmeNT&rehABiliTATiON
Objectives
n	 To develop a national integrated treatment 
and rehabilitation service that provides drug 
free and harm reduction approaches for 
problem substance users; and 
n	 To encourage problem substance users to 
engage with, and avail of, such services.
Key Performance Indicators
n	 00% of problem drugs users accessing 
treatment within one month of assessment 
by 202;
n	 00% of problem drugs users aged under 
- 8 accessing treatment within one week of 
assessment by 202;
n	 25% increase in residential rehabilitation 
places by 202, based on 2008 figures; 
n	 25% increase in Hepatitis C cases among 
drug users treated by 202; and
04   The variation in Dublin/rest of country targets arises 
from the point of development of drug prevalence in 
the country now, the increasingly dispersed nature 
of more recent usage and the scale and location of 
treatment & rehabilitation responses developed to 
date.
05   The proportion of persons age 8 to 24 whose highest 
level of education attained is lower secondary or 
below, and who did not receive either formal or non 
- formal education in the previous four weeks.
n	 Put a drugs interventions programme in place 
by 202, incorporating a treatment referral 
option, for people who come to the attention 
of the Gardaí and the Probation Service due 
to behaviour caused by substance misuse.              
reSeArCh
Objectives
n	 To ensure the availability of data to accurately 
inform decisions on initiatives to counteract 
problem substance use; and
n	 To provide appropriate research to fulfil 
the information needs of Government in 
formulating policies to address problem 
substance use. 
Key Performance Indicators
n	 EMCDDA indicators developed on the extent 
and nature of problem drug use in Ireland; 
n	 Comprehensive and timely reporting systems 
in place for:
 q treatment and rehabilitation; and
 q  progression of offenders with drug - related 
offences through the criminal justice 
system
n	 Completion of identified research programme 
by the NACD.
CO-OrDiNATiON
Objectives 
n	 To bring greater coherence to the co - 
ordination of substance misuse policy in 
Ireland across all sectors; and 
n	 To maintain and strengthen partnerships 
with communities to tackle the problems of 
substance misuse. 
Key Performance Indicators
n	 The Office of the Minister for Drugs 
established by mid 2009; and
n	 Development of an overall performance 
management framework by end 200. 
ACTiONPlAN
7.7 The Steering Group recommends a series 
of actions to be taken across the full range 
of Departments and agencies involved in 
delivering drugs policy to ensure that the 
aims and objectives outlined above are met. 
These actions are listed below and their 
implementation will be overseen by the Office 
of the Minister for Drugs, supported by the 
Oversight Forum on Drugs, as appropriate. 
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No Area/Pillar ACTiON Agency
 National Substance 
Misuse Strategy  
Establish a Steering Group in autumn 2009 to develop proposals for an 
overall Substance Misuse Strategy, incorporating the already agreed interim 
National Drugs Strategy   
D/H&C and OMD 
(joint chairs)
SuPPlyreDuCTiON
2 Supply Reduction Establish LPFs in all LDTF areas and other areas experiencing serious and 
concentrated problems of drug misuse 
D/JELR D/EHLG; An 
Garda Síochána (all 3 
sharing lead)
3 Supply Reduction Include drugs issues in a central way in the work of JPCs to ensure that 
there is a concerted effort against drugs in the areas involved.
The issue of drug - related intimidation from the lower level to the most 
serious should be raised at both the JPCs and the LPFs with a view to 
devising appropriate and sustainable local responses to the issue.
D/EHLG (lead); 
D/JELR; Local 
Authorities; An Garda 
Síochána; DTFs
4 Supply Reduction Foster community engagement in areas most affected by the drug problem 
through the establishment and support of appropriate drug networks. 
DTFs; OMD; C&V 
sectors 
5 Supply Reduction Develop a framework to provide an appropriate response to the issue of 
drug - related intimidation in the community.
An Garda Síochána 
(lead); Family Support 
Network; D/JELR
6 Supply Reduction Put in place an integrated system to track the progression of offenders with 
drug - related offences through the criminal justice system
D/JELR (lead); An 
Garda Síochána; The 
Courts Service; Irish 
Prison Service
7 Supply Reduction Develop an initiative to target adults involved in the drugs trade who are 
using young children (some under the legal age of culpability) to engage in 
illegal activities associated with the drug trade.
An Garda Síochána 
8 Supply Reduction Continue to implement increased security procedures in prisons, including 
the development of the drug detection dog service.
Irish Prison Service 
9 Supply Reduction In relation to drugs and driving:
n		 implement random road side drug testing as soon as this is technically 
and legally possible;
n	   review legislation on the issue of driving under the influence of drugs 
and consider appropriate enforcement options;
n	   expand the forensic analysis programme of the Medical Bureau of Road 
Safety to deal with drug driving;
n	   train Gardaí, doctors and nurses in all relevant issues around drugs/
driving; and
n	   introduce detailed examination of full toxicology reports of all drivers 
involved in fatal road traffic accidents to ascertain the level of drug use 
involved.   
D/Transport (lead); 
Road Safety Authority; 
An Garda Síochána; 
HSE; Medical Bureau 
of Road Safety
0 Supply Reduction Engage in appropriate enforcement strategies to ensure compliance with 
the prohibition of the sale of alcohol to persons under 8 years of age.
Further reforms to the licensing laws to combat the sale or supply of 
alcohol to persons under 8 years of age should be considered where they 
are justified by reference to an evidence - based approach. 
An Garda Síochána 
D/JELR
 Supply Reduction Continue to monitor the resources of the Forensic Science Laboratory, to 
ensure that appropriate levels are in place to facilitate timely prosecution of 
offenders, as well as purity/potency testing on seized drugs.
D/JELR 
2 Supply Reduction Contribute to the timely prosecution of drug - related offences by the 
introduction of a presumptive testing regime, in appropriate circumstances. 
D/JELR (lead); An 
Garda Síochána; FSL
3 Supply Reduction Review the current operation and effectiveness of the Drug Court, including 
the exploration of other international models.
D/JELR 
4 Supply Reduction Monitor the activities of headshops, and all businesses involved in the sale 
of psychoactive substances, with the objective of ensuring that no illegal 
activity is undertaken.
Ensure that steps are taken to reform legislation in this respect where it is 
deemed to be appropriate.
D/H&C (lead); 
An Garda Síochána; 
D/JELR; Irish 
Medicines Board; 
D/EHLG; Revenue’s 
Custom Services
5 Supply Reduction Keep drugs - related legislation under continuous review, with particular 
focus on new synthetic substances, new or changed uses of psychoactive 
substances, and against the background of EU and broader international 
experience and best practice.  
D/H&C (lead);  
An Garda Síochána; 
D/JELR; Revenue’s 
Customs Service; Irish 
Medicines Board; 
OMD; C&V sectors
6 Supply Reduction Keep legislation under continuous review to deal with the evolving 
situation in regard to drug precursors, against the background of EU and 
broader international experience and best practice.  
D/H&C (lead); 
Revenue’s Customs 
Service; Irish 
Medicines Board; 
OMD; C&V sectors
99
N
atio
n
al D
ru
gs Strategy  (Interim
) 2009 - 206
No Area/Pillar ACTiON Agency
7 Supply Reduction Continue to work with partners at EU and other international levels to 
intercept drugs, and precursors for diversion to the manufacture of drugs, 
being trafficked to Ireland.
An Garda Síochána; 
Revenue’s Customs 
Service (joint leads); 
D/JELR; D/FA; OMD 
8 Supply Reduction Monitor the volume of drugs seized in the Irish jurisdiction on an annual 
basis as a percentage of total European seizures, based on EMCDDA 
figures.
An Garda Síochána 
(lead); Revenue’s 
Customs Service;  
D/H&C; HRB
PreveNTiON
19 Prevention Develop a framework for the future design of targeted prevention and 
education interventions in relation to drugs and alcohol, using a tiered or 
graduated approach. 
OMD (lead); HSE; 
D/E&S; OMCyA; 
An Garda Síochána; 
DTFs and Service 
Providers
20 Prevention Improve the delivery of SPHE in primary and post - primary schools 
through:
n	 the implementation of the recommendations of the SPHE evaluation in 
post - primary schools; and 
n		the development of a whole school approach to substance use education 
in the context of SPHE.
D/E&S (lead);  
D/H&C; HSE
21 Prevention Ensure that substance use policies are in place in all schools and are 
implemented.
Monitor the effectiveness of the implementation of substance use policies in 
schools through the whole - school evaluation process and the inspectorate 
system and ensure that best practice is disseminated to all schools. 
D/E&S 
22 Prevention Promote the putting in place of substance misuse policies and the 
development of a brief interventions approach, where appropriate, in:
n	 informal education sector; 
n	training centres; 
n	3rd level institutions; 
n	workplaces; and 
n	youth, sport and community organisations.
OMD and all 
other relevant 
Departments/ 
Agencies
23 Prevention Implement SPHE in youthreach Centres of Education and in youth 
Encounter Projects and ensure that substance misuse policies are in place 
in these recognised Centres for Education.
Implement age appropriate substance prevention/awareness programmes 
in training settings, including VTOS and Community Training facilities.
Introduce monitoring and follow - up procedures in relation to substance 
prevention activity in the above settings.
D/E&S (lead); 
FÁS
24 Prevention Co - ordinate the activities and funding of youth interventions in out - of 
- school settings (including the non - formal youth sector) to optimise their 
impact through targeting risk factors, while developing protective factors 
for youth at risk. 
OMCyA
25 Prevention Continue to develop facilities for both the general youth population and 
those most at risk through:
n	  increased access to community, sports and school facilities in out of 
school hours; and 
n	 the development of youth cafés.
OMCyA (lead); 
D/E&S
26 Prevention Implement a uniform set of drugs and alcohol education standards, 
using the DEWF framework being implemented by Drugs Task Forces at 
present.
OMCyA (lead); D/
E&S; HSE
27 Prevention Further develop a national website to provide fully integrated information 
and access to a National Helpline.
HSE (lead) & relevant 
agencies 
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No Area/Pillar ACTiON Agency
28 Prevention Develop a sustained range of awareness campaigns that: 
n	  ensure that local and regional campaigns complement and add value to 
national campaigns; 
n	  optimise the use of ICT in drugs and alcohol awareness initiatives (e.g. 
through internet search engines and social network websites); 
n	   consider a co - ordinated approach by all key players to the development 
and implementation of a designated drug/alcohol awareness week/
day with agreed themes and methodologies;
n	  target:
q	   3rd level educational institutions, workplaces and recreational 
venues; 
q	  at risk groups (Travellers, new communities, LGBTs, homeless people, 
prisoners and, sex workers); and 
q	 education/awareness among drug users to minimise the levels of 
usage and to promote harm reduction measures
HSE (lead); DTFs 
and other relevant 
agencies
29 Prevention Develop a series of prevention measures that focus on the family under the 
following programme headings:
n	 supports for families experiencing difficulties due to drug/alcohol use;
n	 parenting skills; and 
n	 	targeted measures focusing on the children of problem drug and/or 
alcohol users aimed at breaking the cycle and safeguarding the next 
generation
HSE and D/E&S (joint 
leads);
OMCyA; D/SFA;
DTFs and Service 
Providers
30 Prevention Develop selective prevention measures aimed at reducing underage and 
binge drinking.
HSE (lead); D/H&C; 
DTFs and Service 
Providers
31 Prevention Maintain the focus of existing programmes targeting ESL and the retention 
of students in schools.  
Improve the measurement of the outcomes of such programmes in order to 
target and expand them in areas of greatest need.
D/E&S
TreATmeNT&rehABiliTATiON
-DevelopmentofgeneralProblemSubstanceuseServices
32 Treatment & 
Rehabilitation
Develop a comprehensive integrated national treatment and rehabilitation 
service for all substance users using a 4 - tier model approach.  This will 
incorporate:
n	 	the ongoing development of the spread and range of treatment 
services;
n	  the recommendations of the Report of the Working Group on Drugs 
Rehabilitation;  
n	  the recommendations of the Report of the HSE Working Group on 
Residential Treatment & Rehabilitation (Substance Abuse); and 
n	  the provision of access to substance misuse treatment within one month 
of assessment.
HSE 06 (lead); 
Depts and Agencies; 
C&V sectors
33 Treatment & 
Rehabilitation
Maximise operational synergies between Drug Addiction Services, Alcohol 
Treatment & Rehabilitation Services, General and Emergency Hospital 
Services and Mental Health Services.  Within this context, there should be 
a focus on addressing the needs of dual diagnosis clients.
HSE (lead); 
Voluntary sector
34 Treatment & 
Rehabilitation
Expand the availability of, and access to:
n	detox facilities;  
n	methadone services;  
n	under - 8 services; and  
n	needle exchange services 
    where required.
HSE (lead); C&V 
sectors.
35 Treatment & 
Rehabilitation
Review the Methadone Treatment Protocol to maximise the provision 
of treatment, to facilitate appropriate progression pathways (including 
exit from methadone treatment where appropriate) and to encourage 
engagement with services.  The review will include engagement with the 
community and voluntary sectors.
Examine and implement as appropriate, alternative substitute opiate 
treatment services.
HSE (lead);
D/H&C
D/H&C
06  The National Drug Rehabilitation Implementation 
Committee (NDRIC), chaired by the HSE, has a key 
role to play in the delivery of the recommendations 
of the two reports referred to in action 32.
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No Area/Pillar ACTiON Agency
36 Treatment & 
Rehabilitation
Continue to develop and implement across health services the screening/
assessment of people presenting with early indicators of drug and alcohol 
issues, utilising a uniform brief intervention tool, and including referral 
where appropriate.
HSE (Lead); 
C&V sectors
37 Treatment & 
Rehabilitation
Develop and implement a mechanism for early identification, and onward 
referral where appropriate, of substance misuse among under 8 service 
users in the wider statutory, community and voluntary sectors.
OMCyA (lead); 
D/JELR Services (An 
Garda Síochána; IPS; 
The Probation Service) 
D/E&S Services  
(D/E&S, Schools and 
3rd Level Institutions) 
C&V sectors
38 Treatment & 
Rehabilitation
Develop a drugs interventions programme, incorporating a treatment 
referral option, for people (primarily youth and young adults) who come 
to the attention of the Gardaí and the Probation Service, due to behaviour 
caused by substance misuse. 
An Garda Síochána 
(lead); D/JELR (IyJS); 
HSE; Probation 
Service; OMCyA; C&V 
youth Services; OMD
39 Treatment & 
Rehabilitation
Maintain and develop treatment services dealing with Blood Borne Viruses 
(BBVs), with particular emphasis on Hepatitis C treatment services.
HSE
40 Treatment & 
Rehabilitation
Develop a response to drug - related deaths through: 
n	 A National Overdose Prevention Strategy;
n	  A co - ordinated health response to the rise in deaths indirectly related 
to substance abuse; and 
n	 A review of the regulatory framework in relation to prescribed drugs.
HSE (lead); 
D/H&C 
D/H&C(lead); 
Irish Medicines Board
4 Treatment & 
Rehabilitation
Support families trying to cope with substance - related problems, in line 
with the recommendations of the Report of the Working Group on Drugs 
Rehabilitation.
HSE  (lead); 
FSA; Depts and 
Agencies; FSN; DTFs; 
C&V sectors.
42 Treatment & 
Rehabilitation
Continue to develop and expand: 
(i) Service User Fora; and  
(ii) Drug User Fora  
in line with the recommendations of the Report of the Working Group on 
Drugs Rehabilitation.
(i) HSE (lead); 
(ii)OMD; DTFs; C&V 
sectors.
TreATmeNT&rehABiliTATiON
-Specificgroups
43 Treatment & 
Rehabilitation
Continue the expansion of treatment, rehabilitation and other health and 
social services in prisons. 
Develop an agreed protocol for the seamless provision of treatment services 
as a person moves between prison (including prisoners on remand) and 
the community.
IPS (lead); The 
Probation Service; 
HSE; C&V sectors.
44 Treatment & 
Rehabilitation
Address the treatment and rehabilitation needs of:  
n	 Travellers;  
n	 New Communities;  
n	 LGBTs;  
n	 Homeless; and  
n	 Sex Workers 
This should be facilitated by engagement with representatives of those 
communities and/or services working with those groups as appropriate.
HSE (lead); 
C&V sectors.
TreATmeNT&rehABiliTATiON-
qualityandStandardsframework
45 Treatment & 
Rehabilitation
Develop a clinical and organisational governance framework for all 
treatment and rehabilitation services, in line with the Report of the Working 
Group Examining Quality & Standards for Addiction Services, and subject 
to a timeframe for compliance given the resource implications involved.
HSE (lead);
Voluntary sector
46 Treatment & 
Rehabilitation
Develop a regulatory framework on a statutory basis for the provision of 
counselling within substance misuse services.
D/H&C (lead); HSE
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TreATmeNT&rehABiliTATiON
-TrainingandSkillsDevelopment
47 Treatment & 
Rehabilitation
Develop national training standards for all involved in the provision of 
substance misuse services.  
Coordinate training provision within a single national substance misuse 
framework. This will include the continued development of responsive training 
and educational courses and modules for people working in treatment and 
rehabilitation services to meet current and emerging needs.
HSE (lead); 
voluntary sector; 
key academic 
institutions.
48 Treatment & 
Rehabilitation
Develop an appropriate educational model for: 
(i) paramedic (ambulance service) and (ii) nurse and midwife training to 
ensure that those qualifying are familiar with relevant drug treatment issues 
and alternative care pathways.  
Include comprehensive coverage of problem substance issues in 
undergraduate doctor training.
Lead Agencies: 
(i) Pre - Hospital 
Emergency Care 
Council (PHECC)  
(ii) An Bord Altranais  
The Medical Council
reSeArCh/iNfOrmATiON
49 Research/
Information
Continue to implement and develop, as appropriate, the five key EMCDDA 
epidemiological indicators and the associated data collection systems:
(i)   Prevalence and patterns of drug use among the general population 
(this will include the continuation of the Drug Prevalence Survey and 
ESPAD); 
(ii)  Prevalence and patterns of problem drug use; 
(iii)  Demand for drug treatment; 
(iv)  Drug - related deaths and mortality of drug users; and 
(v)  Drug - related infectious diseases
Consider the development of appropriate problem alcohol use 
epidemiological indicators and the associated data collection, building on 
existing monitoring systems and prevalence surveys.
(i) & (ii)NACD (lead)
(iii); (iv) & (v) HRB 
(lead); HSE and other 
relevant Departments 
and agencies
D/H&C (Lead); HSE; 
HRB; NACD.
50 Research/
Information
Develop, in association with the EMCDDA, and implement new indicators 
at national level for the following three areas:
n	 harm reduction;  
n	 public expenditure; and  
n	 drugs and crime.
HRB (lead) and other 
relevant Departments 
and agencies
5 Research/
Information
Monitor problem substance (including alcohol) use among those presenting 
to hospital Emergency Departments.
HSE
52 Research/
Information
Seek to put in place a unique identifier to facilitate the development of 
reporting systems in the health area while respecting the privacy rights of 
the individuals concerned.
D/H&C (lead); other 
relevant Depts and 
Agencies
53 Research/
Information
Implement the recommendations of the Review of the Coroner Service to 
reduce delays in reporting so that information is available on a timely basis 
for the NDRDI.
D/JELR
54 Research/
Information
Consider the further development of systems monitoring changing drug 
trends in line with the EU Early Warning System.
NACD (lead);  
D/JELR; HRB; OMD; 
FSL.
55 Research/
Information
The Minister of State, the OMD and the NACD will develop and prioritise 
a research programme, revised on an annual basis. This would consider the 
following areas, among others, as possibilities for research:
n		Areas of research recommended in the Report of the Working Group on 
Drugs Rehabilitation;
n			Harm reduction approaches, based on an evidence - based approach 
covering developments internationally;
n			Examining the evidence of the effectiveness of the progression of clients 
from substitute maintenance treatments to abstinence;
n			Psychosocial adjustment, and quality of life, of patients on long - term 
methadone maintenance treatment.  
n		Examining the misuse and prolonged use of psychotropic drugs;
n		Factors influencing deaths that are indirectly related to drugs;
n		New developments in treatments for drugs;
n			The impact of alcohol and drugs on the Irish health and justice 
systems;
n		Further research on psychiatric co - morbidity among drug users;
n			Prevalence patterns of problem substance use among prisoners and 
homeless people; and 
n			Examining the feasibility of developing an indicator to monitor changes 
in the prevalence of substance misuse among youth at risk.
NACD (lead); 
OMD 
OMCyA
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56 Research/
Information
Develop a research management framework in regard to problem substance 
use in Ireland. Disseminate research findings and models of best practice. 
NACD (Lead); HRB; 
OMD
CO-OrDiNATiON
57 Co - ordination Establish an Office of the Minister for Drugs with the roles and responsibilities 
outlined in chapter 6.
D/CRGA
58 Co - ordination Establish the Oversight Forum on Drugs (OFD) with the terms of reference 
set out in chapter 6.
D/CRGA
59 Co - ordination Develop an overall performance management framework for the NDS 
across all Departments and Agencies to assess and monitor progress.
OMD
60 Co - ordination Continue to develop engagement with specifically identified at risk groups, 
including:
n		Travellers;  
n		New Communities;  
n		LGBTs;  
n		Homeless; and  
n		Sex Workers 
at the appropriate national/regional/local level in the design and planning 
of interventions under the NDS.
OMD (lead); 
other relevant 
Departments and 
Agencies
6 Co - ordination Develop protocols between relevant Departments and agencies to ensure 
that a more co - ordinated approach is put in place to support Ireland’s 
international role and responsibilities in relation to problem drug use.
OMD (lead); Other 
relevant Departments 
and Agencies
62 Co - ordination Review and renew the participation and commitment of members of the 
Drugs Task Forces. 
Revise the Drugs Task Force Handbook to take account of the new 
structural arrangements. 
Review  Drugs Task Force boundaries.  
Examine the optimum structure for the employment arrangements of 
Drugs Task Force personnel.
OMD (lead);  
other relevant 
Departments and 
Agencies
63 Co - ordination Consider the need for/desirability of a dedicated treatment agency, looking 
at UK and international best practice models.  
OMD (lead);  
other relevant 
Departments and 
Agencies
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glOSSAryOfTermS
Addiction Training Unit ATU
Alcohol and Drug Research Unit ADRU
Assistant Principal AP
Blood Borne Virus BBV
Central Statistics Office CSO
Central Treatment List CTL
Cognitive Behavioural Coping Skills CBCS
Community & Voluntary (Sectors) C&V
Community Childcare Subvention Scheme CCSS
Community Employment CE
Community Policing Fora CPF
Criminal Assets Bureau CAB
Delivering Equality of Opportunity In Schools DEIS
Department of Community, Rural & Gaeltacht Affairs D/CRGA
Department of Education & Science D/E&S
Department of Environment, Heritage & Local Government D/EHLG
Department of Health & Children D/H&C
Department of Justice, Equality & Law Reform D/JELR
Department of Social & Family Affairs D/SFA
Department of Transport D/TRANSPORT
Drug and Alcohol National Occupational Standards DANOS
Drug Education Workers Forum DEWF
Drugs Strategy Unit DSU
Drugs Task Force DTF
Early School Leaving ESL
Economic and Social Research Institute ESRI
Educational Welfare Officer EWO
European Monitoring Centre for Drugs & Drug Addiction EMCDDA
European School Survey Project on Alcohol and other Drugs ESPAD
European Union EU
Foras Áiseanna Saothair FÁS
Forensic Science Laboratory FSL
General Medical Services (Scheme) GMS
General Practitioner GP
Health Behaviour in School - Aged Children survey HBSC
Health Protection Surveillance Centre HPSC
Health Research Board HRB
Health Service Executive HSE
Home School Community Liaison Scheme HSCL
Hospital In - Patient Enquiry HIPE
Human Immunodeficiency Virus HIV
Information and Communications Technology ICT
Intravenous Drug User IDU
Inter - Departmental Group on Drugs IDG
Irish Association of Alcohol and Addiction Counsellors IAAAC
Irish Association of Counselling and Psychotherapy IACP
Irish Business and Employers Confederation IBEC 
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glOSSAryOfTermS
Irish College of General Practitioners ICGP
Irish Council for Psychotherapy ICP
Irish Pharmacy Union IPU
Irish Prison Service IPS
Irish youth Justice Service IyJS
Joint Policing Committees JPC
Key Performance Indicator KPI
Lesbian, Gay, Bisexual, Transgender LGBT
Local Drugs Task Forces LDTFs
Local Policing Fora LPF 
Management Advisory Committee  MAC
Maritime Analysis Operations Centre – Narcotics MAOC - N
Mid - Term Review MTR
National Addiction Training Programme NATP
National Advisory Committee on Drugs NACD
National Drugs Rehabilitation Implementation Committee NDRIC
National Drugs Strategy NDS
National Drugs Strategy Team NDST
National Drug - Related Deaths Index NDRDI
National Drug Treatment Reporting System NDTRS
National Educational Psychological Service NEPS
National Educational Welfare Board NEWB
National Health Service NHS
National Treatment Agency NTA
National University of Ireland, Galway NUIG
Needle Exchange Programme NEP
Non - Government Organisation NGO
Office of the Minister for Children and youth Affairs OMCyA
Office of the Minister for Drugs OMD
Oversight Forum on Drugs OFD
Police Using Leading Systems Effectively PULSE
Quality in Alcohol and Drugs Services QuADS
Quarterly National Household Survey QNHS
Regional Drugs Task Forces RDTFs
Research Outcome Study in Ireland ROSIE
Revitalising Areas by Planning Investment and Development RAPID
School Completion Programme SCP
National Health and Lifestyle Survey SLÁN
Senior Rehabilitation Co - ordinator SRC
Sexually Transmitted Infection STI
Special Projects to assist disadvantaged youth SPy
Social Personal Health Education SPHE
United Nations UN
Vocational Education Committee VEC
World Health Organisation WHO
young Peoples Facilities and Services Fund yPFSF
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AppENdix 1
memBerShiPOfSTeeriNggrOuP
Name Organisation
Kathleen Stack (Chair)
Michael Conroy
Eddie Arthurs
Marie Mc Bride
Department of Community, Rural & Gaeltacht Affairs
Patricia O’Connor  
(Replaced during process by Aoife Davey)
National Drugs Strategy Team
Mairéad Lyons 
(Replaced during process by Dr Eamon Keenan)
National Advisory Committee on Drugs
Fergus McCabe
Martin Hayes
Meetings also attended by:
n  Anna Quigley
Community Sector
Tony Geoghegan
Feidhlim Ó Seasnáin (Replaced during process by 
Brendan Murphy)
Voluntary Sector
John Garry
Meetings also attended by: 
   n  Niall Cullen
   n  Paula Cooney
Department of Justice, Equality & Law Reform
Irish Probation Service
Eamon Corcoran
Meetings also attended by:
   n  Anna - May Harkin
Department of Health & Children
Andrew Duggins  
(Replaced during process by Liam Hughes) 
Meetings also attended by:
   n  John Moloney
Department of Education & Science
Theresa Donohue 
(Replaced during process by Colin Hehir)
Department of Environment, Heritage & Local 
Government
Gretta Crowley
Eddie Matthews
Dr Brion Sweeney
Meetings also attended by:
   n  Liam Keane
   n  Joe Doyle
   n  Alice O’Flynn
Health Service Executive
Barry O’Brien
Colette Quinn
Meetings also attended by:
   n  Joseph O’Connor
   n  Pat Byrne
An Garda Síochána
Michael Colgan Revenue’s Customs Service
Gerard Gasparro
Meetings also attended by:
   n  Miriam Conway
   n  Eamon Carey
FÁS
Pat Murray
(replaced during the process by Donal Landers) 
Meetings also attended by:
   n  Frances Nangle - Connor
Irish Prison Service
Sheila Heffernan Drug Treatment Centre Board
Eddie Darcy youth Council of Ireland
Cathal Morgan Homeless Agency
Jean Long (attended for Research Pillar) Health Research Board
Linda O’Rourke (Secretary) Department of Community, Rural & Gaeltacht Affairs
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wriTTeNSuBmiSSiONSreCeiveD
PersonalSubmissions
Claire Bissett Patrick Morgan
Alan Carmody Pat Mulcahy
John Corr Denis Murray
John Coonan Eamonn Murray
Con Doherty Dolores Nally
Maurice Fitzgerald Kenneth O’Brien
Michael Fox Liam O’Brien
Gary Gomringer Paul O Brien
C.F. Holohan Seán Ó Rallaghaigh
Karen Kelly Darren J. Prior
Sean Lynch Marie Claire Van Hout 
Dr Duncan J Martin Monica Sharpley
David Mc Cabe Helen Stone
Dr Ian McCabe Silvano Taddei
David McCarron Anonymous
Dan McCarthy Mary
May McGilloway Stuart
Mark McGuire            Mary Mc Hugh                               
John Moloney
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OrgANiSATiONS
Addiction Response Crumlin
Alcohol and Drug Research Unit - Health Research Board
Aisling Group
Aislinn Adolescent Addiction Treatment Centre 
Alcohol Action Ireland
Ana Liffey Drug Project
Association For Health Promotion Ireland
Ballyfermot Voluntary Drugs and Alcohol Network
Ballymun LDTF (including Thematic Submission - Dual Diagnosis)
Ballyphehane Action For youth Committee
Barnardos
Beaumont Hospital
Bray Partnership
Canal Communities LDTF
Catholic youth Care (CyC)
Children Acts Advisory Board (CAAB)
Church of Scientology
Clondalkin Addiction Support Programme (CASP)
Clondalkin Drug Task Force
Cobh Community Concern Group
Combat Poverty Agency
Community Awareness of Drugs
Community Sector Submission - Citywide
Health Service Executive - Consultant Psychiatry Group
Coolmine Therapeutic Community
Cornmarket Project, Wexford
County Wexford Community Based Drug initiative
County Wexford Drugs Outreach Services
Crisis Pregnancy Agency
Crosscare Drug & Alcohol 
Department of Arts, Sport and Tourism
Department of Defence
Department of Education & Science
Department of Foreign Affairs
Department of Health & Children and HSE - Joint Submission
Department of Public Health and Primary Care in Trinity College
Donegal Local Development Company Ltd
Drug Education Workers Forum
Drug Policy Action Group
Drug Treatment Centre Board
Drug Treatment Court
Dublin Aids Alliance

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OrgANiSATiONS
Dublin Simon Community
Dublin West Sinn Fein
Dun Laoghaire Rathdown Community Addiction Team (Geraldine Fitzpatrick)
Dun Laoghaire Rathdown County Council (Chris Furlong)
Dun Laoghaire Rathdown County Council (Angela Sweeney)
ECO - UNESCO
Edendery Addressing Substance Misuse (EASA)
Eolach
Exchange House
Family Support Agency
Family Support Network
Fatima Regeneration Board
FDyS youth Work Ireland
Finglas Cabra LDTF
Foroige
Galway Traveller Movement Ltd
Greater Blanchardstown Response to Drugs
Hadd Family Support Group
Harm Reduction Services Group (HRSG)
Headstrong: National youth Mental Health Foundation
Homeless Agency
Hope House Foxford Co. Mayo
Horizon House
HSE Addiction Services (Maura Maye & Caitrona White)
HSE Addiction Services  (Dermot O’Regan)
HSE Addiction Services - GP Co - ordinator Group
HSE Addiction Services Dublin North East
HSE Education Officers Drugs Strategy
Inchicore Community Drug Team
Irish Association of Alcohol & Addiction Counsellors
Irish Bishops’ Drugs Initiative
Irish Pharmacy Union
Irish Prison Service
Irish Rural Link
Jim O’Dwyer - LDTF
Drug Treatment Services (Prisons) HSE (Julian Pugh - Co - ordinator)
Kilbarrack Coast Community Drug Programme 
Kildare youth Services
Lesbian, Gay, Bisexual and Transgender Community
Maigue Cluster
Meath Primary Health Care Project for Travellers
Mid West Drug Education Workers Forum
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OrgANiSATiONS
Midlands RDTF
National Advisory Committee on Drugs
National Drugs Strategy Team
North East Regional Drugs Task Force
North East Voluntary Addiction Service
North Inner City Local Drugs Task Force
NUI Maynooth - Students of Addiction Studies Course
NWRDTF & North West Alcohol Forum
Office of the Revenue Commissioners
Primary Care Safetynet for Homeless People
Progression Routes Initiative
Regional Co - ordinators and Development Workers Network
Rosebud Counselling
South Kerry Community youth Based Initiatives
South Kerry Development Partnership
Students of University of Limerick & HSE Addiction Studies:
Carl O’Rourke & Anne Hanney
Pauline Walsh, Edward O’Shaughnessy & Jerry Scanlan
Eimear Gilchrist
Diarmuid Breatnach
Sandra Heelan & Seamus Nolan
SWAN Family Support
Tallaght LDTF
Teen Challenge
Traveller Organisations
Traveller Visibility Group
UISCE 
Voluntary Drug Treatment Network
Walkinstown Greenhills Resource Centre
West Regional Authority
Wicklow Travellers Group
you’re Equal - Cork Network Group
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AppENdix 3
DeTAilSOfPuBliCCONSulTATiONmeeTiNgS
22nd April 2008 Royal Marine Hotel, Dún Laoghaire
24th April 2008 Hodson Bay Hotel, Athlone
29th April 2008 Hilton Dublin Airport Hotel, Malahide Road, Dublin 7
st May 2008 Ardilaun Hotel, Salthill, Galway
6th May 2008 Ashdown Park Hotel, Gorey
8th May 2008 Plaza Hotel, Tallaght
2th May2008 Clarion Hotel, Sligo
3th May 2008 Hilton Dublin City Hotel, Charlemont Place, Dublin 2
5th May 2008 Heritage Hotel, Portlaoise
9th May 2008 Greenhills Hotel, Limerick
20th May 2008 Fels Point Hotel, Tralee
2st May 2008 Silver Springs Hotel, Cork
22nd May 2008 Woodlands Hotel, Waterford
29th May 2008 Fairways Hotel, Dundalk
3rd June 2008 Croke Park
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AppENdix 4 
CONSulTATiON meeTiNgS wiTh gOverNmeNT DePArTmeNTS AND
STATuTOryAgeNCieS
Meetings took place with the following key Government Departments and Statutory Agencies.  These meetings were 
attended by members of the Steering Group and representatives of PA Consulting Group.  The meetings were broadly 
based upon the same four questions which were asked at the public consultation meetings.
n An Garda Síochána
n Association of County and City Councils
n Association of Municipal Authorities of Ireland
n Department of Education & Science
n Department of Enterprise, Trade Employment & FÁS 
n Department of Environment, Heritage & Local Government
n Department of Health & Children and the Health Service Executive
n Department of Justice, Equality & Law Reform
n Department of Social & Family Affairs / Office of Social Inclusion
n Health Research Board 
n Health Service Executive - Consultant Psychiatrist Group
n Irish Prison Service
n The Probation Service 
n National Advisory Committee on Drugs
n National Drugs Strategy Team
n Office for the Minister of Children and youth Affairs
n Office of the Revenue Commissioners, Customs Division and Drugs Law Enforcement Branch
n The Courts Service
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AppENdix 5
CONSulTATiON meeTiNgS wiTh SeCTOrAl grOuPS, OrgANiSATiONS
ANDfOCuSgrOuPS
Meetings took place with the following Sectoral Groups, Organisations and Focus Groups.  These meetings were 
attended by members of the Steering Group and representatives of PA Consulting Group.  The meetings were broadly 
based upon the same four questions which were asked at the public consultation meetings.
n Alcohol Action Ireland
n Chairs of Local Drugs Task Forces
n Chairs of Regional Drugs Task Forces
n Citywide, Community Sector Nationwide
n Coordinators of Local Drugs Task Forces
n Coordinators of Regional Drugs Task Forces
n Drug Action Policy Group
n Drug Education Workers Forum
n Drug Treatment Centre Board
n Ethnic Minority Groups representatives 
n EATA 
n Family Support Network
n Irish Association of Alcohol and Addiction Counsellors
n Irish College of General Practitioners
n Irish Pharmacy Union
n Irish Traveller Movement/Pavee Point
n Lesbian Gay Bisexual Transgender (LGBT) community (GLEN and Belongto)
n National Voluntary Drug Sector & Voluntary Drug Treatment Network 
n National youth Council of Ireland
n National Homeless Agencies 
n Prisoner Groups
n Ruhama and Chrysalis
n Union for Improved Services Communication and Education (UISCE)
n Walk Tall and SPHE
fOCuSgrOuPS:
n Participants in CE schemes – Kilbarrack
n Homeless agencies
n Residents in Cuan Mhuire
n young people focus group - Neilstown
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AppENdix 6
DeTAilSOflOCAlAND
regiONAlDrugSTASKfOrCeS
Local Drugs Task Forces
BallyfermotlocalDrugsTaskforce
Addiction Services  
Bridge House 
Cherry Orchard Hospital
Ballyfermot
Dublin 0  
Tel: 6206488
Fax: 620640
 
BallymunlocalDrugsTaskforce
Axis Centre 
Main Street 
Ballymun
Dublin 9
Tel: 883242  
Fax: 883244
Blanchardstown localDrugsTaskforce
22a Main Street 
Blanchardstown  
Dublin 5
Tel: 8604845  
Fax: 8604848  
 
Bray localDrugsTaskforce 
Unit 2, First Floor 
24 Florence Road
Bray
Co. Wicklow
Tel: 2762975
Fax: 276294
CanalCommunities localDrugsTaskforce
Addiction Services 
Bridge House 
Cherry Orchard Hospital
Ballyfermot 
Dublin 0
Tel: 620643
Fax: 620640
ClondalkinlocalDrugsTaskforce
Unit 5 
Oakfield 
Clondalkin
Dublin 22
Tel: 4579445
Fax: 4579422
 
CorklocalDrugsTaskforce 
Community Care Offices 
St Finbarrs Hospital  
Douglas Road, Cork
Tel: 02 492332
Fax: 02 492337 
DublinNortheast localDrugsTaskforce
Le Chéile 
Collins Avenue East, 
Donnycarney 
Dublin 5  
Tel: 8465074
Fax: 846507
 
Dublin12localDrugsTaskforce
Addiction Services  
Bridge House 
Cherry Orchard Hospital
Ballyfermot
Dublin 0 
Tel: 6206422
Fax: 620640
Dunlaoghaire/rathdown localDrugsTaskforce
Centenary House 
35 york Road  
Dun Laoghaire
Co. Dublin 
Tel: 2803335 
Fax: 2300690 
finglas/Cabra localDrugsTaskforce 
Tolka Clinic 
2 Broombridge Close
Ballyboggan Road
Dublin   
Tel: 8307440
Fax: 8820330
NorthinnerCity localDrugsTaskforce
22 Lower Buckingham St. 
Dublin 
Tel: 8366592 
Fax: 8366286
SouthinnerCity localDrugsTaskforce
Addiction Services  
Bridge House 
Cherry Orchard Hospital, Ballyfermot
Dublin 0
Tel: 6206438  
Fax: 620640
TallaghtlocalDrugsTaskforce
c/o Dodder Valley Partnership
Killinarden Enterprise Centre 
Tallaght 
Dublin 24
Tel: 4664243
Fax: 4664288  
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Regional Drugs Task Forces:
 
eastCoastregionalDrugsTaskforce
(covering Dun Loaghaire, Rathdown and Wicklow)
st Floor Office         
Morton’s Lane
Wicklow Town
Co Wicklow
Tel: 0404 2004
Fax: 0404 20024
midlandregionalDrugsTaskforce
(covering Laois, Longford, Offaly and Westmeath)
c/o HSE Midland
Unit 4 Central Business Park          
Clonminch
Tullamore
Co Offaly
Tel: 057 935 788
Fax: 057 935 7823
midwestern regionalDrugsTaskforce
(covering Clare, Limerick and Tipperary NR) 
Unit 5  
Steamboat Quay
Dock Road
Limerick
Work: 06 445 392
www.mwrdtf.ie
NortheasternregionalDrugsTaskforce
(covering East Cavan, Louth, Meath and Monaghan)
 Castle Street
Kells
Co Meath
Tel: 046 924 8642
Fax: 046 924 8203
Northwest regionalDrugsTaskforce
(covering Donegal, Leitrim, Sligo and West Cavan)
c/o Health Promotion Department 
Main Street 
Ballyshannon
Donegal 
Tel: 07 985 2000
Fax: 07 985 287
www.nwdrugstaskforce.ie
SouthernregionalDrugsTaskforce
(covering Cork and Kerry) 
c/o Drugs and Alcohol Services
Southern HSE
St Finbarrs Hospital
Douglas Road 
Cork
Tel: 02 492335
Fax: 02 492337 
Southeast regionalDrugsTaskforce
(covering Carlow, Kilkenny, Tipperary SR, Waterford 
and Wexford) 
Farronshoneen youth & Community Centre
Upper Grange
Waterford
Tel:   05 84 44
western regionalDrugsTaskforce
(covering Galway, Mayo and Roscommon)
Unit 6 Galway Technology Park
Parkmore
Galway 
Tel: 09 480 05
www.wrdtf.ie
NorthDublinCity&CountyregionalDrugsTask
force
(covering North Dublin City and Fingal) 
Estuary House
Swords Business Park
Swords
Tel: 83 5583 
www.ndublinrdtf.ie
SouthwestregionalDrugsTaskforce
(covering South Dublin City, South Dublin, Kildare 
and West Wicklow)
Block A
Maudlins Hall
Dublin Road  
Naas
Co. Kildare  
Tel: 045 848538
Fax: 045 848585 
www.swrdtf.ie 
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AppENdix 7
reCOmmeNDATiONS frOm The
rePOrTOfThewOrKiNggrOuPON
DrugSrehABiliTATiON
KEy RECOMMENDATIONS
1.  Rehabilitation can only be delivered effectively 
through an inter - agency approach based on 
a continuum of care that operates within the 
context of enhanced case management and a 
quality standards framework. The development 
of protocols for interagency working, with 
service level agreements between agencies 
and co - ordination by rehabilitation co - 
ordinators, is required. 
2.  An adequate level of treatment provision is 
central to rehabilitation.  An expansion of 
the range of treatment options, including 
an increase in the number of residential 
detoxification beds, for recovering drug users 
is essential.  The HSE led Working Group on 
Residential Treatment/Rehabilitation should 
consider the issue of treatment provision 
and make detailed recommendations in this 
regard. 
3.  The impact of Community Employment 
on rehabilitation should be built upon by 
complementary support and involvement 
from the HSE, the Department of Education 
and Science and relevant agencies to ensure 
that the health and educational needs of 
participants are being properly addressed 
during their period of participation, as well as 
pre and post such participation. 
4.  The housing, childcare, educational and health 
needs and the employment opportunities of 
recovering drug users should be addressed 
through specific initiatives.   
iNTegrATeDrehABiliTATiONServiCe 
RECOMMENDATIONS
1.  The development of protocols, at national 
and local level, to facilitate the level of inter 
- agency co - operation, integration and 
information sharing needed to implement 
shared care plans.  The protocols will cover 
the arrangements for the seamless transition 
of people as they move from the environment 
of one agency to that of another as well as 
issues such as a common understanding of 
confidentiality, common assessment tools, 
tracking and monitoring, how disputes 
between organisations should be settled and 
so on. The protocols will address the sharing 
of information between the agencies, while 
respecting client confidentiality and privacy. 
  The broad national protocols will be developed 
through the National Drugs Rehabilitation 
Implementation Committee and will be 
approved through the Inter - departmental 
Group on Drugs and, at Ministerial level, 
through the Cabinet Committee on Social 
Inclusion.
2.  The local protocols will be agreed by the 
organisations involved in the model at local 
level.  The Treatment and Rehabilitation 
Sub - groups of the Drugs Task Forces, each 
with a rehabilitation co - ordinator among its 
membership, will be responsible for drawing 
up and achieving agreement on these 
protocols under the framework of the broad 
national - level protocol.  The local protocols 
will be approved through the National Drugs 
Rehabilitation Implementation Committee. 
3.  Service Level Agreements (SLAs) will 
be developed in line with the protocols, 
so that there is clarity on the roles and 
responsibilities of each party.  Again this 
will be  done at broad national level as 
well as at local level.  The development 
of the SLAs will be overseen at a national 
level by the National Drugs Rehabilitation 
Implementation Committee and they will be 
approved through the Inter - departmental 
Group on Drugs.   The national level SLAs 
will be reflected in local SLAs.  The local 
SLAs will be agreed by relevant organisations 
directly involved in rehabilitation.  The 
development of these SLAs will be overseen 
by the Rehabilitation Co - ordinators and 
they will be agreed by the Treatment and 
Rehabilitation Sub - groups of the Drugs Task 
Forces before being referred to the National 
Drugs Rehabilitation Implementation 
Committee for final approval.  
4.  The employment and management of 
rehabilitation co - ordinators (including a 
senior rehabilitation co - ordinator) to co - 
ordinate the overall drugs rehabilitation effort 
across the country within the parameters 
outlined above, including the development 
of protocols governing the referral of clients 
between services and facilitating the 
putting in place of SLAs between agencies, 
monitoring case management arrangements 
and facilitating the development of a quality 
standards framework. 
5.  The establishment of a rehabilitation co - 
ordinators network to facilitate building on 
successes and avoiding repetition of failures.
9
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6.  The development of criteria to ensure that all 
State - funded treatment and rehabilitation 
programmes accord with quality standards 
which are to be set out by the National Drugs 
Rehabilitation Implementation Committee in 
conjunction with the HSE (Action 50 of the 
National Drugs Strategy refers).  
7.  The development of national template 
assessment instruments for problem drug 
users at different stages (including initial 
qualification as a problem drug user) of their 
drug use/rehabilitation.
8.  The development of templates for individual 
rehabilitation care plans.
9.  In line with best governance practice, all 
services involved in drugs rehabilitation 
should be subject to a periodic external 
evaluation process.  Provision for this should 
be made in the Service Level Agreements.
10. The nomination of personnel in the HSE 
to fulfil their lead role in relation to case 
management whereby that organisation is 
responsible for ensuring that each person 
is appropriately supported through the 
rehabilitation system.  
11. The nomination of case managers (who can 
be located in the HSE or in the community 
or voluntary sectors) to liaise with all relevant 
agencies to ensure that appropriate services 
ranging from comprehensive assessment 
to appropriate supports are in place for 
each client.  The role of case manager will 
include ensuring that the client’s needs are 
satisfactorily assessed and that, while under 
the management of his/her service, the client 
receives an appropriate range of services 
commensurate with his/her needs. 
12. The development of training structures, 
building on those existing, with appropriate 
accreditation, for case managers and key 
workers in drugs rehabilitation - addressing 
issues such as assessment, case management, 
care planning, training for inter - agency 
working, awareness training in relation to 
the services provided by other organisations 
and accountability. All service provider staff 
should have sufficient training to deliver the 
aspect of rehabilitation for which they are 
responsible. 
13. The provision of appropriate drug related 
training for non - drug specific mainstream 
service personnel who provide rehabilitation 
programmes to problem drug users.
14. As Treatment and Rehabilitation Sub - groups 
of Drugs Task Forces are a key element in the 
rehabilitation effort, every Drug Task Force 
must ensure that it has an effective Sub - 
group in place.
15. An on - going Directory of Service Providers for 
drug treatment and   rehabilitation in Ireland 
should be developed and maintained.
16. The National Drug Treatment Reporting 
System should be developed to provide 
enhanced tracking and monitoring of problem 
drug users as they progress through treatment 
and rehabilitation.  
meDiCAlSuPPOrT
RECOMMENDATIONS
1.  An appropriate level of treatment services 
for problem drug users should be made 
available.  Service providers should discuss 
all treatment options with individual clients, 
including options around detoxification. 
2.  The range of treatment options for recovering 
drug users, particularly counselling and 
therapeutic services, needs to be expanded 
and existing drug specific services should 
be re - orientated with a view to enabling 
a comprehensive drugs service aimed at all 
drugs to be provided.
3.  Clients should be supervised by medical 
personnel during detoxification in all settings 
and should be supported by appropriately 
qualified service providers.
4.  As an interim measure, the number of 
residential detoxification beds provided 
should be increased by 250007 pending the 
outcome of the work of the Working Group 
on Residential Treatment/Rehabilitation008. 
5.  The role of the voluntary sector in the 
provision of detox facilities should be 
reviewed and integrated within an overall 
strategic detox provision.
6.  An increase in the number and geographical 
spread of residential detox places provided by 
the non - statutory voluntary and community 
sectors is required.   This would be organised 
in co - operation with the health services to 
ensure the appropriate level of involvement 
of medical personnel.  The Working Group 
on Residential Treatment/Rehabilitation 
should make detailed recommendations in 
07  From 23 to 48.
08   The Department of Health & Children and the Health 
Service Executive are reserving their position on this 
recommendation pending the completion of the report 
of the Working Group on Residential Treatment/
Rehabilitation in the Context of Addiction.
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this regard, including recommending the 
optimum number and geographical spread of 
such detox facilities.  
7.  The possibility of developing cross Drugs Task 
Forcefacilities should be explored.
8.  The involvement of more local GPs in drug 
treatment should be pursued. GPs should 
be encouraged to support clients through a 
process of detoxification and should facilitate 
the phased withdrawal from methadone 
where opiate users aim for total abstinence 
(Action 56 of the National Drugs Strategy 
refers)0209.  
9.  A concerted effort should be made to increase 
the number of participating pharmacies.  By 
providing services in the community in which 
the problem drug user lives, the pharmacist 
can aid the stabilisation and rehabilitation 
of the problem drug user. Furthermore, 
their involvement in the overall treatment 
programme for the recovering problem drug 
user would facilitate early identification of 
any problems being encountered (Action 56 
of the National Drugs Strategy refers).    
COmmuNiTyemPlOymeNT
RECOMMENDATIONS
1.  The health requirements of CE participants 
should be addressed during their period on 
schemes. This would involve direct involvement 
of the HSE, working in partnership with the 
schemes, in all Drugs Task Force CE Schemes, 
with service level agreements covering such 
issues as counselling, therapeutic support, 
mental health support, as well as general 
health (including dental health) and social 
services.  Such initiatives would support the 
building of confidence and self esteem.
2.  The educational requirements of CE 
participants should be addressed during 
their period on schemes.  This would involve 
direct involvement of the VECs, working in 
partnership with the schemes, in all Drugs 
Task Force CE Schemes, with service level 
agreements covering such issues as numeracy 
and literacy and general educational 
requirements, leading in some cases to re 
- entry to formal education. Again such 
initiatives would support the building of 
confidence and self esteem.
09   Action 56 as revised by the Mid - Term Review of the 
National Drugs Strategy calls for the continuation of 
the increase in the numbers of GPs (particularly level II 
GPs) and pharmacists participating in the methadone 
protocol, particularly in the areas of most need.
3.  The number of drug - specific CE places 
should be increased from ,000 to ,300 to 
provide more opportunities in view of the 
levels of demand and the settling down of 
Regional Drugs Task Forces (Action 74 of 
the National Drugs Strategy refers030). It is 
envisaged that this will be done through an 
increase in the overall number of CE places 
with consequential financial implications.  
4.  Participation on CE Schemes should be 
viewed as a progressive continuum with 
the options of the pre - CE initiative (see 6 
below), Drugs Task Force CE Schemes and 
mainstream CE Schemes being available to 
clients as appropriate.  This would extend, as 
needed, the period of support available.
5.  Links to other appropriate training 
programmes, such as Local Training Initiatives 
(LTI), should be further developed with 
the support of Local Employment Services 
(LES)/Area Based Partnerships to encourage 
progression from CE.
6.  A pre - CE stabilisation initiative, focusing 
on preparation for participation in CE 
programmes, should be developed. Issues to 
be covered will include scope and content.  It 
is envisaged that the duration of any scheme 
should not exceed three months. Entry into 
the pre - CE scheme should follow a joint 
assessment involving HSE treatment services 
and CE providers.
7.  Effective implementation of the Drugs Task 
Force CE schemes as part of an overall 
rehabilitation framework is dependent 
on a clear commitment to the model at 
both management level and local delivery 
level within FÁS.  It is recommended that 
consideration be given to assigning a post 
at appropriate management level within FÁS 
with the specific responsibility of overseeing 
and monitoring the effective implementation 
and delivery of the Drugs Task Force CE 
schemes.
8.  With respect to the Community Service 
Programme for 2007, the issue of provision of 
counselling, educational and back - up services 
should be addressed through engagement 
with the HSE and VECs at a local level as 
projects are developed, or as recovering drug 
users are included in projects. 
0   Action 74 of the National Drugs Strategy calls for an 
increase in the number of training and employment 
opportunities for problem drug users by 30%.
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emPlOymeNT
RECOMMENDATIONS
1.  Access to ongoing support (through the 
national employment services [LES/FÁS] 
personnel in conjunction with relevant case 
managers) should be available to employers 
of former and stabilised drugs users, as well as 
to other employees of the firm/organisation. 
These services would also act as mediator in 
cases where difficulties arise. 
2.  The case manager should act as a support 
for the recovering drug user in employment, 
addressing any issues or difficulties that might 
arise.
3.  Awareness training on the issues associated 
with recovering drug users should be 
developed and made available to prospective 
employers. 
4.  Stronger links with employers, employer 
organisations and Trade Unions need to be 
established to facilitate easier access for 
recovering drug users to the workplace.  The 
Social Partnership Labour Group on Market 
Issues could be a forum that would facilitate 
this.
5.  The potential benefits, including economic 
benefits, of fulfilling corporate social 
responsibility through initiatives, including 
the employment of rehabilitated drug users, 
should be emphasised.
6.  Networks of recovered drug users who are 
now in employment should be established to 
give support to each other and to help, and 
motivate, those who are contemplating the 
move to mainstream employment.
ACCeSSTOeDuCATiON
RECOMMENDATIONS
1.  The barriers for recovering drug users to 
accessing education should be identified and 
removed, where possible.  This would involve 
both systemic barriers (overly restrictive 
criteria for accessing schemes) and support 
barriers to facilitate the availing of schemes 
(fees, transport, childcare etc.)
2.  Linked to  above, it is recommended that an 
“Education Fund for Drugs Rehabilitation” be 
established.  This would (i) allow replacement 
funds be made available to problem drug 
users (in prescribed circumstances) in 
instances where they are not entitled to 
avail of mainstream schemes/grants relating 
to education and training and (ii) provide 
a “helping hand” to recovering drug users 
through providing funding (a) to support 
access to, and continuation with, a variety 
of courses and (b) to contribute towards 
reasonable costs involved
3.  An Outreach approach should be developed 
by VECs to identify adult education needs of 
problem drug users in rehabilitation and to 
develop responses.
hOuSiNg
RECOMMENDATIONS
1.  The specific issues in relation to the accessing 
by problem drug users of emergency, 
transitional and long term accommodation 
should be examined with a view to putting 
in place, at local level, the inter - agency 
procedures necessary to facilitate recovering 
drug users in accessing appropriate 
accommodation and the services necessary 
to ensure that tenancies can be maintained.
2.  Local authorities should liaise with the relevant 
Drugs Task Force with the aim of facilitating 
those recovering drug users who wish to 
return, to or move into, a community.  Local 
Authorities should continue to bear in mind 
the preferences of the applicant in deciding 
on the locality of housing to be allocated, 
especially in view of the fact that returning 
them to their local community may not be the 
most appropriate option in all cases.
3.  Dedicated supported accommodation, 
staffed appropriately, should be provided 
to cater for those who have difficulties with 
an independent living environment.  The 
provision of such accommodation is part of 
the existing homeless strategies and should 
be strengthened as part of the new homeless 
strategy
4.  Building on recent initiatives, the provision 
of transitional/half - way housing for 
recovering drug users should continue tobe 
increased, (for example, through use of the 
Department of Environment, Heritage and 
Local Government Capital Funding Scheme). 
This involves largely independent living, with 
fallback and periodic support available, as 
well as networking with other recovered drug 
users.  The trained care staff required for such 
housing should be supplied by the HSE and 
voluntary providers.
5.  Tenant Liaison Officers and others involved 
in tenant management issues should receive 
training to deal with all aspects of drugs - 
related tenant issues. 
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6.  The Long - Term Housing needs of problem 
drug users, who are capable of independent 
living, should be addressed, for example, 
through the rental accommodation scheme. 
7.  Through the Drugs Task Forces, arrangements 
should be put in place for Local Authorities to 
nominate a contact point to whom matters 
arising in relation to tenancy issues pertaining 
to people in rehabilitation may be directed in 
the first instance.
rehABiliTATiONOfOffeNDerS
RECOMMENDATIONS
1.  Drug treatment and rehabilitation programmes 
should be made available to all problem drug 
users in prison in the context of mandatory 
drugs testing and drug - free prisons (Action 
2204 of the National Drugs Strategy and the 
Irish Prison Service Drugs Policy and Strategy 
‘Keeping Drugs out of Prison’ refer).
2.  Arrangements should be put in place to 
ensure that a continuum of care will be 
available for all problem drug users when they 
leave prison.  These arrangements should be 
robust and flexible enough to ensure that 
those released early, with short notice, or 
those on temporary release, are adequately 
followed up.   
3.  A review of the operation of the Local Prisons 
Liaison Groups, whose current terms of 
reference include the co - ordination of prison 
based drug treatment programmes with 
services and supports available in outside 
communities, should take place. 
   Action 22 of the National Drgus Strategy calls for an 
expansion of prison - based programmes with the aim 
of having treatment and rehabilitation services avail-
able to those who need them including drug treatment 
programmes, which specifically deal with the re - inte-
gration of the drug using offender into the family/com-
munity.
ChilDCAre
reCOmmeNDATiONS
1.  The HSE, in conjunction with the Office of 
the Minister for Children, should decide on 
how best to integrate childcare facilities with 
treatment and rehabilitation services and 
subsequently progress the matter (Action 54 
of the National Drugs Strategy refers052).
2.  An audit of gaps in existing childcare provision 
for children of problem drug users should be 
carried out.  Research may be needed to 
ascertain the number of children with drug 
misusing parents and best practice in relation 
to integrating childcare into treatment and 
rehabilitation services. 
3.  Childcare services for the children of problem 
drug users should adopt an  approach focused 
on the development of the children.
4.  Parenting programmes for problem drug 
users should be further developed and 
implemented taking evidence based best 
practice into account.
rOleOffAmilieS 
iNTherehABiliTATiONPrOCeSS
RECOMMENDATIONS
1.  Service providers should actively encourage 
family participation and reconciliation of 
problem drug users with estranged family 
members (e.g. returning to family home). 
Structured support services may be needed 
in some cases to assist the process. In this 
context, the rights of problem drug users 
who do not want their family involved in the 
recovery process should be respected.
2.  Service providers should be trained to deal 
with families who are trying to cope with the 
drug - related problems of a family member. 
3.  Families should be seen as service users 
in their own right, given that they often 
have a direct role in the recovery process. 
Information, support and advice should be 
made available to parents (and others as 
appropriate) who are coping with a family 
member’s drug misuse.  Family members 
need to be informed in a timely manner 
about the different stages of the recovery 
process.
2   Action 54 of the National Drugs Strategy calls on the 
Health Service Executive to consider, as a matter of 
priority, how best to integrate childcare facilities with 
treatment and rehabilitation centres and how childcare 
can best be provided in a residential treatment setting. 
This action will also be carried out with the Office of 
the Minister for Children. 
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4.  The potential of the involvement of the
family in supporting the recovering drug 
users should be utilised.
5.  A pilot short - stay respite programme for 
families of problem drug users should be 
developed.  Subsequent expansion of the 
initiative would depend on the outcome of 
the evaluation of the pilot.
reSeArCh
RECOMMENDATIONS
1.  Future research and future evaluations of 
service provision should be informed by 
the emerging trends in drug misuse.  Such 
research should focus primarily on (i) the 
outcomes of rehabilitation services and (ii) 
adapting existing services to deal with the 
consequences of new drug trends.
2.  Building on the Research Outcome Study 
in Ireland (ROSIE 063) research should be 
undertaken to examine the outcomes of 
those who have completed methadone 
programmes.
3.  In line with the childcare recommendations in 
this report, research is required to ascertain 
the number of children with drug misusing 
parents, the issues this raises and best 
practice in relation to integrating childcare 
into treatment and rehabilitation services.
4.  Research should be undertaken into 
progression pathways to employment for 
recovering drug users.
3   ROSIE Findings :  Summary of  - year Outcomes 
– National Advisory Committee on Drugs, 2006.
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AppENdix  8
Key iSSueSANDreCOmmeNDATiONS
OfTherePOrTOfThehSewOrKiNg
grOuPONreSiDeNTiAlTreATmeNT&
rehABiliTATiON(SuBSTANCeABuSe)
Key Issues and Recommendations regarding the 
Role of Inpatient Detoxification and Residential 
Rehabilitation 
The concept of the Four Tier Model of Care as the 
framework for the future organisation of alcohol and 
drug services in Ireland is endorsed.
All four Tiers of this model need to be fully resourced 
for the model to be fully effective because one Tier 
cannot be developed or function in isolation from 
other Tiers.
While not all problem alcohol or drug users will require 
Tier 4 (inpatient/residential) services, client outcomes 
are generally recognised as being superior for inpatient 
versus outpatient provision for those whose care plan 
calls for Tier 4 services.
The Four Tier Model of Care implies that clients should 
be offered the least intensive intervention appropriate 
to their need when they present for treatment 
initially. Where this does not succeed, more intensive 
interventions should be offered.
The Working Group highlights the need for a 
standardised assessment protocol which allows for 
the systematic identification of the needs of the client 
ensuring that they are referred to the most appropriate 
treatment modality in the most appropriate setting.
The Group recommends that where inpatient 
detoxification is required, it should be as a rule 
provided in dedicated units. The use of general 
hospital or psychiatric beds for detoxification should 
be the exception since the evidence base indicates 
better outcomes from specialist units.
Attention is drawn to the fact that detoxification of 
itself is not an effective treatment and that it must 
be followed up by post - detoxification psychosocial 
interventions as part of a client - centred rehabilitation 
programme.
The Group emphasises that the transition from 
detoxification from alcohol or any other drug into 
rehabilitation should be seamless so as to avoid waiting 
lists and delays which can result in client relapse. It is 
recognised that in the case of relapse to opiate use, 
there is a major risk of fatal overdoses occurring at this 
time.
Key Issues and Recommendations regarding Existing 
Service Provision 
The Working Group calculated that currently in Ireland 
there are:
n 23 dedicated beds for medical detoxification 
and stabilisation;
n 5 beds for community - based residential 
detoxification;
n 634.5 residential rehabilitation beds, of which, 
a significant proportion (3%) are for the 
treatment of alcohol problems only; and
n 55 step - down/halfway house beds most of 
which (76%) are for men only.
We estimate that currently the equivalent of 3 beds 
are used for detoxification in general hospital settings 
and the equivalent of 66 beds in psychiatric facilities; 
which is not in accordance with best practice.
We recommend that clients with co - morbidity issues 
who are in residential drug and alcohol services 
should be provided with adequate support by the 
mental health services, and that clear pathways into 
residential mental health services for those requiring 
them should be agreed, as outlined in the NACD 
commissioned report on Mental Health and Addiction 
Services and the Management of Dual Diagnosis in 
Ireland (MacGabhann et al., 2004)
We further recommend that there should be flexibility 
to refer people with co - morbidity across catchment 
areas where an appropriate psychiatric service is not 
available in their own catchment area.
The Group recommends that a similar National 
Working Group be established to estimate the current 
capacity of community - based services within Tiers , 
2 and 3 as well as looking at the balance between all 
four Tiers.
The Working Group recommmends that GPs with Level 
Two training be resourced to work within community 
- based residential programmes to provide residential 
detoxification.
The Group also highlights the need to review 
community based or outpatient detoxification services, 
including the role of Level 2 GPs in their provision.
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The Working Group noted that prison provides an 
opportunity for both detoxification and rehabilitation 
and would welcome the extension of the existing 
programmes within Mountjoy prison as well as the 
establishment of similar programmes in all other 
prisons within the State. In this regard there is a 
particular need to integrate alcohol treatment into 
overall programmes within Irish prisons.
The provision of step - down or halfway house 
accommodation for newly–released prisoners who 
have been detoxified or who have started rehabilitation 
programmes is particularly important, not least 
because of the vulnerability of such individuals to 
relapse and overdose.
A mechanism to track progression from treatment 
services to rehabilitation is required. This linkage can 
be achieved by use of an unique identifier which we 
recommend be used for all contacts with drug services 
to enable integrated care planning in line with the 
Rehabilitation Strategy, and so that, with appropriate 
confidentiality procedures, cross referencing can be 
carried out.
We recommend that a regularly updated directory of 
current residential services be made publicly available 
which would detail the programme approach and type 
of service provided.
In preparing the analysis and overview of current 
residential rehabilitation facilities, the Group noted 
the need for an initiative which would examine in - 
depth the configuration of existing services available, 
their programme approach, ethos etc.
Key Issues and Recommendations relating to the 
Assessment of Need for Inpatient Detoxification, 
Stabilisation and Residential Rehabilitation 
There is a need for more refined data on drug and 
alcohol - related problems such as accidents at work, 
absenteeism and drug - related deaths, in order to 
allow the use of more sophisticated needs assessment 
models in future. 
The Working Group based their estimation of need 
for inpatient detoxification and stabilisation services 
on the SCAN Consensus Project (a population - based 
model); the residential rehabilitation requirement was 
based on the transition from inpatient and outpatient 
detoxification to residential treatment; and the 
numbers of adolescents requiring treatment was based 
on population surveys and estimates of problematic 
substance use.
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NOTES
